Target (44)
Compound (608)
Article Title (121)
Assay (226)
sphingosine-1-phosphate, 33P labeled {[(4Z)-2-amino-3-hydroxyoctadec-4-en-1-yl]oxy}phosphonic acid S1P [32P]S1P [33P]S1P BDBM22202 sphingosine-1-phosphate sphingosine-1-phosphate, 32P labeled
(2S,3R)-Sphingosine CHEBI:67106 CHEMBL1835439 BDBM50496601
US10676467, Compound S1P (2S,3R,4E)-2-amino-4-octadecene-1,3-diol 1-(dihydrogen phosphate) (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate BDBM50158348 CHEMBL225155 sphingosine-1-phosphate sphingosine 1-phosphate US11584726, Example S1P
2-Amino-octadec-4-ene-1,3-diol(Sphingosine) BDBM50009730 CHEMBL67166 (E)-2-Amino-octadec-4-ene-1,3-diol
MLS000689021 cid_16187246 1-(1-methylcyclopentyl)-4-(1-methylpiperidin-1-ium-1-yl)-1-phenylbut-2-yn-1-ol;iodide 1-(1-methylcyclopentyl)-4-(1-methylpiperidin-1-ium-1-yl)-1-phenyl-but-2-yn-1-ol;iodide BDBM82762 SMR000286246 1-(1-methylcyclopentyl)-4-(1-methyl-1-piperidin-1-iumyl)-1-phenyl-2-butyn-1-ol;iodide
MLS000737371 cid_246835 1-pyrrolidinohexan-1-one SMR000528284 BDBM66628 1-(1-pyrrolidinyl)-1-hexanone 1-pyrrolidin-1-ylhexan-1-one
US11780852, Example 1-1 US10072026, Example 1-1 US12358931, Example 1-2 BDBM277407 US10947254, Example 1-1
BDBM256622 US9487511, 1 US9718814, 1 US10414761, Example 1 US9920047, 1 US10053456, 1 US10968213, Example 1
US9676783, 1 US8865698, 1 BDBM136584 US10047097, 1 US10005783, 1 US11267818, Example 1 US10774085, Example 1
US8993631, 14-1 US9006249, Example 1-1 US9603819, Example 1-1 BDBM153112
BDBM405553 US10351547, Compound 1-1 US10597377, Compound 1-1
BDBM439600 US10633389, Example 1-1 US20230279020, Example 1-1
US10806724, Example 1-1 US10335399, Example 1-1 BDBM403437
US11110095, Example 1-1 BDBM420036 US10485803, Example 1-1
US11299492, Example 1-1 US11718616, Example 1-1 BDBM549192
US9695183, 1 US9062078, 1 US9475819, 1 US9637496, 1 BDBM163865
PHENCYCLIDINE (Phencyclidine, PCP)1-(1-Phenyl-cyclohexyl)-piperidine 1-(1-Phenyl-cyclohexyl)-piperidine(phencyclidine) 1-(1-phenylcyclohexyl)piperidine 1-(1-Phenyl-cyclohexyl)-piperidine(phencyclidine(PCP)) BDBM50000662 CHEMBL275528 1-(1-Phenyl-cyclohexyl)-piperidine 1-(1-Phenyl-cyclohexyl)-piperidine(PCP) 1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE
1-methyl-1-(2-{[(1-phenylcyclopentyl)carbonyl]oxy}ethyl)piperidinium 1-phenyl-1-cyclopentanecarboxylic acid 2-(1-methyl-1-piperidin-1-iumyl)ethyl ester SMR000306289 1-phenylcyclopentanecarboxylic acid 2-(1-methylpiperidin-1-ium-1-yl)ethyl ester cid_3518900 2-(1-methylpiperidin-1-ium-1-yl)ethyl 1-phenylcyclopentane-1-carboxylate BDBM80454 MLS000727592
US11248006, Compound 1-1-1 BDBM537978
1-[1-(phenylmethyl)piperidin-4-yl]pentan-1-one SMR000038553 cid_657664 1-[1-(phenylmethyl)-4-piperidinyl]-1-pentanone BDBM87386 1-(1-benzyl-4-piperidyl)pentan-1-one 1-(1-benzylpiperidin-4-yl)pentan-1-one MLS000071181
1-(1-adamantyl)ethylurea 1-[1-(1-adamantyl)ethyl]urea MLS000060973 N-[1-(1-adamantyl)ethyl]urea SMR000069201 cid_2835837 BDBM53568
MLS000064468 1-(1-piperidinylsulfonyl)-1H-1,2,3-benzotriazole 1-piperidinosulfonylbenzotriazole BDBM62757 cid_2216937 SMR000078215 1-(1-piperidinylsulfonyl)benzotriazole 1-piperidin-1-ylsulfonylbenzotriazole
MLS001203449 1-(2-Hydroxy-2-phenyl-ethyl)-1-methyl-azepanium 2-(1-methylazepan-1-ium-1-yl)-1-phenyl-ethanol;iodide 2-(1-methylazepan-1-ium-1-yl)-1-phenylethanol;iodide SMR000515666 cid_24746774 2-(1-methyl-1-azepan-1-iumyl)-1-phenylethanol;iodide BDBM61331
MLS001215822 SMR000544780 1-(phenylmethyl)-2-[1-(1-piperidinyl)ethyl]benzimidazole cid_4754707 1-benzyl-2-(1-piperidin-1-ylethyl)benzimidazole BDBM75180 1-benzyl-2-(1-piperidinoethyl)benzimidazole 1-(phenylmethyl)-2-(1-piperidin-1-ylethyl)benzimidazole
BDBM89542 SMR000005367 3-(benzotriazol-1-yl)-1-(4-phenylpiperazin-1-yl)propan-1-one 3-Benzotriazol-1-yl-1-(4-phenyl-piperazin-1-yl)-propan-1-one 3-(1-benzotriazolyl)-1-(4-phenyl-1-piperazinyl)-1-propanone cid_653134 MLS000075694 3-(benzotriazol-1-yl)-1-(4-phenylpiperazino)propan-1-one
BDBM143176 US9994576, 1 US9266895, 1 US8940744, 1 US11040980, Example 1
BDBM172449 US20240307363, Compound 1 US9090625, 1 US9260450, 1 US9938289, 1
US10011604, 1 US9795611, 1 BDBM200573 US10590139, Example 1 US9227975, 1
US11548883, Compound 1 BDBM489291 US10961242, Compound 1 Example 1-1
US9144538, 1'-1- Carbonylimidazole BDBM181135 US9138393, 1'-1- Carbonylimidazole
BDBM222999 US10034864, Example 1 US11207302, Example 1 US9789094, 1 US9320732, 1 US10967060, Example 1 US20240173303, Example 1
1-(1-pyrazolylmethyl)-1-cyclopropanecarboxylic acid 1-(pyrazol-1-ylmethyl)cyclopropane-1-carboxylic acid MLS-0466816.0001 1-(pyrazol-1-ylmethyl)cyclopropanecarboxylic acid BDBM89505 cid_37134560
[2-(1-methylazepan-1-ium-1-yl)-1-phenylethyl] acetate;iodide cid_24761196 BDBM61351 MLS001196933 1-[2-(acetyloxy)-2-phenylethyl]-1-methylazepanium SMR000555824 [2-(1-methylazepan-1-ium-1-yl)-1-phenyl-ethyl] ethanoate;iodide acetic acid [2-(1-methylazepan-1-ium-1-yl)-1-phenyl-ethyl] ester;iodide acetic acid [2-(1-methyl-1-azepan-1-iumyl)-1-phenylethyl] ester;iodide
1-(4-phenoxybutanoyl)piperidine cid_2164024 MLS000534396 4-phenoxy-1-(1-piperidinyl)-1-butanone 4-phenoxy-1-piperidino-butan-1-one SMR000141828 4-phenoxy-1-piperidin-1-ylbutan-1-one 4-phenoxy-1-piperidin-1-yl-butan-1-one BDBM48269
1-(4-methylphenyl)-1-phenyl-3-(1-piperidinyl)-1-propanol;hydrochloride 1-(4-methylphenyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride 1-phenyl-3-piperidino-1-(p-tolyl)propan-1-ol;hydrochloride cid_24761216 BDBM66778 SMR000555811 1-(4-methylphenyl)-1-phenyl-3-piperidin-1-yl-propan-1-ol;hydrochloride MLS001196884
BDBM158073 US9024044, 1 US9655879, 1 US9227949, 1
US9108951, 1 US9394276, 1 BDBM161051 US9725435, 1
US9540388, 1 BDBM174770 US9102686, 1 US10053462, 1
US9820989, 1 US8889870, 1 BDBM139541 US9388176, 1
cid_647179 MLS000029966 1-(phenylmethyl)-3-(1-pyrrolidin-1-ylcarbonylcyclohexyl)urea 1-Benzyl-3-[1-(pyrrolidine-1-carbonyl)-cyclohexyl]-urea 1-benzyl-3-[1-(pyrrolidine-1-carbonyl)cyclohexyl]urea SMR000000429 1-[1-[oxo(1-pyrrolidinyl)methyl]cyclohexyl]-3-(phenylmethyl)urea BDBM31000
cid_807668 SMR000108283 1-(2,3-dihydroindol-1-yl)-4-phenylbutan-1-one MLS000112369 BDBM49319 1-indolin-1-yl-4-phenyl-butan-1-one 1-(2,3-dihydroindol-1-yl)-4-phenyl-1-butanone 1-(2,3-dihydroindol-1-yl)-4-phenyl-butan-1-one
1-[1-(phenylmethyl)-4-triazolyl]-1-cyclohexanol SMR000012946 cid_651657 1-[1-(phenylmethyl)-1,2,3-triazol-4-yl]cyclohexan-1-ol MLS000073429 BDBM59598 1-(1-Benzyl-1H-[1,2,3]triazol-4-yl)-cyclohexanol 1-(1-benzyltriazol-4-yl)cyclohexan-1-ol 1-(1-benzyltriazol-4-yl)cyclohexanol
1-(2-amino-1-benzimidazolyl)-3-phenyl-1-propanone 1-(2-aminobenzimidazol-1-yl)-3-phenyl-propan-1-one MLS000076575 1-(2-Amino-benzoimidazol-1-yl)-3-phenyl-propan-1-one SMR000014251 BDBM39192 1-(2-aminobenzimidazol-1-yl)-3-phenylpropan-1-one cid_647938 1-(2-azanylbenzimidazol-1-yl)-3-phenyl-propan-1-one
BDBM228827 3-Cyclopentyl-1-(pyrrolidin-1-yl)propan-1-one (1)
BDBM614941 D5-1-1-2 US20230271937, Example D5-1-1-2
US10478423, Cpd. 1 US9408850, 1 US9597317, 1 BDBM239009 US10028934, Compound 1
US8735395, 1 US10723709, Example 1 BDBM123097 US11312693, Example 1 US9200006, 1
US9242969, 1 US10245267, Example 1 BDBM202656 US9694016, 1 US10709712, Example 1
US9845333, 1 US8969352, 1 US10183953, Example 1 US9611277, Example 1 BDBM143742
1-(3-pyridin-1-ium-1-ylpropyl)pyridin-1-ium;iodide 1-[3-(1-pyridin-1-iumyl)propyl]pyridin-1-ium;iodide BDBM61357 cid_24761674 MLS001174940 SMR000587876
BDBM50240498 CHEMBL298028 1-[(S)-2-(Pyrrolidine-1-carbonyl)-pyrrolidin-1-yl]-octan-1-one (S)-1-(2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl)octan-1-one
US10392346, Example 1 US9499486, 1 US9751837, Example 1 US10941115, Example 1 US10125100, Example 1 BDBM255476
US11059828, Example 1 US11667644, Example 1 USRE48841, Example 1 US9586962, Example 1 BDBM118348 US8653263, 1
US8791123, 1 US9782415, Example 1 BDBM127628 US10251889, Example 1 US10758542, Example 1 US9796724, Example 1
US9051270, 1 US10087143, Compound 1 US9758483, Compound 1 US11673864, Compound 1 US10738009, Compound 1 BDBM161216
US9688629, 1 BDBM164794 US11623921, Example 1 US9920031, Example 1 US10604504, Example 1 US9802915, Example 1
US9724347, Example 1 BDBM161376 US10238658, Example 1 US9108950, 1 US9993478, Example 1 US10813932, Example 1
cid_3147120 4-Azepan-1-yl-1-phenyl-1-pyridin-3-yl-but-2-yn-1-ol 4-(1-azepanyl)-1-phenyl-1-(3-pyridinyl)-2-butyn-1-ol BDBM90694 4-(azepan-1-yl)-1-phenyl-1-pyridin-3-ylbut-2-yn-1-ol SMR000429453 4-(azepan-1-yl)-1-phenyl-1-(3-pyridyl)but-2-yn-1-ol 4-(azepan-1-yl)-1-phenyl-1-pyridin-3-yl-but-2-yn-1-ol MLS000767122
MLS000734636 3-[1-(1-phenylcyclopropanecarbonyl)-3-piperidyl]-1-[4-(2-pyridyl)piperazino]propan-1-one 3-[1-(1-phenylcyclopropyl)carbonylpiperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one 3-[1-[oxo-(1-phenylcyclopropyl)methyl]-3-piperidinyl]-1-[4-(2-pyridinyl)-1-piperazinyl]-1-propanone 1-(3-{1-[(1-phenylcyclopropyl)carbonyl]piperidin-3-yl}propanoyl)-4-pyridin-2-ylpiperazine BDBM33786 cid_16187317 3-[1-(1-phenylcyclopropanecarbonyl)piperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one SMR000317813
1-(1-adamantyl)tetrazole BDBM40666 1-Adamantan-1-yl-1H-tetrazole MLS000526859 1-(1-adamantyl)-1,2,3,4-tetrazole cid_3143905 SMR000117333
1-(1-naphthalenyl)ethenylphosphonic acid MLS000079039 SMR000038809 1-naphthalen-1-ylethenylphosphonic acid BDBM40948 cid_657859 1-(1-naphthyl)vinylphosphonic acid
BDBM242740 US9422299, 1 US10030025, Compound 1 US10836768, Cpd no 1 US9987274, Compound 1 US11731974, Compound 1 US20240199618, Compound 1
US10640534, Compound 1 US11667673, Compound 1 BDBM363504 US10717764, Compound 1 US9850277, Compound 1 US10689414, Compound 1 US11021515, Compound 1
SMR000317007 3-[1-(cyclohexene-1-carbonyl)-3-piperidyl]-1-[4-(2-pyridyl)piperazino]propan-1-one 3-[1-(cyclohexene-1-carbonyl)piperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one 1-{3-[1-(cyclohex-1-en-1-ylcarbonyl)piperidin-3-yl]propanoyl}-4-pyridin-2-ylpiperazine 3-[1-(cyclohexen-1-ylcarbonyl)piperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one cid_16191146 MLS000735909 3-[1-[1-cyclohexenyl(oxo)methyl]-3-piperidinyl]-1-[4-(2-pyridinyl)-1-piperazinyl]-1-propanone BDBM43154
1-(5,5-dimethyl-3-pyrrolidin-1-ium-1-ylidene-cyclohexen-1-yl)pyrrolidine;iodide 1-[5,5-dimethyl-3-(1-pyrrolidin-1-iumylidene)-1-cyclohexenyl]pyrrolidine;iodide cid_15945020 MLS000391875 1-(5,5-dimethyl-3-pyrrolidin-1-ium-1-ylidenecyclohexen-1-yl)pyrrolidine;iodide BDBM65214 SMR000260908
1-[1-(1-cyclopentyl-5-tetrazolyl)propyl]-4-piperidinecarboxamide cid_3208671 MLS000856668 1-[1-(1-cyclopentyltetrazol-5-yl)propyl]isonipecotamide 1-[1-(1-cyclopentyltetrazol-5-yl)propyl]piperidine-4-carboxamide BDBM73643 SMR000278613 1-[1-(1-cyclopentyl-1,2,3,4-tetrazol-5-yl)propyl]piperidine-4-carboxamide
BDBM44722 cid_3609825 MLS000117076 1-[2-(phenylmethylthio)-4,5-dihydroimidazol-1-yl]-1-propanone 1-[2-(benzylthio)-2-imidazolin-1-yl]propan-1-one 1-(2-benzylsulfanyl-4,5-dihydroimidazol-1-yl)propan-1-one 1-[2-(phenylmethylsulfanyl)-4,5-dihydroimidazol-1-yl]propan-1-one SMR000094030
MLS000517106 1-ethyl-1-naphthalen-1-yl-3-pyridin-3-ylthiourea SMR000343257 BDBM34955 1-ethyl-1-(1-naphthalenyl)-3-(3-pyridinyl)thiourea 1-ethyl-1-(1-naphthyl)-3-(3-pyridyl)thiourea cid_2488324 1-ethyl-1-naphthalen-1-yl-3-pyridin-3-yl-thiourea
cid_15055241 SMR000352410 1-(5,5-dimethyl-3-piperidin-1-ium-1-ylidene-cyclohexen-1-yl)piperidine;iodide BDBM80506 1-[5,5-dimethyl-3-(1-piperidin-1-iumylidene)-1-cyclohexenyl]piperidine;iodide 1-(5,5-dimethyl-3-piperidin-1-ium-1-ylidenecyclohexen-1-yl)piperidine;iodide MLS001007143
(E)-1-(2,5-dimethyl-1-phenyl-pyrrol-3-yl)-3-phenylazanyl-2-pyridin-1-ium-1-yl-3-sulfanylidene-prop-1-en-1-olate (E)-3-anilino-1-(2,5-dimethyl-1-phenyl-pyrrol-3-yl)-2-pyridin-1-ium-1-yl-3-thioxo-prop-1-en-1-olate cid_11834435 (E)-3-anilino-1-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-(1-pyridin-1-iumyl)-3-sulfanylidene-1-propen-1-olate BDBM63047 (E)-3-anilino-1-(2,5-dimethyl-1-phenylpyrrol-3-yl)-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate SMR000155338 MLS000535963
1-(4-bromophenyl)-2-quinolin-1-ium-1-yl-propan-1-one;bromide BDBM79762 1-(4-bromophenyl)-2-quinolin-1-ium-1-ylpropan-1-one;bromide cid_24747090 SMR000514499 MLS001210380 1-[2-(4-Bromo-phenyl)-1-methyl-2-oxo-ethyl]-quinolinium 1-(4-bromophenyl)-2-(1-quinolin-1-iumyl)-1-propanone;bromide
SMR000008714 BDBM48297 3-piperidino-1-p-phenetyl-propan-1-one 1-(4-ethoxyphenyl)-3-(1-piperidinyl)-1-propanone MLS000070479 1-(4-ethoxyphenyl)-3-piperidin-1-yl-propan-1-one cid_114250 1-(4-ethoxyphenyl)-3-piperidin-1-ylpropan-1-one 1-(4-Ethoxy-phenyl)-3-piperidin-1-yl-propan-1-one
1-(3-fluorophenyl)-1-phenyl-4-pyrrolidin-1-yl-but-2-yn-1-ol BDBM43117 1-(3-fluorophenyl)-1-phenyl-4-pyrrolidin-1-ylbut-2-yn-1-ol cid_2915585 1-(3-fluorophenyl)-1-phenyl-4-pyrrolidino-but-2-yn-1-ol 1-(3-fluorophenyl)-1-phenyl-4-(1-pyrrolidinyl)-2-butyn-1-ol SMR000270580 MLS000663971
BDBM104697 US8569311, 1-1
BDBM123152 US8742110, 1-1
BDBM135585 US8846000, 1-1
BDBM148047 US8962608, 1-1
BDBM149490 US8975265, 1-1
BDBM153129 US8993756, 1-1
BDBM173886 US9688645, 1-1
BDBM182286 US9145391, 1-1
BDBM194731 US9670211, 1-1
BDBM213789 US9284317, 1-1
BDBM237713 US9394282, 1-1
BDBM247250 US9447029, 1-1
BDBM257390 US9493441, 1-1
BDBM33300 rhodanine, 1-1
BDBM360661 US9828381, 1-1
US8703761, 1-1 BDBM120753
US8987273, 1-1 BDBM151090
US9278925, 1-1 BDBM220140
US9675539, 1-1 BDBM168294
US9926318, 1-1 BDBM380483
US9943516, 1-1 BDBM388441
BDBM150327 US8987249, 1 US9713606, 1 US10238633, Example 1
BDBM190890 US9181249, 1 US10077266, Example 1 US9708313, 1
Et 1 ET-1 BDBM50289653 Endothelin 1 ENDOTHELIN
US10047086, 1 BDBM103887 US9695168, 1 US10640503, Example 1
US10093697, 1. US10487111, Example 1. US9694018, 1 BDBM76994
US20240101566, Compound 1 BDBM661373 US20240101566, Compound 1-1
US20240174652, Example 1 BDBM677325 US20240174652, Example 1-1
US9346787, 1 BDBM155565 US10092556, Example 1 US9012475, 1
US9346797, 1 BDBM230865 US10603310, Compound 1 US10045974, 1
1-naphthalenesulfonate naphthalene-1-sulfonate alpha-naphthalenesulfonate naphthalene-1-sulfonate(1-) BDBM50029034
BDBM421500 US10538496, Compound 1-1 US10508088, ID HDTK010 US10508088, Example 1-1
US10112937, Example 1 US9464084, 1 US10703749, Example 1 US10150765, Example 1 BDBM254127
US10457647, Example 1 US9512084, 1 US11673868, Example 1 US11180460, Example 1 BDBM259402
US10544126, Example 1 US9475795, 1 BDBM250522 US10167273, Example 1 US11512066, Example 1
US11369599, Compound 1 US9174982, 1 BDBM189455 US20240043404, Example 1 US10213433, Compound 1
4-Naphthalen-1-yl-piperazin-1-ium 1-NP BDBM50007407 1-Naphthalen-1-yl-piperazine CHEMBL277120
BDBM296194 US10953005, Example 1 US10555944, Example 1 US10137124, Example 1 US10172851, Example 1 US10112942, Example 1
BDBM391501 US11702416, Example 1 US11059821, Example 1 US9957268, Example 1 US10781209, Example 1 US10472358, Example 1
US10172845, Example 1 US10881652, Example 1 BDBM304971 US10144734, Example 1 US10441581, Example 1 US11648243, Example 1
US10239868, Entry 1 US10287274, Entry 1 US20240425487, Entry 1 US9802924, Entry 1 US10676464, Entry 1 BDBM352197
US11174244, Compound 1 US10556885, Compound 1 US11673881, Compound 1 US10287267, Compound 1 BDBM385041 US10508099, Compound 1
US11560376, Compound 1 US20230293519, Compound 1 US11419869, Compound 1 BDBM465213 US20230271960, Compound 1 US10793564, Compound 1
US8551978, I-1 BDBM6354 US9572802, Compound I-1 US9394275, I-1 US8816088, 1 US9682957, I-1
1-{[(2R)-3-(benzyloxy)-1-oxo-1-{2H-spiro[1-benzofuran-3,4'-piperidine]-1'-yl}propan-2-yl]carbamoyl}-1-methylethan-1-aminium BDBM50187320
BDBM50187307 1-{[(2R)-3-(benzyloxy)-1-oxo-1-{2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}propan-2-yl]carbamoyl}-1-methylethan-1-aminium
4-(4-acetylphenoxy)-1-(benzotriazol-1-yl)butan-1-one MLS000058058 cid_2087132 1-(benzotriazol-1-yl)-4-(4-ethanoylphenoxy)butan-1-one BDBM59645 4-(4-acetylphenoxy)-1-(1-benzotriazolyl)-1-butanone SMR000067407
MLS000911745 (2R)-2-(1-naphthalenylmethyl)-1-[(1-phenylcyclopropyl)methyl]piperazine cid_23641145 SMR000471520 (2R)-2-(1-naphthylmethyl)-1-[(1-phenylcyclopropyl)methyl]piperazine BDBM78943 (2R)-2-(naphthalen-1-ylmethyl)-1-[(1-phenylcyclopropyl)methyl]piperazine
3-besyl-1-(2-ethylpiperidino)propan-1-one 3-(benzenesulfonyl)-1-(2-ethyl-1-piperidinyl)-1-propanone 3-(benzenesulfonyl)-1-(2-ethylpiperidin-1-yl)propan-1-one SMR000670608 BDBM97257 1-(2-ethylpiperidin-1-yl)-3-(phenylsulfonyl)propan-1-one MLS001162389 cid_6459212
SUAM-1221 BDBM50051539 4-Phenyl-1-[(S)-2-(pyrrolidine-1-carbonyl)-pyrrolidin-1-yl]-butan-1-one 4-Phenyl-1-[2-(pyrrolidine-1-carbonyl)-pyrrolidin-1-yl]-butan-1-one CHEMBL289651 (S)-4-phenyl-1-(2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl)butan-1-one
2-[2-(ethylthio)benzimidazol-1-yl]-1-piperidino-ethanone SMR000012738 2-(2-ethylsulfanylbenzimidazol-1-yl)-1-piperidin-1-ylethanone BDBM41128 2-(2-ethylsulfanylbenzimidazol-1-yl)-1-piperidin-1-yl-ethanone MLS000072568 2-(2-Ethylsulfanyl-benzoimidazol-1-yl)-1-piperidin-1-yl-ethanone 2-[2-(ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone cid_650759
BDBM66234 3-Benzotriazol-1-yl-1-[4-(4-methoxy-phenyl)-piperazin-1-yl]-propan-1-one SMR000005373 cid_655830 3-(1-benzotriazolyl)-1-[4-(4-methoxyphenyl)-1-piperazinyl]-1-propanone 3-(benzotriazol-1-yl)-1-[4-(4-methoxyphenyl)piperazino]propan-1-one 3-(benzotriazol-1-yl)-1-[4-(4-methoxyphenyl)piperazin-1-yl]propan-1-one MLS000030029
1-(3-morpholinoprop-1-ynyl)cyclohexanol 1-(3-morpholin-4-ylprop-1-ynyl)cyclohexanol BDBM69120 1-(3-morpholin-4-ylprop-1-ynyl)cyclohexan-1-ol cid_784919 1-[3-(4-morpholinyl)prop-1-ynyl]-1-cyclohexanol SMR000304810 MLS000722814
4-(1-naphthalenylamino)-1-butanol 4-(naphthalen-1-ylamino)butan-1-ol SMR000011690 BDBM55187 cid_646092 4-(1-naphthylamino)butan-1-ol MLS000072707 4-(Naphthalen-1-ylamino)-butan-1-ol
5-(1-phenoxyethyl)-1-(phenylsulfonyl)pyrazole cid_3799501 1-(benzenesulfonyl)-5-(1-phenoxyethyl)pyrazole 5-(1-phenoxyethyl)-1-(phenylsulfonyl)-1H-pyrazole MLS000327899 1-besyl-5-(1-phenoxyethyl)pyrazole SMR000168440 BDBM77427
MLS000121279 benzotriazol-1-yl(naphthalen-1-yl)methanone SMR000118701 BDBM32680 benzotriazol-1-yl(1-naphthyl)methanone 1-benzotriazolyl(1-naphthalenyl)methanone Benzotriazol-1-yl-naphthalen-1-yl-methanone cid_685693
US20240308995, Example 1-158 US20240308995, Example 1-156 US20240308995, Example 1-154 US20240308995, Example 1-1 US20240308995, Example 1-163 US20240308995, Example 1-162 BDBM696921 US20240308995, Example 1-160
1-methyl-1-{[(2R)-1-oxo-5-phenyl-1-{2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}pentan-2-yl]carbamoyl}ethan-1-aminium BDBM50187312
1-{[(2R)-1-{1,1-dioxo-2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}-1-oxo-5-phenylpentan-2-yl]carbamoyl}-1-methylethan-1-aminium BDBM50187319
BDBM50187306 1-{[(2R)-3-(benzyloxy)-1-{1,1-dioxo-2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}-1-oxopropan-2-yl]carbamoyl}-1-methylethan-1-aminium
BDBM50187314 1-methyl-1-{[(2R)-1-oxo-5-phenyl-1-{2H-spiro[1-benzofuran-3,4'-piperidine]-1'-yl}pentan-2-yl]carbamoyl}ethan-1-aminium
BDBM50187315 1-{[(2R)-1-{1,1-dioxo-2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}-1-oxo-4-phenylbutan-2-yl]carbamoyl}-1-methylethan-1-aminium
BDBM50187335 1-methyl-1-{[(2R)-1-oxo-4-phenyl-1-{2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}butan-2-yl]carbamoyl}ethan-1-aminium
1-[2-(cyclododecyloxy)-2-oxoethyl]-1-methylpyrrolidinium BDBM65276 cid_16188604 cyclododecyl 2-(1-methylpyrrolidin-1-ium-1-yl)acetate;iodide 2-(1-methylpyrrolidin-1-ium-1-yl)acetic acid cyclododecyl ester;iodide cyclododecyl 2-(1-methylpyrrolidin-1-ium-1-yl)ethanoate;iodide SMR000306333 2-(1-methyl-1-pyrrolidin-1-iumyl)acetic acid cyclododecyl ester;iodide MLS000727636
2-[3-[cyclopropyl(oxo)methyl]-1-indolyl]-1-(1-piperidinyl)ethanone BDBM71639 MLS000033892 2-(3-Cyclopropanecarbonyl-indol-1-yl)-1-piperidin-1-yl-ethanone 2-(3-cyclopropylcarbonylindol-1-yl)-1-piperidin-1-yl-ethanone 2-[3-(cyclopropanecarbonyl)indol-1-yl]-1-piperidin-1-ylethanone 2-[3-(cyclopropanecarbonyl)indol-1-yl]-1-piperidino-ethanone SMR000014345 cid_649076
3-methyl-1-[4-(4-phenyl-1-piperazinyl)-1-piperidinyl]-1-butanone 3-methyl-1-[4-(4-phenylpiperazino)piperidino]butan-1-one cid_948802 MLS000556254 SMR000147571 3-methyl-1-[4-(4-phenylpiperazin-1-yl)piperidin-1-yl]butan-1-one BDBM48645 3-Methyl-1-[4-(4-phenyl-piperazin-1-yl)-piperidin-1-yl]-butan-1-one
BDBM292104 US10183942, Example 1-8 US11299492, Example 1 US11718616, Example 1 US10526330, Example 1 US10100049, Example 1 US10913740, Example 1-8
cid_2997879 BDBM80514 MLS000879903 1-(5,5-dimethyl-3-pyrrolidin-1-ium-1-ylidene-cyclohexen-1-yl)-4-phenyl-piperazine;iodide 1-[5,5-dimethyl-3-(1-pyrrolidin-1-iumylidene)-1-cyclohexenyl]-4-phenylpiperazine;iodide SMR000065668 1-(5,5-dimethyl-3-pyrrolidin-1-ium-1-ylidenecyclohexen-1-yl)-4-phenylpiperazine;iodide
cid_653801 1-benzyl-3-[1-(4-phenylpiperazine-1-carbonyl)cyclohexyl]urea 1-(phenylmethyl)-3-[1-(4-phenylpiperazin-1-yl)carbonylcyclohexyl]urea 1-[1-[oxo-(4-phenyl-1-piperazinyl)methyl]cyclohexyl]-3-(phenylmethyl)urea BDBM59255 1-Benzyl-3-[1-(4-phenyl-piperazine-1-carbonyl)-cyclohexyl]-urea MLS000027834 SMR000000431
1-(1-phenylpropoxy)-3-piperidino-propan-2-ol;hydrochloride SMR000641026 1-(1-phenylpropoxy)-3-piperidin-1-ylpropan-2-ol;hydrochloride 1-(1-phenylpropoxy)-3-piperidin-1-yl-propan-2-ol;hydrochloride 1-(1-phenylpropoxy)-3-(1-piperidinyl)-2-propanol;hydrochloride cid_16807026 MLS001167170 BDBM69875
SMR000294542 1-[1-(1-adamantyl)butyl]-3-(oxolan-2-ylmethyl)thiourea N-[1-(1-adamantyl)butyl]-N'-(tetrahydro-2-furanylmethyl)thiourea 1-[1-(1-adamantyl)butyl]-3-(2-oxolanylmethyl)thiourea 1-[1-(1-adamantyl)butyl]-3-(tetrahydrofurfuryl)thiourea MLS000665871 BDBM57850 cid_2957716
cid_675984 2-(1-bromonaphthalen-2-yl)oxy-1-piperidin-1-ylethanone MLS001035339 SMR000664549 2-(1-bromanylnaphthalen-2-yl)oxy-1-piperidin-1-yl-ethanone 2-(1-bromo-2-naphthoxy)-1-piperidino-ethanone BDBM75685 2-[(1-bromo-2-naphthalenyl)oxy]-1-(1-piperidinyl)ethanone
1-PIM BDBM7886 US9138393, 1-Phenyl- imidazole US9144538, 1-Phenylimidazole CHEMBL275066 1-phenyl-1H-imidazole 1-phenylimidazole
BDBM614933 B4-1-1-2 US20230271937, Example B4-1-2-2 US20230271937, Example B4-1-1-2
4-methyl-2-[1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)butan-2-yl]-[1]benzothiolo[2,3-d]pyridazin-1-one SMR000626147 4-methyl-2-[1-oxidanylidene-1-(4-piperidin-1-ylpiperidin-1-yl)butan-2-yl]-[1]benzothiolo[2,3-d]pyridazin-1-one BDBM58548 4-methyl-2-[1-(4-piperidinopiperidine-1-carbonyl)propyl]benzothiopheno[2,3-d]pyridazin-1-one cid_22514112 4-methyl-2-[1-oxo-1-[4-(1-piperidinyl)-1-piperidinyl]butan-2-yl]-[1]benzothiolo[2,3-d]pyridazin-1-one MLS001115823
1-[1-(benzenesulfonyl)indol-3-yl]ethanone SMR000231760 MLS000704562 BDBM78674 1-[1-(phenylsulfonyl)-1H-indol-3-yl]ethanone cid_848535 1-(1-besylindol-3-yl)ethanone 1-[1-(benzenesulfonyl)-3-indolyl]ethanone 1-[1-(phenylsulfonyl)indol-3-yl]ethanone
cid_6182704 MLS000568512 (E)-1-(2-bromophenyl)-3-(2-furanylmethylamino)-2-(1-pyridin-1-iumyl)-3-sulfanylidene-1-propen-1-olate (E)-1-(2-bromophenyl)-3-(furan-2-ylmethylamino)-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate (E)-1-(2-bromophenyl)-3-(2-furfurylamino)-2-pyridin-1-ium-1-yl-3-thioxo-prop-1-en-1-olate (E)-1-(2-bromophenyl)-3-(furan-2-ylmethylamino)-2-pyridin-1-ium-1-yl-3-sulfanylidene-prop-1-en-1-olate BDBM52312 SMR000154634
1-(2'-hydroxyphenyl)-3-(1-naphthyl)-2-propen-1-one CHEMBL487051 (2E)-1-(2'-Hydroxyphenyl)-3-(1-naphtyl)-2-propen-1-one BDBM50246224 (2E)-1-(2'-hydroxyphenyl)-3-(1-naphthyl)-2-propen-1-one
1-(3-hexadecyl-1-imidazol-1-iumyl)-2-propanone;bromide cid_16187389 1-(3-cetylimidazol-1-ium-1-yl)acetone;bromide SMR000279526 MLS000717958 1-(3-hexadecylimidazol-1-ium-1-yl)propan-2-one;bromide BDBM48773
3-[1-(1-Phenyl-ethyl)-1H-benzoimidazol-2-yl]-propan-1-ol 3-[1-(1-phenylethyl)-2-benzimidazolyl]-1-propanol cid_2896825 SMR000518659 3-[1-(1-phenylethyl)benzimidazol-2-yl]propan-1-ol BDBM66701 MLS001207704
1-(1'-Methyl-[4,4']bipiperidinyl-1-yl)-heptadecan-1-one; hydrochloride BDBM50174644 CHEMBL535605
BDBM182055 US9145391, 1-26 US9145391, 1-24 US9145391, 1-25 US9145391, 1-23
BDBM331846 US10189849, Compound 1 US10927120, Compound 1 US10696682, Compound 1 US9957276, Compound 1
BDBM384287 US10590114, No. 1 US11591316, Compound 1 US11111235, No. 1 US9932325, Example 1
BDBM391405 US9957265, 1-59 US9957265, 1-58 US9957265, 1-19 US9957265, 1-18
BDBM396939 US9981975, Example 1 US11591338, Example 1 US10442810, Example 1 US10844069, Example 1
BDBM404342 US10343992, Example 1 US10689345, Example 1 US11066365, Example 1 US11053198, Example 1
BDBM418433 US10457677, Example 1 US10745399, Example 1 US10975075, Example 1 US11608338, Example 1
BDBM50081195 US10065961, Compound 1 US10941151, Compound 1 CHEMBL3422010 US10683295, Compound 1 US9475814, 1
CHEMBL537414 BDBM50174663 1-(1'-Methyl-[4,4']bipiperidinyl-1-yl)-pentadecan-1-one; hydrochloride
US10391089, Compound 1 US9675614, 1 BDBM176815 US10980794, Cmpd No 1 US10307413, Compound 1
US10428087, Example 1 US11401280, Example 1 BDBM394282 US9975907, Example 1 US10829502, Example 1
US10479794, Example 1 US10875867, Example 1 BDBM284710 US10023575, Example 1 US11691977, Example 1
US11129828, Example 1 US9290456, 1 US10463663, Example 1 US9931340, Example 1 CHEMBL2338786 BDBM50431078
US11236096, Example 1 US11014930, Example 1 US10233189, Example 1 US10787457, Example 1 BDBM370340
US20250223270, Example 1 US10889555, Example 1 BDBM477236 US11634395, Example 1 US12344588, Example 1
US9908895, Example 1 US9777017, Example 1 BDBM344017 US10370387, Example 1 US11161855, Example 1
US9957265, 1-46 US9957265, 1-49 US9957265, 1-48 US9957265, 1-47 BDBM391433
US9957265, 1-89 US9957265, 1-88 US9957265, 1-87 BDBM391473 US9957265, 1-86
cid_2859675 2-methyl-1-(1-naphthylmethyl)-1H-imidazole 2-methyl-1-(1-naphthylmethyl)imidazole 2-methyl-1-(1-naphthalenylmethyl)imidazole SMR000140605 MLS000533167 BDBM63019 2-methyl-1-(naphthalen-1-ylmethyl)imidazole
1-oxido-4-pyridin-1-iumcarboxylic acid 3-[(1-oxido-4-pyridin-1-iumyl)-oxomethoxy]propyl ester SMR000687983 3-(1-oxidanidylpyridin-1-ium-4-yl)carbonyloxypropyl 1-oxidanidylpyridin-1-ium-4-carboxylate 3-(1-oxidopyridin-1-ium-4-carbonyl)oxypropyl 1-oxidopyridin-1-ium-4-carboxylate cid_8895388 1-oxidopyridin-1-ium-4-carboxylic acid 3-(1-oxidopyridin-1-ium-4-carbonyl)oxypropyl ester MLS001150191 BDBM70098
cid_16196375 1-benzhydryl-4-(5,5-dimethyl-3-piperidin-1-ium-1-ylidenecyclohexen-1-yl)piperazine;iodide BDBM55833 MLS001032863 1-benzhydryl-4-(5,5-dimethyl-3-piperidin-1-ium-1-ylidene-cyclohexen-1-yl)piperazine;iodide SMR000363502 1-(5,5-dimethyl-3-piperidin-1-ium-1-ylidene-cyclohexen-1-yl)-4-(diphenylmethyl)piperazine;iodide 1-[5,5-dimethyl-3-(1-piperidin-1-iumylidene)-1-cyclohexenyl]-4-(diphenylmethyl)piperazine;iodide
1-[4-(2,5-dimethylphenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-yl-propan-1-one 1-[4-(2,5-dimethylphenyl)-1-piperazinyl]-3-phenyl-2-(1-pyrrolyl)-1-propanone SMR000127923 BDBM48648 MLS000522656 1-[4-(2,5-dimethylphenyl)piperazino]-3-phenyl-2-pyrrol-1-yl-propan-1-one 1-[4-(2,5-dimethylphenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-ylpropan-1-one cid_9550139
1-[5,5-dimethyl-3-(1-pyrrolidinyl)-1-cyclohex-2-enylidene]azepan-1-ium;iodide 1-(5,5-dimethyl-3-pyrrolidin-1-yl-cyclohex-2-en-1-ylidene)azepan-1-ium;iodide BDBM42459 cid_16196225 1-(5,5-dimethyl-3-pyrrolidino-cyclohex-2-en-1-ylidene)azepan-1-ium;iodide MLS001011154 1-(5,5-dimethyl-3-pyrrolidin-1-ylcyclohex-2-en-1-ylidene)azepan-1-ium;iodide SMR000353130
1-[5-[4-(4-ethanoylphenyl)piperazin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]propan-1-one 1-[5-[4-(4-acetylphenyl)piperazin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]propan-1-one 1-[5-[4-(4-acetylphenyl)piperazino]sulfonylindolin-1-yl]propan-1-one 1-[5-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-2,3-dihydroindol-1-yl]-1-propanone BDBM62321 cid_15994862 MLS-0425663.0001
BDBM100226 cid_15055242 SMR000353133 1-(5,5-dimethyl-3-pyrrolidin-1-yl-cyclohex-2-en-1-ylidene)piperidin-1-ium;iodide 1-(5,5-dimethyl-3-pyrrolidin-1-ylcyclohex-2-en-1-ylidene)piperidin-1-ium;iodide 1-[5,5-dimethyl-3-(1-pyrrolidinyl)-1-cyclohex-2-enylidene]piperidin-1-ium;iodide MLS001011184 1-(5,5-dimethyl-3-pyrrolidino-cyclohex-2-en-1-ylidene)piperidin-1-ium;iodide
MLS001215789 1-[4-(3,4-Dimethyl-benzenesulfonyl)-piperazin-1-yl]-3-[1,2,4]triazol-1-yl-butan-1-one SMR000605515 1-[4-(3,4-dimethylphenyl)sulfonylpiperazino]-3-(1,2,4-triazol-1-yl)butan-1-one BDBM74028 1-[4-(3,4-dimethylphenyl)sulfonylpiperazin-1-yl]-3-(1,2,4-triazol-1-yl)butan-1-one 1-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]-3-(1,2,4-triazol-1-yl)-1-butanone cid_6489217
SMR000127921 1-[4-(3-chlorophenyl)piperazino]-3-phenyl-2-pyrrol-1-yl-propan-1-one MLS000522654 1-[4-(3-chlorophenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-yl-propan-1-one 1-[4-(3-chlorophenyl)-1-piperazinyl]-3-phenyl-2-(1-pyrrolyl)-1-propanone BDBM68752 cid_9550920 1-[4-(3-chlorophenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-ylpropan-1-one
SMR000127922 1-[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-phenyl-2-(1-pyrrolyl)-1-propanone 1-[4-(2,3-dimethylphenyl)piperazino]-3-phenyl-2-pyrrol-1-yl-propan-1-one MLS000522655 cid_9550432 1-[4-(2,3-dimethylphenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-ylpropan-1-one BDBM77215 1-[4-(2,3-dimethylphenyl)piperazin-1-yl]-3-phenyl-2-pyrrol-1-yl-propan-1-one
2-(1-methyl-1-pyrrolidin-1-iumyl)acetic acid 3-phenylpropyl ester;iodide 1-Methyl-1-(3-phenyl-propoxycarbonylmethyl)-pyrrolidinium 3-phenylpropyl 2-(1-methylpyrrolidin-1-ium-1-yl)acetate;iodide MLS000591850 SMR000218526 2-(1-methylpyrrolidin-1-ium-1-yl)acetic acid 3-phenylpropyl ester;iodide 3-phenylpropyl 2-(1-methylpyrrolidin-1-ium-1-yl)ethanoate;iodide cid_12004630 BDBM82710
MLS001222276 1-(4-benzylpiperidin-1-yl)-2-(2-methoxyphenoxy)propan-1-one 2-(2-methoxyphenoxy)-1-[4-(phenylmethyl)-1-piperidinyl]-1-propanone 1-(4-Benzyl-piperidin-1-yl)-2-(2-methoxy-phenoxy)-propan-1-one SMR000606710 1-(4-benzylpiperidino)-2-(2-methoxyphenoxy)propan-1-one cid_6471824 BDBM80591 2-(2-methoxyphenoxy)-1-[4-(phenylmethyl)piperidin-1-yl]propan-1-one
[1-[2-(1-naphthalenyloxy)ethyl]-3-indolyl]-(1-pyrrolidinyl)methanethione SMR000199364 1-[2-(1-naphthyloxy)ethyl]-3-(1-pyrrolidinylcarbonothioyl)-1H-indole [1-(2-naphthalen-1-yloxyethyl)indol-3-yl]-pyrrolidin-1-ylmethanethione BDBM88856 [1-(2-naphthalen-1-yloxyethyl)indol-3-yl]-pyrrolidin-1-yl-methanethione MLS000580477 cid_1284790 [1-[2-(1-naphthoxy)ethyl]indol-3-yl]-pyrrolidino-methanethione
1-[4-[4-nitro-3-(1-phenylethylamino)phenyl]piperazin-1-yl]butan-1-one BDBM77444 1-[4-[4-nitro-3-(1-phenylethylamino)phenyl]piperazino]butan-1-one SMR000197149 5-(4-butyryl-1-piperazinyl)-2-nitro-N-(1-phenylethyl)aniline 1-[4-[4-nitro-3-(1-phenylethylamino)phenyl]-1-piperazinyl]-1-butanone MLS000576681 cid_2925534
2-(4-bromophenoxy)-1-(2,3-dihydroindol-1-yl)-1-propanone 2-(4-bromophenoxy)-1-indolin-1-yl-propan-1-one 1-[2-(4-bromophenoxy)propanoyl]indoline cid_2953773 MLS000050463 SMR000076368 2-(4-bromanylphenoxy)-1-(2,3-dihydroindol-1-yl)propan-1-one BDBM89736 2-(4-bromophenoxy)-1-(2,3-dihydroindol-1-yl)propan-1-one
BDBM37093 1-[2-(2-bromophenoxy)propanoyl]indoline cid_3244853 MLS000090377 2-(2-bromanylphenoxy)-1-(2,3-dihydroindol-1-yl)propan-1-one 2-(2-bromophenoxy)-1-(2,3-dihydroindol-1-yl)propan-1-one 2-(2-bromophenoxy)-1-indolin-1-yl-propan-1-one SMR000024987 2-(2-bromophenoxy)-1-(2,3-dihydroindol-1-yl)-1-propanone
BDBM111125 US10112950, Example 1 US9695180, 1 US10556908, Example 1
BDBM155355 US10918640, Example 1 US10383871, Example 1 US9006269, 1
BDBM173249 US10323032, Example 1 US9604982, Example 1 US9096596, 1
BDBM250091 US10501411, Example 1 US9452980, 1 US11697636, Example 1
BDBM266453 US9718822, 1 US9902741, Example 1 US9750744, Example 1
BDBM50136979 1-oxo-1-piperidin-1-ylpropan-2-aminium
CHEMBL205082 BDBM50182584 2pyrrolidin-1-yl-1-phenylpentan-1-one
US10112931, Example 1 US9434719, 1 US9688672, Example 1 BDBM247479
US10125133, Example 1 US10968221, Example 1 US9695167, 1 BDBM103874
US10183932, Example 1 US9822102, Example 1 BDBM246096 US9434690, 1
US10654855, Example 1 US9492453, 1 BDBM256827 US11236095, Example 1
US10689373, Example 1 US10011588, Example 1 BDBM185185 US9156829, 1
US11046652, Example 2-1 US11046652, Example 1-1 BDBM506807
US11052093, Compound 1 US9090562, 1 BDBM171997 US10155002, Compound 1
US11247981, Example 1 BDBM124182 US8754227, 1 US10221160, Example 1
US11311528, Ex. 1-1 US11311528, Ex. 1-2 BDBM550527
US11358936, Compound 1-11 BDBM557300 US11358936, Compound 1-1
US8637508, 1 US10035794, Example 1 BDBM116227 US10683287, Example 1
US8865911, 1 BDBM136706 US10231967, Example 1 US9918985, Example 1
US9447106, 1 US10005782, Compound 1 BDBM249873 US9556188, Compound 1
US9540373, 1 USRE47636, Example 1 US9879026, Example 1 BDBM201012
US9610299, Example 1 US9000015, 1 BDBM153684 US10507215, Compound 1
US9662330, Compound 1 US10080750, Compound 1 US9321760, 1 BDBM224324
US9708272, 1 US10513499, Compound 1 BDBM261511 US11254644, Compound 1
US9745328, Compound 1 US9079866, 1 BDBM168628 US9884878, Compound 1
US9796729, 1 BDBM321134 US10385066, Example 1 US10174049, Example 1
US9951027, 2-1-2 BDBM389165 US9951027, 2-1-1
WO2022093856, Example 1-1 BDBM548365 WO2022093856, Example 1-60
1-(1-naphthalenylsulfonyl)-2-benzimidazolamine MLS-0435751.0001 cid_45253885 1-naphthalen-1-ylsulfonylbenzimidazol-2-amine BDBM67407 [1-(1-naphthylsulfonyl)benzimidazol-2-yl]amine
3-(1-naphthalenylmethylamino)-1-propanol 3-(1-naphthylmethylamino)propan-1-ol MLS000082276 cid_664896 SMR000046025 3-(naphthalen-1-ylmethylamino)propan-1-ol BDBM114633
BDBM50187317 1-{[(2R)-1-{2,3-dihydrospiro[indene-1,4'-piperidine]-1'-yl}-1-oxo-4-phenylbutan-2-yl]carbamoyl}-1-methylethan-1-aminium
BDBM50187322 1-{[(2R)-1-{2,3-dihydrospiro[indene-1,4'-piperidine]-1'-yl}-1-oxo-5-phenylpentan-2-yl]carbamoyl}-1-methylethan-1-aminium
US9138393, 1- Acetylimidazole BDBM7944 N-Acetylimidazole 1-(1H-imidazol-1-yl)ethan-1-one Imidazole N-1 deriv. 5 US9144538, 1-Acetylimidazole
(+)-1-(1'-(4-bromobenzyl)-3-phenyl-3,4'-bipiperidin-1-yl)ethanone BDBM50292665 (+/-)-1-(1'-(4-bromobenzyl)-3-phenyl-3,4'-bipiperidin-1-yl)ethanone CHEMBL498556 (-)-1-(1'-(4-bromobenzyl)-3-phenyl-3,4'-bipiperidin-1-yl)ethanone
1-(1-adamantyl)-3-[2-(1-cyclohexenyl)ethyl]urea BDBM78044 cid_5055981 SMR000114932 N-(1-adamantyl)-N'-[2-(1-cyclohexen-1-yl)ethyl]urea MLS000550537 1-(1-adamantyl)-3-[2-(cyclohexen-1-yl)ethyl]urea
MLS000718147 BDBM44236 SMR000279915 1-(4-phenylphenyl)-2-pyridin-1-ium-1-ylethanone;bromide cid_12399585 1-(4-phenylphenyl)-2-(1-pyridin-1-iumyl)ethanone;bromide 1-(4-phenylphenyl)-2-pyridin-1-ium-1-yl-ethanone;bromide
MLS002471740 SMR001395155 (2R)-1-[2-(1-naphthalenyl)ethyl]-2-(1-naphthalenylmethyl)piperazine cid_44143120 (2R)-1-(2-naphthalen-1-ylethyl)-2-(naphthalen-1-ylmethyl)piperazine BDBM79318 (2R)-1-[2-(1-naphthyl)ethyl]-2-(1-naphthylmethyl)piperazine
SMR001395154 (2R)-1-[2-(1-adamantyl)ethyl]-2-(1-naphthalenylmethyl)piperazine BDBM79340 (2R)-1-[2-(1-adamantyl)ethyl]-2-(naphthalen-1-ylmethyl)piperazine (2R)-1-[2-(1-adamantyl)ethyl]-2-(1-naphthylmethyl)piperazine cid_44144225 MLS002471739
1-(1-acetyl-4-piperidinyl)-1-cyclohexyl-3-(4-ethoxyphenyl)urea cid_4290599 SMR000097103 1-(1-acetylpiperidin-4-yl)-1-cyclohexyl-3-(4-ethoxyphenyl)urea MLS000120186 1-(1-acetyl-4-piperidyl)-1-cyclohexyl-3-p-phenetyl-urea 1-cyclohexyl-1-(1-ethanoylpiperidin-4-yl)-3-(4-ethoxyphenyl)urea BDBM38841
1-cyclohexyl-4-[1-(1-cyclopentyl-1,2,3,4-tetrazol-5-yl)pentyl]piperazine 1-cyclohexyl-4-[1-(1-cyclopentyltetrazol-5-yl)pentyl]piperazine SMR000004850 MLS000073898 cid_656327 1-Cyclohexyl-4-[1-(1-cyclopentyl-1H-tetrazol-5-yl)-pentyl]-piperazine BDBM62061 1-cyclohexyl-4-[1-(1-cyclopentyl-5-tetrazolyl)pentyl]piperazine
11-(1-methylpiperidin-1-ium-1-yl)undecyl ethanoate;iodide MLS000712970 SMR000282737 acetic acid 11-(1-methyl-1-piperidin-1-iumyl)undecyl ester;iodide cid_16192865 acetic acid 11-(1-methylpiperidin-1-ium-1-yl)undecyl ester;iodide 11-(1-methylpiperidin-1-ium-1-yl)undecyl acetate;iodide BDBM80488
4-(2-(4-aminopiperidin-1-yl)- 1-methyl-6-oxo-5-p-tolyl-1,6- dihydropyrimidin-4-yl)-benzonitrile US10023543, Example 1 US9771329, Example 1 US10328077, Example 1 US9573930, Example 1 US9776974, Example 1 US10548896, Example 1 BDBM283128 US11084793, Example 1 US10207999, Example 1 US10849898, Example 1 US10960005, Example 1
BDBM80402 SMR000147738 1-(8-Hydroxyimino-7-oxo-octyl)-1-methyl-azepanium 2-keto-8-(1-methylazepan-1-ium-1-yl)caprylaldoxime;iodide 8-(1-methyl-1-azepan-1-iumyl)-2-oxooctanal oxime;iodide MLS000556421 cid_9551654 1-hydroxyimino-8-(1-methylazepan-1-ium-1-yl)octan-2-one;iodide
MLS000086456 cid_3237235 1-pyrrolidino-3-(2-thienylsulfonyl)propan-1-one SMR000022351 1-pyrrolidin-1-yl-3-thiophen-2-ylsulfonyl-propan-1-one 1-(1-pyrrolidinyl)-3-thiophen-2-ylsulfonyl-1-propanone 1-[3-(thien-2-ylsulfonyl)propanoyl]pyrrolidine BDBM48564 1-pyrrolidin-1-yl-3-thiophen-2-ylsulfonylpropan-1-one
MLS002701845 N'-(1-isoquinolin-1-ylethyl)-4-pyridin-2-yl-piperazine-1-carbothiohydrazide N'-[1-(1-isoquinolinyl)ethyl]-4-(2-pyridinyl)-1-piperazinecarbothiohydrazide SMR001565437 BDBM80814 N'-(1-isoquinolin-1-ylethyl)-4-pyridin-2-ylpiperazine-1-carbothiohydrazide N'-[1-(1-isoquinolyl)ethyl]-4-(2-pyridyl)piperazine-1-carbothiohydrazide cid_3000691
SMR000429506 BDBM73770 MLS000767182 cid_16409851 (1E)-4,4-dicyano-1-phenyl-2-(1-pyridin-1-iumyl)-1-buta-1,3-dienolate (1E)-4,4-dicyano-1-phenyl-2-pyridin-1-ium-1-yl-buta-1,3-dien-1-olate (1E)-4,4-dicyano-1-phenyl-2-pyridin-1-ium-1-ylbuta-1,3-dien-1-olate
1-[1-(3-piperidin-1-ylsulfonylphenyl)sulfonylpiperidin-4-yl]benzotriazole BDBM40266 MLS000033591 1-{1-[3-(Piperidine-1-sulfonyl)-benzenesulfonyl]-piperidin-4-yl}-1H-benzotriazole 1-[1-[3-(1-piperidinylsulfonyl)phenyl]sulfonyl-4-piperidinyl]benzotriazole SMR000006482 1-[1-(3-piperidinosulfonylphenyl)sulfonyl-4-piperidyl]benzotriazole cid_644899
BDBM59050 1-[4-[4-(1-naphthalenylmethylamino)phenyl]-1-piperazinyl]ethanone MLS001205360 cid_1087699 SMR000523945 1-[4-[4-(1-naphthylmethylamino)phenyl]piperazino]ethanone 1-(4-{4-[(Naphthalen-1-ylmethyl)-amino]-phenyl}-piperazin-1-yl)-ethanone 1-[4-[4-(naphthalen-1-ylmethylamino)phenyl]piperazin-1-yl]ethanone
BDBM63725 2-chloranyl-1-[4-(1-phenylethyl)piperazin-1-yl]ethanone;hydrochloride MLS001006280 cid_16196748 2-chloro-1-[4-(1-phenylethyl)-1-piperazinyl]ethanone;hydrochloride 2-chloro-1-[4-(1-phenylethyl)piperazin-1-yl]ethanone;hydrochloride 2-chloro-1-[4-(1-phenylethyl)piperazino]ethanone;hydrochloride SMR000384241
SMR000033191 1-{[4-(1H-pyrrol-1-yl)phenyl]acetyl}indoline BDBM40369 cid_3243138 MLS000047180 1-(2,3-dihydroindol-1-yl)-2-(4-pyrrol-1-ylphenyl)ethanone 1-indolin-1-yl-2-(4-pyrrol-1-ylphenyl)ethanone 1-(2,3-dihydroindol-1-yl)-2-[4-(1-pyrrolyl)phenyl]ethanone
MLS000123160 SMR000123814 1-[(4-ethoxy-1-naphthalenyl)sulfonyl]azepane 1-[(4-ethoxy-1-naphthyl)sulfonyl]azepane BDBM46863 1-(4-ethoxynaphthalen-1-yl)sulfonylazepane cid_776924 1-(4-Ethoxy-naphthalene-1-sulfonyl)-azepane
cid_3238280 4-methyl-2-(1-oxidanylidene-1-piperidin-1-yl-propan-2-yl)-[1]benzothiolo[2,3-d]pyridazin-1-one 4-methyl-2-(1-methyl-2-oxo-2-piperidin-1-ylethyl)[1]benzothieno[2,3-d]pyridazin-1(2H)-one 4-methyl-2-(1-oxo-1-piperidin-1-ylpropan-2-yl)-[1]benzothiolo[2,3-d]pyridazin-1-one 2-(2-keto-1-methyl-2-piperidino-ethyl)-4-methyl-benzothiopheno[2,3-d]pyridazin-1-one BDBM35390 4-methyl-2-[1-oxo-1-(1-piperidinyl)propan-2-yl]-[1]benzothiolo[2,3-d]pyridazin-1-one MLS000093662 SMR000029280
BDBM249319 US10300060, Example 9-1 US9763943, 9-1 US9993479, 9-1 US10765676, Example 9-1 US9463192, 9-1
US10300060, Example 13-1 US9763943, 13-1 US9463192, 13-1 BDBM249322 US9993479, 13-1 US10765676, Example 13-1
US10300060, Example 21-1 US9993479, 21-1 US9763943, 21-1 US10765676, Example 21-1 BDBM249339 US9463192, 21-1
US9763943, 8-1 US9993479, 8-1 US10300060, Example 8-1 US10765676, Example 8-1 BDBM249316 US9463192, 8-1
1-(1-naphthyl)-3-(3-pyrrolidinopropyl)urea cid_3237901 MLS000090797 N-1-naphthyl-N'-(3-pyrrolidin-1-ylpropyl)urea 1-(1-naphthalenyl)-3-[3-(1-pyrrolidinyl)propyl]urea SMR000025400 BDBM73287 1-naphthalen-1-yl-3-(3-pyrrolidin-1-ylpropyl)urea
1-adamantyl-(1-propyl-4-piperidyl)amine N-(1-adamantyl)-1-propylpiperidin-4-amine N-1-adamantyl-1-propyl-4-piperidinamine SMR000496476 MLS000974665 N-(1-adamantyl)-1-propyl-piperidin-4-amine N-(1-adamantyl)-1-propyl-4-piperidinamine BDBM65864 cid_2846583
cid_2983964 BDBM76453 MLS000582937 SMR000201646 1-azepanecarboxylic acid (1-chloro-2-naphthalenyl) ester azepane-1-carboxylic acid (1-chloro-2-naphthyl) ester (1-chloranylnaphthalen-2-yl) azepane-1-carboxylate (1-chloronaphthalen-2-yl) azepane-1-carboxylate 1-chloro-2-naphthyl 1-azepanecarboxylate
1-(1-piperidinylmethyl)-2-naphthalenol BDBM91378 1-(piperidin-1-ylmethyl)naphthalen-2-ol 1-(piperidinomethyl)-2-naphthol cid_21436 MLS002637703 SMR001354233 1-Piperidin-1-ylmethyl-naphthalen-2-ol
1-(4-pyrrolidinosulfonylphenyl)sulfonylazepane 1-[4-(1-pyrrolidinylsulfonyl)phenyl]sulfonylazepane BDBM45293 1-[4-(Pyrrolidine-1-sulfonyl)-benzenesulfonyl]-azepane SMR000003091 1-(4-pyrrolidin-1-ylsulfonylphenyl)sulfonylazepane cid_646007 MLS000068718
1-{[(2R)-3-(1H-indol-3-yl)-1-oxo-1-{2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}propan-2-yl]carbamoyl}-1-methylethan-1-aminium BDBM50187332
SMR000518432 naphthalen-1-yl(piperidin-1-yl)methanone MLS001202928 cid_229390 1-naphthyl(piperidino)methanone Naphthalen-1-yl-piperidin-1-yl-methanone 1-naphthalenyl(1-piperidinyl)methanone BDBM73895
1-(4-phenoxybutanoyl)-4-phenylpiperazine BDBM77224 cid_2290599 4-phenoxy-1-(4-phenyl-1-piperazinyl)-1-butanone MLS000534483 SMR000141919 4-phenoxy-1-(4-phenylpiperazino)butan-1-one 4-phenoxy-1-(4-phenylpiperazin-1-yl)butan-1-one
BDBM56867 2-(1-adamantylcarbonyl)-N-butylhydrazinecarbothioamide MLS000533729 1-(adamantane-1-carbonylamino)-3-butylthiourea 1-(1-adamantylcarbonylamino)-3-butyl-thiourea 1-(adamantane-1-carbonylamino)-3-butyl-thiourea 1-[[1-adamantyl(oxo)methyl]amino]-3-butylthiourea cid_2882343 SMR000141167
CHEMBL305607 BDBM50092967 1-(4-(4-(1-(4-(4-methoxyphenylsulfonyl)phenyl)vinyl)piperidin-1-yl)piperidin-1-yl)propan-1-one 1-(4-{1-[4-(4-Methoxy-benzenesulfonyl)-phenyl]-vinyl}-[1,4']bipiperidinyl-1'-yl)-propan-1-one
CHEMBL72551 1-(4-(4-(1-(4-(4-methoxyphenylsulfonyl)phenyl)vinyl)piperidin-1-yl)piperidin-1-yl)butan-1-one BDBM50092965 1-(4-{1-[4-(4-Methoxy-benzenesulfonyl)-phenyl]-vinyl}-[1,4']bipiperidinyl-1'-yl)-butan-1-one
SMR000286217 1-methyl-1-(1-methylpiperidin-4-yl)-3-[2-(3-prop-1-en-2-ylphenyl)propan-2-yl]urea 1-methyl-3-[2-[3-(1-methylethenyl)phenyl]propan-2-yl]-1-(1-methyl-4-piperidinyl)urea cid_808435 BDBM55673 MLS000677413 3-[1-(3-isopropenylphenyl)-1-methyl-ethyl]-1-methyl-1-(1-methyl-4-piperidyl)urea
Aryl 1-indanylketone, 1 BDBM92912
BDBM107215 US8598345, Table 1-1
BDBM113573 US9365529, 1 US8633196, 1
BDBM120086 US8697715, 1 US9259470, 1
BDBM143693 US9682959, 1 US9751856, 1
BDBM156376 US9018381, 1 US9248140, 1
BDBM160334 US9040714, 1 US9693992, 1
BDBM185592 US9493431, 1 US9156856, 1
BDBM197403 US9216968, 1 US9732066, 1
BDBM209580 US10016420, 1 US9273011, 1
BDBM221517 US9303045, 1 US9695195, 1
BDBM234448 US10004738, 1 US9353084, 1
BDBM254918 US9675594, 1 US9499542, 1
BDBM292120 US10100049, Example 1-1
BDBM346997 US10202388, Compound 1-1
BDBM395308 US10308636, Example 1-1
BDBM421630 US10508088, Example 1-1
BDBM47168 US8957219, II-1-1
BDBM50187691 US9951026, 1-1 CHEMBL3828178
BDBM50242703 CHEMBL4069378 US9926330, 1-1
BDBM515791 US11053226, Example 1-1
BDBM516376 US11053242, Compound 1-1
BDBM524862 US11168102, Example 1-1.
BDBM548605 WO2022098806, Compound 1-1
BDBM552449 WO2022098807, Example 1-1
BDBM556273 US11345701, Compound 1-1
BDBM652848 US20240059703, Example 1-1
BDBM658661 US20240083921, Compound 1-1
BDBM661388 US20240101566, Compound 1-1
BDBM677326 US20240174652, Example 1-1
BDBM712710 US12195473, Compound 1-1
BDBM757743 US12358931, Example 1-1
BDBM762924 US20250250267, Example 1-1
CHEMBL4082572 BDBM50242702 US9932350, 1-1
US10028960, Example 1-1 BDBM279818
US10047103, 1 US9688695, 1 BDBM175968
US10080744, Example 1/1 BDBM285730
US10464918, Compound 1-1 BDBM419657
US10584134, Example 1-1 BDBM435142
US10696689, Compound 1-1 BDBM448916
US10952995, Compound 1-1 BDBM487144
US11186590, Compound 1-1 BDBM527731
US20230271964, Example 1-1 BDBM616044
US8614234, 1 BDBM110533 US9725433, 1
US8921389, 1 BDBM141545 US9695170 1
US8933098, 1 US8933099, 1 BDBM142234
US8952157, 1 US9303025, 1 BDBM144820
US8987254, 1 BDBM150686 US9999624, 1
US8987335, 1 BDBM151605 US9555024, 1
US9040534, 1 BDBM160060 US10047092, 1
US9051321, 1 BDBM133657 US8846711, 1
US9073869, 1 BDBM138492 US8877775, 1
US9079834, 1-1 BDBM60467 BDBM168607
US9206232, 1 US8613914, 1 BDBM110233
US9273052, 1 BDBM209853 US9566277, 1
US9358227, 1 US8901140, 1 BDBM139988
US9388149, 1 (Diastereoisomer 1) BDBM236793
US9409895, 1 BDBM241090 US9630945, 1
US9475775, 1 BDBM254734 US9597333, 1
US9598426, 1 BDBM168126 US9073936, 1
US9598436, 1 BDBM144614 US8969586, 1
US9611251, 1 US9115117, 1 BDBM175099
US9670166, 1 BDBM211684 US9290459, 1
US9682953, 1.A-1 BDBM143113
US9694002, 1 US9546164, 1 BDBM70807
US9908875, 1 BDBM187353 US9169243, 1
US9918969, 1 BDBM251889 US9475809, 1
US9969749, Example 1-1 BDBM393907
(S)-N-(1-(1-hydroxy-1-phenylpropyl)piperidin-4-yl)-1-naphthamide CHEMBL228866 BDBM50203477
1-hexadecylquinolin-1-ium;iodide SMR000264906 1-cetylquinolin-1-ium;iodide BDBM48758 cid_15945189 MLS000418438
BDBM445663 Ex. 1/KM-06-30/(I-1) US11028104, Example 1 US10683309, Example 1
BDBM50319352 CHEMBL1083421 3-[1-(1-adamantyl)-1H-tetrazol-5-yl]-1-phenylpropan-1-one
BDBM50606343 US20230321108, Isomer 1 of Example 1 US20230286979, Isomer 1 of Example 1 CHEMBL5188354
BDBM7887 1-Benzylimidazole (BI) CHEMBL14192 1-benzylimidazole 1-benzyl-1H-imidazole US9138393, 1-benzylimidazole
CHEMBL226863 BDBM50204159 alpha1-(1-amino-1-phenylmethane)-alpha2-(1-hydroxy-1-phenylmethane) phosphinic acid
1-(5-indolin-1-ylsulfonylindolin-1-yl)ethanone MLS001162271 SMR000670943 1-[5-(2,3-dihydroindol-1-ylsulfonyl)-2,3-dihydroindol-1-yl]ethanone BDBM58684 cid_866903
1-ethenyl-1H-imidazole BDBM7942 1-Vinylimidazole US9144538, 1-Vinylimidazole US9138393, 1-Vinylimidazole 1-Subsituted 1H-imidazole, 8 Imidazole N-1 deriv. 3
2-(4-(1-cyclopentyl-1,2,3,4- tetrahydroisoquinolin-1- yl)piperidin-1-yl)-1- (pyrrolidin-1-yl)ethan-1-one BDBM480024 US10899738, Cpd. No 74
BDBM21620 Methoxynaphthalen-1-yl, 8 2-bromo-1-(4-methoxynaphthalen-1-yl)ethanone 2-bromo-1-(4-methoxynaphthalen-1-yl)ethan-1-one
BDBM50118936 2-Amino-3-methyl-1-piperidin-1-yl-pentan-1-one 3-methyl-1-oxo-1-piperidin-1-ylpentan-2-aminium CHEMBL93507
BDBM96161 SMR000177795 MLS000562781 3-(4,7-dimethyl-1-quinolin-1-iumyl)-1-propanesulfonate 3-(4,7-dimethylquinolin-1-ium-1-yl)propane-1-sulfonate cid_3144378
CHEMBL214335 (+)-1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine (-)-1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine 1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine BDBM50188048
CHEMBL429298 1-(5-chloronaphthalen-1-ylsulfonyl)-1,4-diazepane 1-[(5-chloro-1-naphthyl)sulfonyl]-1,4-diazepane BDBM50216681 1-(5-chloronaphthalene-1-sulfonyl)homopiperazine
cid_365016 1-(2,6-dihydroxyphenyl)dodecan-1-one MLS001048914 BDBM57937 SMR000387105 1-(2,6-dihydroxyphenyl)-1-dodecanone 1-[2,6-bis(oxidanyl)phenyl]dodecan-1-one
BDBM50102373 3-(4-(naphthalen-1-yl)piperazin-1-yl)-1-(thiophen-3-yl)propan-1-one 3-(4-Naphthalen-1-yl-piperazin-1-yl)-1-thiophen-3-yl-propan-1-one CHEMBL135295
BDBM80456 1-methyl-1-[(2,4,6-trimethyl-1-cyclohex-3-enyl)methyl]piperidin-1-ium;iodide SMR000284416 1-methyl-1-[(2,4,6-trimethylcyclohex-3-en-1-yl)methyl]piperidin-1-ium;iodide MLS000688496 cid_16189254
N-[1-(1-adamantyl)propylideneamino]-4-pyridinecarboxamide cid_5084898 BDBM41931 MLS000537162 N-[1-(1-adamantyl)propylideneamino]isonicotinamide SMR000159911 N'-[1-(1-adamantyl)propylidene]isonicotinohydrazide N-[1-(1-adamantyl)propylideneamino]pyridine-4-carboxamide
1-(2,3-dihydroindol-1-yl)-2-(1-methylindol-3-yl)sulfonyl-ethanone cid_2157548 1-(2,3-dihydroindol-1-yl)-2-(1-methylindol-3-yl)sulfonylethanone 1-(2,3-dihydroindol-1-yl)-2-[(1-methyl-3-indolyl)sulfonyl]ethanone MLS000101449 SMR000017792 1-indolin-1-yl-2-(1-methylindol-3-yl)sulfonyl-ethanone BDBM81014
1-[1-(1-cyclopentyl-1,2,3,4-tetrazol-5-yl)propyl]-4-(phenylmethyl)piperazine;hydrochloride BDBM89829 MLS000527581 cid_9549572 1-Benzyl-4-[1-(1-cyclopentyl-1H-tetrazol-5-yl)-propyl]-piperazine SMR000118055 1-[1-(1-cyclopentyl-5-tetrazolyl)propyl]-4-(phenylmethyl)piperazine;hydrochloride 1-benzyl-4-[1-(1-cyclopentyltetrazol-5-yl)propyl]piperazine;hydrochloride
MLS000684685 2-phenoxy-1-[2-(phenylmethylthio)-4,5-dihydroimidazol-1-yl]-1-propanone 1-(2-benzylsulfanyl-4,5-dihydroimidazol-1-yl)-2-phenoxypropan-1-one 2-phenoxy-1-[2-(phenylmethylsulfanyl)-4,5-dihydroimidazol-1-yl]propan-1-one cid_4558613 1-[2-(benzylthio)-2-imidazolin-1-yl]-2-phenoxy-propan-1-one BDBM66579 SMR000323191
1-(2,5-dimethyl-1-phenyl-pyrrol-3-yl)-2-[(1-oxidopyridin-1-ium-2-yl)thio]ethanone cid_2453287 SMR000343845 MLS000770655 BDBM115030 1-(2,5-dimethyl-1-phenyl-pyrrol-3-yl)-2-(1-oxidanidylpyridin-1-ium-2-yl)sulfanyl-ethanone 1-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone 1-(2,5-dimethyl-1-phenylpyrrol-3-yl)-2-(1-oxidopyridin-1-ium-2-yl)sulfanylethanone
(E)-3-(1-naphthalenyl)-1-pyridin-4-yl-2-propen-1-one (E)-3-naphthalen-1-yl-1-pyridin-4-yl-prop-2-en-1-one cid_5338258 MLS000573147 (E)-3-naphthalen-1-yl-1-pyridin-4-ylprop-2-en-1-one 3-(1-naphthyl)-1-(4-pyridinyl)-2-propen-1-one BDBM42528 (E)-3-(1-naphthyl)-1-(4-pyridyl)prop-2-en-1-one SMR000185081
1-(1-bromo-2-naphthoxy)-3-imidazol-1-yl-propan-2-ol 1-(1-bromanylnaphthalen-2-yl)oxy-3-imidazol-1-yl-propan-2-ol MLS000099488 cid_2945320 1-[(1-bromo-2-naphthyl)oxy]-3-(1H-imidazol-1-yl)-2-propanol BDBM66293 SMR000074127 1-[(1-bromo-2-naphthalenyl)oxy]-3-(1-imidazolyl)-2-propanol 1-(1-bromonaphthalen-2-yl)oxy-3-imidazol-1-ylpropan-2-ol
1-[1-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]-oxomethyl]cyclohexyl]-3-phenylurea 1-[1-[4-(2-furoyl)piperazine-1-carbonyl]cyclohexyl]-3-phenyl-urea cid_650330 MLS000030020 1-[1-[4-(furan-2-carbonyl)piperazine-1-carbonyl]cyclohexyl]-3-phenylurea 1-{1-[4-(Furan-2-carbonyl)-piperazine-1-carbonyl]-cyclohexyl}-3-phenyl-urea SMR000000435 BDBM39578 1-[1-[4-(furan-2-ylcarbonyl)piperazin-1-yl]carbonylcyclohexyl]-3-phenyl-urea
1-[3-[1-(2-aminoethylthio)-2-nitro-ethyl]indol-1-yl]ethanone;hydrochloride 1-{3-[1-(2-Amino-ethylsulfanyl)-2-nitro-ethyl]-indol-1-yl}-ethanone SMR000148934 1-[3-[1-(2-azanylethylsulfanyl)-2-nitro-ethyl]indol-1-yl]ethanone;hydrochloride cid_2827475 BDBM79529 MLS000558218 1-[3-[1-(2-aminoethylsulfanyl)-2-nitroethyl]indol-1-yl]ethanone;hydrochloride 1-[3-[1-(2-aminoethylthio)-2-nitroethyl]-1-indolyl]ethanone;hydrochloride
3-[1-(3-fluoro-4-phenylphenoxy)ethyl]-1-(1-naphthalenylsulfonyl)pyrazole SMR000168807 3-{1-[(2-fluoro[1,1'-biphenyl]-4-yl)oxy]ethyl}-1-(1-naphthylsulfonyl)-1H-pyrazole 3-[1-(3-fluoranyl-4-phenyl-phenoxy)ethyl]-1-naphthalen-1-ylsulfonyl-pyrazole MLS000331280 3-[1-(3-fluoro-4-phenyl-phenoxy)ethyl]-1-(1-naphthylsulfonyl)pyrazole cid_4371774 3-[1-(3-fluoro-4-phenylphenoxy)ethyl]-1-naphthalen-1-ylsulfonylpyrazole BDBM55499
SMR000211403 1-[3-(1-naphthyl)prop-2-ynyl]-1-(3-phenylprop-2-ynyl)pyrrolidin-1-ium;bromide BDBM65174 1-(3-naphthalen-1-ylprop-2-ynyl)-1-(3-phenylprop-2-ynyl)pyrrolidin-1-ium;bromide MLS000587356 cid_12005538 1-(3-Naphthalen-1-yl-prop-2-ynyl)-1-(3-phenyl-prop-2-ynyl)-pyrrolidinium 1-[3-(1-naphthalenyl)prop-2-ynyl]-1-(3-phenylprop-2-ynyl)pyrrolidin-1-ium;bromide
cid_24819361 3-[1-(4-ethenylphenyl)carbonylpiperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one MLS001105217 BDBM61768 1-[4-(2-pyridyl)piperazino]-3-[1-(4-vinylbenzoyl)-3-piperidyl]propan-1-one 3-[1-(4-ethenylbenzoyl)piperidin-3-yl]-1-(4-pyridin-2-ylpiperazin-1-yl)propan-1-one 3-[1-[(4-ethenylphenyl)-oxomethyl]-3-piperidinyl]-1-[4-(2-pyridinyl)-1-piperazinyl]-1-propanone SMR000665246
cid_25162991 MLS002153704 (2S)-2-[4-(aminomethyl)-1,2,3-triazol-1-yl]-6-azanyl-1-piperazin-1-yl-hexan-1-one BDBM79253 AS-Mono-GK-DP SMR001231082 (2S)-6-amino-2-[4-(aminomethyl)triazol-1-yl]-1-piperazin-1-ylhexan-1-one (2S)-6-amino-2-[4-(aminomethyl)triazol-1-yl]-1-piperazino-hexan-1-one (2S)-6-amino-2-[4-(aminomethyl)-1-triazolyl]-1-(1-piperazinyl)-1-hexanone
cid_2967179 1-indol-1-yl-3-(2-methylolbenzimidazol-1-yl)propan-2-ol 1-[2-(hydroxymethyl)benzimidazol-1-yl]-3-indol-1-ylpropan-2-ol 1-[2-(hydroxymethyl)-1-benzimidazolyl]-3-(1-indolyl)-2-propanol 1-[2-(hydroxymethyl)-1H-benzimidazol-1-yl]-3-(1H-indol-1-yl)-2-propanol SMR000079507 MLS000066044 BDBM37761 1-[2-(hydroxymethyl)benzimidazol-1-yl]-3-indol-1-yl-propan-2-ol
1-(1,3-benzodioxol-5-yl)-3-piperidin-1-yl-propan-1-one MLS000533308 1-(1,3-benzodioxol-5-yl)-3-piperidino-propan-1-one SMR000140746 BDBM89881 1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone 1-(1,3-benzodioxol-5-yl)-3-piperidin-1-ylpropan-1-one cid_147354
1-[4-(4-hydroxyphenyl)piperazino]-3-phenoxy-propan-1-one cid_2420148 1-[4-(4-hydroxyphenyl)piperazin-1-yl]-3-phenoxypropan-1-one SMR000372724 1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-phenoxy-1-propanone 1-[4-(4-hydroxyphenyl)piperazin-1-yl]-3-phenoxy-propan-1-one BDBM59037 MLS001003078
1-[5-[4-(4-chlorophenyl)piperazin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]propan-1-one cid_16000292 1-[5-[[4-(4-chlorophenyl)-1-piperazinyl]sulfonyl]-2,3-dihydroindol-1-yl]-1-propanone BDBM62238 1-[5-[4-(4-chlorophenyl)piperazino]sulfonylindolin-1-yl]propan-1-one MLS-0412050.0001
4-[4-(1-methylpiperidin-1-ium-1-yl)butylsulfanyl]phenol;iodide 1-[4-(4-Hydroxy-phenylsulfanyl)-butyl]-1-methyl-piperidinium 4-[4-(1-methylpiperidin-1-ium-1-yl)butylthio]phenol;iodide 4-[4-(1-methyl-1-piperidin-1-iumyl)butylthio]phenol;iodide SMR000171394 BDBM60499 MLS000553967 cid_12004533
cid_44251469 1-[5-[4-(4-nitrophenyl)piperazino]sulfonylindolin-1-yl]propan-1-one 1-[5-[4-(4-nitrophenyl)piperazin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]propan-1-one 1-[5-[[4-(4-nitrophenyl)-1-piperazinyl]sulfonyl]-2,3-dihydroindol-1-yl]-1-propanone BDBM62322 MLS-0425664.0001
cid_658341 1-(4-methoxyphenyl)-2-phenyl-3-pyrrolidino-propan-1-one SMR000039240 1-(4-methoxyphenyl)-2-phenyl-3-pyrrolidin-1-ylpropan-1-one 1-(4-methoxyphenyl)-2-phenyl-3-(1-pyrrolidinyl)-1-propanone MLS000071402 1-(4-methoxyphenyl)-2-phenyl-3-pyrrolidin-1-yl-propan-1-one BDBM64894
1-(2,5-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one (2E)-1-(2',5'-dimethoxyphenyl)-3-(1-naphthyl)-2-propen-1-one 1-(2',5'-dimethoxyphenyl)-3-(1-naphthyl)-2-propen-1-one BDBM50193009 CHEMBL374279
BDBM73915 MLS001177027 4-[1-(N'-phthalazin-1-ylhydrazino)ethylidene]cyclohexa-2,5-dien-1-one 4-[1-(1-phthalazinylhydrazo)ethylidene]-1-cyclohexa-2,5-dienone SMR000595229 4-[1-(2-phthalazin-1-ylhydrazinyl)ethylidene]cyclohexa-2,5-dien-1-one cid_7930059
1-{[(2R)-1-{1,1-dioxo-2H-spiro[1-benzothiophene-3,4'-piperidine]-1'-yl}-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl}-1-methylethan-1-aminium BDBM50187327
BDBM7899 3-[3-(1H-imidazol-1-yl)propyl]-1-naphthalen-1-ylthiourea 1-alkylimidazole thiourea deriv. 34 1-(3-(1H-Imidazol-1-yl)propyl)-3-naphthalen-1-ylthiourea
US10807956, Example 1 US9611221, Example 1 US9828343, Example 1 BDBM314097 US10179769, Example 1 US9725441, Example 1 3-(benzylamino)pyridazine-4-carboxylic acid US11214542, Example 1 US11639333, Example 1
1-[4-(4-Fluoro-benzoyl)-piperazin-1-yl]-3-methyl-butan-1-one SMR000517035 1-[4-(4-fluorobenzoyl)piperazin-1-yl]-3-methylbutan-1-one BDBM73902 MLS001207374 1-[4-(4-fluorophenyl)carbonylpiperazin-1-yl]-3-methyl-butan-1-one cid_776697 1-[4-(4-fluorobenzoyl)piperazino]-3-methyl-butan-1-one 1-[4-[(4-fluorophenyl)-oxomethyl]-1-piperazinyl]-3-methyl-1-butanone
1-[4-(5-Fluoro-benzotriazol-1-yl)-piperidin-1-yl]-2-methoxy-ethanone 1-[4-(5-fluoranylbenzotriazol-1-yl)piperidin-1-yl]-2-methoxy-ethanone MLS000032829 cid_649205 1-[4-(5-fluorobenzotriazol-1-yl)piperidino]-2-methoxy-ethanone 1-[4-(5-fluoro-1-benzotriazolyl)-1-piperidinyl]-2-methoxyethanone 1-[4-(5-fluorobenzotriazol-1-yl)piperidin-1-yl]-2-methoxyethanone BDBM53498 SMR000006523
BDBM80368 cid_892611 1-indolin-1-yl-2-[(1-phenyltetrazol-5-yl)thio]ethanone MLS000066853 1-(2,3-dihydroindol-1-yl)-2-[(1-phenyl-5-tetrazolyl)thio]ethanone 1-(2,3-dihydroindol-1-yl)-2-[(1-phenyl-1,2,3,4-tetrazol-5-yl)sulfanyl]ethanone SMR000073315 1-{[(1-phenyl-1H-tetrazol-5-yl)thio]acetyl}indoline 1-(2,3-dihydroindol-1-yl)-2-(1-phenyltetrazol-5-yl)sulfanylethanone
BDBM94084 1-[3-[4-(2-methoxyphenyl)piperazino]piperidino]-2-pyrazol-1-yl-ethanone cid_24817464 1-[3-[4-(2-methoxyphenyl)piperazin-1-yl]piperidin-1-yl]-2-pyrazol-1-yl-ethanone 1-[3-[4-(2-methoxyphenyl)piperazin-1-yl]piperidin-1-yl]-2-pyrazol-1-ylethanone SMR000658833 1-[3-[4-(2-methoxyphenyl)-1-piperazinyl]-1-piperidinyl]-2-(1-pyrazolyl)ethanone MLS001105171
cid_16317622 2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-1-(1-piperidinyl)-1-propanone;oxalic acid 2-[4-(4-chlorophenyl)sulfonylpiperazino]-1-piperidino-propan-1-one;oxalic acid SMR001238137 2-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-1-piperidin-1-yl-propan-1-one;ethanedioic acid 2-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-1-piperidin-1-ylpropan-1-one;oxalic acid BDBM83117 MLS002155615
3-[1-(acetyloxymethyl)-1-methylethyl]-1-(4-biphenylmethyl)-1-{2-[1-(4-methylbenzyl)-4-piperidinyl]ethyl}urea BDBM50209695 CHEMBL240341
cid_3311060 4-(1-pyrenyl)-1-butanamine BDBM79243 MLS001360540 4-pyren-1-ylbutan-1-amine 4-pyren-1-ylbutylamine SMR001223776
1-[2-(4-chlorophenyl)-2-oxoethyl]pyridinium iodide MLS001165468 1-(4-chlorophenyl)-2-pyridin-1-ium-1-yl-ethanone;iodide 1-(4-chlorophenyl)-2-pyridin-1-ium-1-ylethanone;iodide BDBM61349 cid_2764938 1-(4-chlorophenyl)-2-(1-pyridin-1-iumyl)ethanone;iodide SMR000549449
2-(1-naphthylamino)-N-(1-phenylethylideneamino)acetamide 2-(naphthalen-1-ylamino)-N-(1-phenylethylideneamino)ethanamide MLS000728015 2-(naphthalen-1-ylamino)-N-(1-phenylethylideneamino)acetamide cid_690302 BDBM34850 SMR000306708 2-(1-naphthalenylamino)-N-(1-phenylethylideneamino)acetamide 2-(1-naphthylamino)-N'-[(1E)-1-phenylethylidene]acetohydrazide
N'-1-adamantyl-N-benzyl-N-(4-pyridinylmethyl)urea 3-(1-adamantyl)-1-(phenylmethyl)-1-(pyridin-4-ylmethyl)urea cid_2968162 MLS000683914 3-(1-adamantyl)-1-benzyl-1-(pyridin-4-ylmethyl)urea BDBM83787 SMR000295669 3-(1-adamantyl)-1-benzyl-1-(4-pyridylmethyl)urea
cid_12247929 2-(3-methyl-1-pyridin-1-iumyl)-1-phenylethanone;bromide 2-(3-methylpyridin-1-ium-1-yl)-1-phenyl-ethanone;bromide 2-(3-methylpyridin-1-ium-1-yl)-1-phenylethanone;bromide 3-methyl-1-(2-oxo-2-phenylethyl)pyridinium MLS001195138 SMR000554477 BDBM61354
(E)-1-[2,5-bis(chloranyl)phenyl]-3-[[4-[bis(fluoranyl)methylsulfanyl]phenyl]amino]-2-pyridin-1-ium-1-yl-3-sulfanylidene-prop-1-en-1-olate MLS001006684 SMR000349628 (E)-1-(2,5-dichlorophenyl)-3-[4-(difluoromethylsulfanyl)anilino]-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate (E)-1-(2,5-dichlorophenyl)-3-[4-(difluoromethylthio)anilino]-2-(1-pyridin-1-iumyl)-3-sulfanylidene-1-propen-1-olate BDBM128228 (E)-1-(2,5-dichlorophenyl)-3-[4-(difluoromethylthio)anilino]-2-pyridin-1-ium-1-yl-3-thioxo-prop-1-en-1-olate cid_16195927
BDBM71106 MLS001005317 (E)-1-[4-(difluoromethoxy)phenyl]-3-(3-methoxyanilino)-2-(1-pyridin-1-iumyl)-3-sulfanylidene-1-propen-1-olate SMR000348664 (E)-1-[4-(difluoromethoxy)phenyl]-3-(m-anisidino)-2-pyridin-1-ium-1-yl-3-thioxo-prop-1-en-1-olate (E)-1-[4-(difluoromethoxy)phenyl]-3-(3-methoxyanilino)-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate (E)-1-[4-[bis(fluoranyl)methoxy]phenyl]-3-[(3-methoxyphenyl)amino]-2-pyridin-1-ium-1-yl-3-sulfanylidene-prop-1-en-1-olate cid_6313124
BDBM93701 (E)-1-(5-chlorothiophen-2-yl)-3-(2,5-dimethylanilino)-2-pyridin-1-ium-1-yl-3-sulfanylideneprop-1-en-1-olate cid_6088826 MLS001005239 SMR000348676 (E)-1-(5-chloranylthiophen-2-yl)-3-[(2,5-dimethylphenyl)amino]-2-pyridin-1-ium-1-yl-3-sulfanylidene-prop-1-en-1-olate (E)-1-(5-chloro-2-thienyl)-3-(2,5-dimethylanilino)-2-pyridin-1-ium-1-yl-3-thioxo-prop-1-en-1-olate (E)-1-(5-chloro-2-thiophenyl)-3-(2,5-dimethylanilino)-2-(1-pyridin-1-iumyl)-3-sulfanylidene-1-propen-1-olate
(5E)-5-[(1-azepanylamino)methylidene]-1-(1-naphthalenyl)-1,3-diazinane-2,4,6-trione BDBM75079 (5E)-5-[(azepan-1-ylamino)methylene]-1-(1-naphthyl)barbituric acid 5-[1-(Azepan-1-ylamino)-meth-(E)-ylidene]-1-naphthalen-1-yl-pyrimidine-2,4,6-trione cid_5620316 (5E)-5-[(azepan-1-ylamino)methylidene]-1-naphthalen-1-yl-1,3-diazinane-2,4,6-trione SMR000435975 MLS000332617
1-[3-(4-methylpiperazin-1-yl)propyl]-3-naphthalen-1-ylurea MLS000090796 1-[3-(4-methyl-1-piperazinyl)propyl]-3-(1-naphthalenyl)urea cid_3237299 1-[3-(4-methylpiperazino)propyl]-3-(1-naphthyl)urea SMR000025399 1-[3-(4-methylpiperazin-1-yl)propyl]-3-naphthalen-1-yl-urea BDBM37696 N-[3-(4-methylpiperazin-1-yl)propyl]-N'-1-naphthylurea
1-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]-1-propanone 1-[4-(7-chloroquinolin-4-yl)piperazino]propan-1-one BDBM87326 1-[4-(7-chloranylquinolin-4-yl)piperazin-1-yl]propan-1-one SMR000459715 1-[4-(7-chloro-4-quinolyl)piperazino]propan-1-one MLS000860931 1-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propan-1-one cid_2823727
cid_2954650 BDBM41466 1-(1-adamantyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]urea SMR000076502 N-1-adamantyl-N'-[3-(2-oxo-1-pyrrolidinyl)propyl]urea 1-(1-adamantyl)-3-[3-(2-oxidanylidenepyrrolidin-1-yl)propyl]urea 1-(1-adamantyl)-3-[3-(2-oxo-1-pyrrolidinyl)propyl]urea MLS000050547 1-(1-adamantyl)-3-[3-(2-ketopyrrolidino)propyl]urea
3-(1-benzylpiperidin-4-yl)-1-(1-pentylindolin-5-yl)propan-1-one 3-(1-Benzyl-piperidin-4-yl)-1-(1-pentyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one BDBM50039231 CHEMBL73339
BDBM50039222 3-(1-Benzyl-piperidin-4-yl)-1-(1-butyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one 3-(1-benzylpiperidin-4-yl)-1-(1-butylindolin-5-yl)propan-1-one CHEMBL74922
CHEMBL307693 1-(1-benzylindolin-6-yl)-3-(1-benzylpiperidin-4-yl)propan-1-one 1-(1-Benzyl-2,3-dihydro-1H-indol-6-yl)-3-(1-benzyl-piperidin-4-yl)-propan-1-one BDBM50039220
CHEMBL308793 BDBM50037173 3-(1-Benzyl-piperidin-4-yl)-1-(1-ethyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one 3-(1-benzylpiperidin-4-yl)-1-(1-ethylindolin-5-yl)propan-1-one
CHEMBL311017 BDBM50037171 3-(1-benzylpiperidin-4-yl)-1-(1-methylindolin-5-yl)propan-1-one 3-(1-Benzyl-piperidin-4-yl)-1-(1-methyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one
CHEMBL74560 3-(1-benzylpiperidin-4-yl)-1-(1-propylindolin-5-yl)propan-1-one 3-(1-Benzyl-piperidin-4-yl)-1-(1-propyl-2,3-dihydro-1H-indol-5-yl)-propan-1-one BDBM50037141
MLS001223860 SMR000678435 1-(4-methylphenyl)-3-(1-naphthalenyl)thiourea 1-(4-methylphenyl)-3-naphthalen-1-ylthiourea BDBM64417 cid_12784448 1-(1-naphthyl)-3-(p-tolyl)thiourea 1-(4-methylphenyl)-3-naphthalen-1-yl-thiourea
Paraquat dichloride MLS001332595 BDBM96275 cid_5351279 Gramoxone 1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium;chloride SMR000875209 1-methyl-4-(1-methyl-4-pyridin-1-iumyl)pyridin-1-ium;chloride
US10647665, Example 1-35 US10647665, Example 1-34 US10647665, Example 1-37 US10647665, Example 1-36 US10647665, Example 1-38+++ US10851050, Example I-1 US10647665, Example 1-33 BDBM441846 US10647665, Example 1-32
1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine CHEMBL212878 BDBM50188116
BDBM285660 US10584132, Compound 1 US10077273, Compound 1 US10934305, Compound 1
BDBM292146 US10100057, Example 1 US9745310, Example 1 US11046702, Example 1
BDBM314688 US9611269, Example 1 US11214573, Example 1 US10513522, Example 1
BDBM316513 US11111242, Example 1 US20250134869, Example 1 US9617258, Example 1
BDBM340118 US10239883, Example 1 US9758524, Example 1 US10934296, Example 1
BDBM343402 US10442803, Example 1 US11091484, Example 1 US9777003, Example 1
BDBM397432 US11332464, Compound 1 US9988375, Compound 1 US10676470, Compound 1
BDBM50189276 CHEMBL212144 1-(1-(3,4-dihydronaphthalen-1-yl)ethylidene)thiosemicarbazide
BDBM518688 US11253514, Compound 1 US11116764, Compound 1 US11458135, Compound 1
US10172864, Compound 1 US10946023, Compound 1 US10028961, Compound 1 BDBM279854
US10226449, cpd 1 US9428502, 1 BDBM244392 US20250017938, Compound 002-1
US10329299, Compound 1 US10675286, Compound 1 BDBM339971 US9775844, Compound 1
US10399945, Example 1 BDBM412262 US10669239, Compound 1 US10927079, Compound 1
US10570125, Example 1 US11084810, Example 1 US11725004, Example 1 BDBM435491
US10596184, Example 1 US9586949, Example 1 US10022387, Example 1 BDBM281476
US10676433, Compound 1 BDBM398042 US10323000, Compound 1 US10322143, Compound 1
US10800769, Example 1 BDBM411427 US10392376, Example 1 US11434233, Example 1
US10807974, Example 1 US11608330, Example 1 BDBM468982 US10995088, Example 1
US11046696, Compound 1 BDBM311521 Ex. Cpd. 1 US10807986, Example 1
US11607396, Example 1 US11071721, Example 1 Synthetic Method #1 BDBM508754
US11702424, Example 1 US10793579, Example 1 BDBM402347 US10329302, Example 1
US11707471, Compound 1 US11701371, Compound 1 BDBM608782 US20230277570, Compound 1
US11713315, Example 1 BDBM472910 US10844057, Example 1 US10836763, Example 1
US20240300954, Entry 1 BDBM489590 US10961249, Entry 1 US11220505, Entry 1
US9145391, 1-6 US9145391, 1-7 US9145391, 1-9 BDBM182040
1-(1-phenyl-1,2,3,4-tetrazol-5-yl)benzotriazole SMR000062673 MLS000036035 1-(1-phenyl-5-tetrazolyl)benzotriazole BDBM95321 cid_2419715 1-(1-phenyltetrazol-5-yl)benzotriazole
1-(4-(Hexyloxy)phenyl)-3-(piperidin-1-yl)propan-1-one CHEMBL121893 BDBM50106183 1-(4-Hexyloxy-phenyl)-3-piperidin-1-yl-propan-1-one
2-(1-Indanylidene)-1-indanone SMR001548030 2-(2,3-dihydroinden-1-ylidene)-3H-inden-1-one cid_226774 2-indan-1-ylideneindan-1-one BDBM114819 MLS002638557
MLS000584134 BDBM46771 [[1-adamantyl(oxo)methyl]amino]thiourea cid_2726512 1-(1-adamantylcarbonylamino)thiourea SMR000203297 (adamantane-1-carbonylamino)thiourea 2-(1-adamantylcarbonyl)hydrazine-1-carbothioamide
cid_2814657 BDBM45739 MLS000858687 SMR000458766 1-(2-pyrrol-1-ylphenyl)piperidine 1-[2-(1H-pyrrol-1-yl)phenyl]piperidine 1-[2-(1-pyrrolyl)phenyl]piperidine
cid_6603077 BDBM73241 SMR000036796 3-(1-azepanyl)-1-(4-methoxyphenyl)-1-propanone;hydrochloride 3-(azepan-1-yl)-1-(4-methoxyphenyl)propan-1-one;hydrochloride MLS000071490
1-[1-(2-chlorophenyl)-2-oxocyclohexyl]-3-cyclohexyl-1-methylthiourea SMR000260093 1-[1-(2-chlorophenyl)-2-oxidanylidene-cyclohexyl]-3-cyclohexyl-1-methyl-thiourea BDBM42064 cid_4006073 1-[1-(2-chlorophenyl)-2-keto-cyclohexyl]-3-cyclohexyl-1-methyl-thiourea MLS000391056
SMR000287759 1-(3-fluorophenyl)-3-[1-(3-methylpiperidine-1-carbonyl)cyclohexyl]urea 1-(3-fluorophenyl)-3-[1-(3-methylpiperidin-1-yl)carbonylcyclohexyl]urea 1-(3-fluorophenyl)-3-[1-[(3-methyl-1-piperidinyl)-oxomethyl]cyclohexyl]urea BDBM63547 cid_3230449 MLS000708292
1-(2,5-dichlorophenyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone 1-[2,5-bis(chloranyl)phenyl]-2-(1-oxidanidylpyridin-1-ium-2-yl)sulfanyl-ethanone MLS001005509 1-(2,5-dichlorophenyl)-2-(1-oxidopyridin-1-ium-2-yl)sulfanylethanone BDBM49963 1-(2,5-dichlorophenyl)-2-[(1-oxidopyridin-1-ium-2-yl)thio]ethanone cid_2413701 SMR000384033
2-[(1-oxido-2-pyridin-1-iumyl)thio]-1-(4-phenylphenyl)ethanone cid_2375394 MLS001013316 2-(1-oxidopyridin-1-ium-2-yl)sulfanyl-1-(4-phenylphenyl)ethanone SMR000385257 2-(1-oxidanidylpyridin-1-ium-2-yl)sulfanyl-1-(4-phenylphenyl)ethanone 2-[(1-oxidopyridin-1-ium-2-yl)thio]-1-(4-phenylphenyl)ethanone BDBM97229
3-phenylpropyl 2-(1-methylpiperidin-1-ium-1-yl)acetate;iodide cid_16192815 2-(1-methylpiperidin-1-ium-1-yl)acetic acid 3-phenylpropyl ester;iodide 2-(1-methyl-1-piperidin-1-iumyl)acetic acid 3-phenylpropyl ester;iodide SMR000283943 BDBM80485 MLS000687269 3-phenylpropyl 2-(1-methylpiperidin-1-ium-1-yl)ethanoate;iodide
SMR000111154 3-[(1-benzylimidazol-2-yl)thio]-1-morpholino-propan-1-one BDBM41421 1-morpholin-4-yl-3-[1-(phenylmethyl)imidazol-2-yl]sulfanyl-propan-1-one cid_2853369 3-(1-benzylimidazol-2-yl)sulfanyl-1-morpholin-4-ylpropan-1-one MLS000106778 1-(4-morpholinyl)-3-[[1-(phenylmethyl)-2-imidazolyl]thio]-1-propanone
N-[1-(1-oxo-1-phenylpropan-2-yl)-4-pyridin-1-iumyl]acetamide;chloride MLS001211361 cid_23724231 4-Acetylamino-1-(1-methyl-2-oxo-2-phenyl-ethyl)-pyridinium BDBM63985 SMR000516888 N-[1-(1-oxidanylidene-1-phenyl-propan-2-yl)pyridin-1-ium-4-yl]ethanamide;chloride N-[1-(2-keto-1-methyl-2-phenyl-ethyl)pyridin-1-ium-4-yl]acetamide;chloride N-[1-(1-oxo-1-phenylpropan-2-yl)pyridin-1-ium-4-yl]acetamide;chloride
1-(2,3-dihydroindol-1-yl)-2-ethoxy-ethanone 1-(2,3-dihydroindol-1-yl)-2-ethoxyethanone cid_2163142 1-(ethoxyacetyl)indoline 2-ethoxy-1-indolin-1-yl-ethanone SMR000074952 BDBM30892 MLS000063308
US10899738, Cpd. No 355 4-(1-(cyclopent-1-en-1-yl)-1- phenyl-2-(pyrrolidin-1- yl)ethyl)-1-((1-(4- (phenylsulfonyl)phenyl) azetidin-3-yl)methyl)piperidine BDBM480293
US11136328, Compound LX-1 US10294230, Compound LX-1 US10584127, Compound LX-1 US9968610, Compound LX-1 BDBM280739 US10030026, Compound LX-1 US10221182, Compound LX-1 US10420768, Compound LX-1
1-[4-[(3,4-dimethoxyphenyl)methyl]piperazin-1-yl]-3-methyl-butan-1-one 1-[4-[(3,4-dimethoxyphenyl)methyl]-1-piperazinyl]-3-methyl-1-butanone 3-methyl-1-(4-veratrylpiperazino)butan-1-one MLS000108824 1-[4-[(3,4-dimethoxyphenyl)methyl]piperazin-1-yl]-3-methylbutan-1-one SMR000104774 cid_742523 BDBM38752
1-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]-3-methylbutan-1-one 1-[4-[(3-methoxyphenyl)methyl]-1-piperazinyl]-3-methyl-1-butanone 1-[4-[(3-methoxyphenyl)methyl]piperazin-1-yl]-3-methyl-butan-1-one SMR000104814 1-(4-m-anisylpiperazino)-3-methyl-butan-1-one cid_704402 BDBM38713 MLS000108864
3-(3-phenylpyrrolidin-1-yl)-1-(3,4,5-trimethoxyphenyl)propan-1-one;hydrochloride cid_2894350 3-(3-phenyl-1-pyrrolidinyl)-1-(3,4,5-trimethoxyphenyl)-1-propanone;hydrochloride 3-(3-phenylpyrrolidino)-1-(3,4,5-trimethoxyphenyl)propan-1-one;hydrochloride 3-(3-phenyl-1-pyrrolidinyl)-1-(3,4,5-trimethoxyphenyl)-1-propanone hydrochloride SMR000268900 MLS000666569 BDBM96657
BDBM90993 SMR000625861 1-(5-methylindazol-1-yl)-4-piperidin-1-ylbutane-1,4-dione 1-(5-methylindazol-1-yl)-4-piperidin-1-yl-butane-1,4-dione cid_22510093 1-(5-methyl-1-indazolyl)-4-(1-piperidinyl)butane-1,4-dione MLS001116065 1-(5-methylindazol-1-yl)-4-piperidino-butane-1,4-dione
(+/-)-1-(1'-(4-bromobenzyl)-3-phenyl-3,4'-bipiperidin-1-yl)propan-1-one BDBM50292669 CHEMBL496175
1-Cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol BDBM50062598 KEMADRIN PROCYCLIDINE CHEMBL86715
1-[4-(2-Hydroxy-1-methyl-ethyl)-piperidin-1-yl]-tridecan-1-one BDBM50281890 CHEMBL17239
1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-propan-1-one BDBM50125636 CHEMBL18810
4-Phenyl-1-[5-(pyrrolidine-1-carbonyl)-cyclopent-1-enyl]-butan-1-one CHEMBL186979 BDBM50155834
BDBM161388 US10124003, Ex. Compound 1 US10835536, Ex. Comp 1 US9108973, 1 US10894048, Ex Comp 1
BDBM50316837 4-phenyl-1-(2-(pyrrolidine-1-carbonyl)cyclopent-1-enyl)butan-1-one CHEMBL1088412
CHEMBL1085858 3-(1-benzylpiperidin-4-yl)-1-(1-phenylindolin-5-yl)propan-1-one BDBM50318852
CHEMBL109626 1-Methyl-1-(1-methyl-4-pyrrolidin-1-yl-but-2-ynyl)-urea BDBM50004728
CHEMBL19123 BDBM50125633 1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-butan-1-one
CHEMBL277828 1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-pentan-1-one BDBM50125635
Naphth-1-ol, 9 alpha-naphthol 1-Naphthol 1-Naphthalenol BDBM23450 CHEMBL122617 naphthalen-1-ol
US10047093, 8-1 US10392392, Example 8-1 BDBM242345 US9416132, 8-1 US10875864, EX. 8-1
US10617673, Example 1 BDBM286100 US11179370, Example 1 US9517228, Example 1 (4'S) US9987253, Example 1
US11285156, Ex.# 145-1 US11285156, Ex.# 145-1-1 BDBM544298 US11285156, Ex.# 145-1-2
US9605007, Example 1 US9315520, Example 2 US9315520, Example 1 US9315520, Comparator 1 BDBM223395 US9315520, 1
1-(2-azanylbenzimidazol-1-yl)-2-phenyl-ethanone 1-(2-aminobenzimidazol-1-yl)-2-phenyl-ethanone MLS-0425645.0001 BDBM62313 1-(2-aminobenzimidazol-1-yl)-2-phenylethanone 1-(2-amino-1-benzimidazolyl)-2-phenylethanone cid_1088429
3-(1-benzylpiperidin-4-yl)-1-(1-methyl-1,2,3,4-tetrahydroquinolin-7-yl)propan-1-one BDBM50039212 3-(1-Benzyl-piperidin-4-yl)-1-(1-methyl-1,2,3,4-tetrahydro-quinolin-7-yl)-propan-1-one CHEMBL76470
cid_1219325 N'-[1-(2-pyridinyl)ethylidene]-1-naphthohydrazide N-[1-(2-pyridinyl)ethylideneamino]-1-naphthalenecarboxamide MLS001147903 N-(1-pyridin-2-ylethylideneamino)naphthalene-1-carboxamide BDBM67373 SMR000672738 N-[1-(2-pyridyl)ethylideneamino]-1-naphthamide
CHEMBL150161 4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one (+)-4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one 4-[3-(4-Chloro-phenyl)-3-hydroxy-pyrrolidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one (-)-4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one (-)-4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one (+)-4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one BDBM50185474
1-(1-benzotriazolyl)-3-(2,3,5-trimethyl-1-indolyl)-2-propanol cid_650830 1-(benzotriazol-1-yl)-3-(2,3,5-trimethylindol-1-yl)propan-2-ol 1-Benzotriazol-1-yl-3-(2,3,5-trimethyl-indol-1-yl)-propan-2-ol BDBM62548 SMR000014382 MLS000034793
BDBM128208 SMR000117800 1-(2,3-dimethyl-1-indolyl)-2-(3,5-dimethyl-1-pyrazolyl)ethanone 1-(2,3-Dimethyl-indol-1-yl)-2-(3,5-dimethyl-pyrazol-1-yl)-ethanone 1-(2,3-dimethylindol-1-yl)-2-(3,5-dimethylpyrazol-1-yl)ethanone cid_802846 MLS000527326
BDBM44755 MLS000117084 1-[2-[(4-fluorophenyl)methylsulfanyl]-4,5-dihydroimidazol-1-yl]propan-1-one SMR000094038 1-[2-[(4-fluorophenyl)methylthio]-4,5-dihydroimidazol-1-yl]-1-propanone cid_4074953 1-[2-[(4-fluorobenzyl)thio]-2-imidazolin-1-yl]propan-1-one
BDBM61526 1-[2-(1-adamantyl)ethoxy]-3-(1-phenylethylamino)-2-propanol;hydrochloride cid_2882626 1-[2-(1-adamantyl)ethoxy]-3-[(1-phenylethyl)amino]-2-propanol hydrochloride MLS000684229 SMR000268028 1-[2-(1-adamantyl)ethoxy]-3-(1-phenylethylamino)propan-2-ol;hydrochloride
CHEMBL70848 1-(4-(4-(1-(4-(4-methoxyphenylsulfonyl)phenyl)vinyl)piperidin-1-yl)piperidin-1-yl)-2-methylpropan-1-one 1-(4-{1-[4-(4-Methoxy-benzenesulfonyl)-phenyl]-vinyl}-[1,4']bipiperidinyl-1'-yl)-2-methyl-propan-1-one BDBM50092971
MLS000566436 1-(1-azepanyl)-3-[4-(3,5-dinitrophenoxy)phenyl]-1-propanone cid_3107732 1-(azepan-1-yl)-3-[4-(3,5-dinitrophenoxy)phenyl]propan-1-one SMR000175073 BDBM94148 1-Azepan-1-yl-3-[4-(3,5-dinitro-phenoxy)-phenyl]-propan-1-one
cid_890322 2-(benzylthio)-1-indolin-1-yl-ethanone MLS000535227 2-benzylsulfanyl-1-(2,3-dihydroindol-1-yl)ethanone 1-(2,3-dihydroindol-1-yl)-2-(phenylmethylsulfanyl)ethanone 1-(2,3-dihydroindol-1-yl)-2-(phenylmethylthio)ethanone 1-[(benzylthio)acetyl]indoline SMR000142663 BDBM49434
1-phenylethanamine 1-phenylethylamine CHEMBL278059 alpha-Methylbenzylamine BDBM50023171 alpha-Phenylethylamine 1-amino-1-phenylethane 1-phenethylamine alpha-methylbenzenemethanamine alpha-aminoethylbenzene
CHEMBL172826 benzyl 2-[1-{1-[1-(1-amino-2-hydroxyethylcarboxamido)-2-carbamoylethylcarboxamido]-2-methylpropylcarboxamido}-2-(1-naphthyl)ethylcarboxamido]propanoate BDBM50015045
US10287258, Example 1 US11673871, Example 34 US11680049, Example 1 US20230278969, Example 1 BDBM50195236 US10669245, Example 1 US11117874, Example 1 CHEMBL3927609
benzyl 2-(1-{1-[1-(1-amino-2-hydroxy-1-methylethylcarboxamido)-2-carbamoylethylcarboxamido]-2-methylpropylcarboxamido}-2-phenylethylcarboxamido)propanoate BDBM50015051 CHEMBL368725
1-(1-benzofuran-2-yl)-3-(4-fluoroanilino)propan-1-one cid_1503535 SMR000307299 1-(2-benzofuranyl)-3-(4-fluoroanilino)-1-propanone 1-(benzofuran-2-yl)-3-(4-fluoroanilino)propan-1-one BDBM55808 MLS000729021 1-(1-benzofuran-2-yl)-3-[(4-fluorophenyl)amino]propan-1-one
1-[6-(4-methylpiperazin-1-yl)sulfonyl-2,3-dihydroindol-1-yl]ethanone SMR000231882 MLS000704444 1-[6-(4-methylpiperazino)sulfonylindolin-1-yl]ethanone 1-[6-[(4-methyl-1-piperazinyl)sulfonyl]-2,3-dihydroindol-1-yl]ethanone 1-acetyl-6-[(4-methyl-1-piperazinyl)sulfonyl]indoline cid_7314915 BDBM90305
2-(3,5-dimethyl-1-pyridin-1-iumyl)-1-(4-phenylphenyl)-1-propanone;bromide SMR000175322 MLS000567567 2-(3,5-dimethylpyridin-1-ium-1-yl)-1-(4-phenylphenyl)propan-1-one;bromide BDBM89274 cid_2848449 1-(2-Biphenyl-4-yl-1-methyl-2-oxo-ethyl)-3,5-dimethyl-pyridinium
BDBM66762 2-(2-methylpyridin-1-ium-1-yl)-1-phenylethanone;bromide 2-methyl-1-(2-oxo-2-phenylethyl)pyridinium bromide 2-(2-methylpyridin-1-ium-1-yl)-1-phenyl-ethanone;bromide 2-(2-methyl-1-pyridin-1-iumyl)-1-phenylethanone;bromide cid_12316824 SMR000549985 MLS001166233
(2S)-6-azanyl-2-(4-butyl-1,2,3-triazol-1-yl)-1-piperazin-1-yl-hexan-1-one;hydrochloride SMR000327432 YU-MONO-KI-DP BDBM52515 MLS000560535 (2S)-6-amino-2-(4-butyl-1-triazolyl)-1-(1-piperazinyl)-1-hexanone;hydrochloride cid_16129542 (2S)-6-amino-2-(4-butyltriazol-1-yl)-1-piperazino-hexan-1-one;hydrochloride (2S)-6-amino-2-(4-butyltriazol-1-yl)-1-piperazin-1-ylhexan-1-one;hydrochloride
1-(5,5-dimethyl-3-pyrrolidin-1-yl-cyclohex-2-en-1-ylidene)-3,5-dimethyl-piperidin-1-ium;iodide BDBM42457 MLS001003803 SMR000347624 1-(5,5-dimethyl-3-pyrrolidino-cyclohex-2-en-1-ylidene)-3,5-dimethyl-piperidin-1-ium;iodide cid_16196162 1-(5,5-dimethyl-3-pyrrolidin-1-ylcyclohex-2-en-1-ylidene)-3,5-dimethylpiperidin-1-ium;iodide 1-[5,5-dimethyl-3-(1-pyrrolidinyl)-1-cyclohex-2-enylidene]-3,5-dimethylpiperidin-1-ium;iodide
1-[1-(1-tert-butyl-5-tetrazolyl)-2-methylpropyl]-4-(phenylmethyl)piperidine SMR000119818 1-[1-(1-tert-butyl-1,2,3,4-tetrazol-5-yl)-2-methyl-propyl]-4-(phenylmethyl)piperidine cid_3193385 BDBM59399 4-benzyl-1-[1-(1-tert-butyltetrazol-5-yl)-2-methyl-propyl]piperidine 4-Benzyl-1-[1-(1-tert-butyl-1H-tetrazol-5-yl)-2-methyl-propyl]-piperidine MLS000122441 4-benzyl-1-[1-(1-tert-butyltetrazol-5-yl)-2-methylpropyl]piperidine
1-[5-[4-(4-acetylphenyl)piperazin-1-yl]sulfonyl-2-methyl-2,3-dihydroindol-1-yl]propan-1-one BDBM62250 1-[5-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-2-methyl-2,3-dihydroindol-1-yl]-1-propanone 1-[5-[4-(4-acetylphenyl)piperazino]sulfonyl-2-methyl-indolin-1-yl]propan-1-one 1-[5-[4-(4-ethanoylphenyl)piperazin-1-yl]sulfonyl-2-methyl-2,3-dihydroindol-1-yl]propan-1-one cid_44182144 MLS-0412139.0001
1-[5-amino-3-(furan-2-yl)-1,2,4-triazol-1-yl]butan-1-one BDBM33643 1-[5-azanyl-3-(furan-2-yl)-1,2,4-triazol-1-yl]butan-1-one MLS000527905 1-(5-Amino-3-furan-2-yl-[1,2,4]triazol-1-yl)-butan-1-one SMR000120479 1-[5-amino-3-(2-furyl)-1,2,4-triazol-1-yl]butan-1-one 1-[5-amino-3-(2-furanyl)-1,2,4-triazol-1-yl]-1-butanone cid_757193
3-cyclopentyl-1-[4-[2-(4-methylphenoxy)-1-oxoethyl]-1-piperazinyl]-1-propanone 3-cyclopentyl-1-[4-[2-(4-methylphenoxy)ethanoyl]piperazin-1-yl]propan-1-one 3-cyclopentyl-1-[4-[2-(4-methylphenoxy)acetyl]piperazin-1-yl]propan-1-one 3-cyclopentyl-1-[4-[2-(4-methylphenoxy)acetyl]piperazino]propan-1-one cid_651244 MLS000033159 BDBM53656 3-Cyclopentyl-1-[4-(2-p-tolyloxy-acetyl)-piperazin-1-yl]-propan-1-one SMR000012885
3-methoxy-1-[4-[4-[3-(3-oxidanylpropyl)piperidin-1-yl]carbonylphenoxy]piperidin-1-yl]propan-1-one cid_24790437 1-[4-[4-[3-(3-hydroxypropyl)piperidine-1-carbonyl]phenoxy]piperidino]-3-methoxy-propan-1-one 1-[4-[4-[[3-(3-hydroxypropyl)-1-piperidinyl]-oxomethyl]phenoxy]-1-piperidinyl]-3-methoxy-1-propanone MLS001082517 BDBM73987 SMR000658221 1-[4-[4-[3-(3-hydroxypropyl)piperidine-1-carbonyl]phenoxy]piperidin-1-yl]-3-methoxypropan-1-one
BDBM89399 1-[2-methyl-5-[4-(piperidine-1-carbonyl)piperidin-1-yl]sulfonyl-2,3-dihydroindol-1-yl]ethanone 1-[2-methyl-5-[4-(piperidine-1-carbonyl)piperidino]sulfonyl-indolin-1-yl]ethanone 1-[2-methyl-5-(4-piperidin-1-ylcarbonylpiperidin-1-yl)sulfonyl-2,3-dihydroindol-1-yl]ethanone 1-[2-methyl-5-[[4-[oxo(1-piperidinyl)methyl]-1-piperidinyl]sulfonyl]-2,3-dihydroindol-1-yl]ethanone MLS001122816 cid_20901939 SMR000628387
cid_1290001 BDBM66276 1-[3-fluoro-4-[4-(1-oxo-2-phenylethyl)-1-piperazinyl]phenyl]-1-propanone 1-[3-fluoro-4-[4-(2-phenylacetyl)piperazino]phenyl]propan-1-one MLS000049193 SMR000074921 1-{3-fluoro-4-[4-(phenylacetyl)-1-piperazinyl]phenyl}-1-propanone 1-[3-fluoranyl-4-[4-(2-phenylethanoyl)piperazin-1-yl]phenyl]propan-1-one 1-[3-fluoro-4-[4-(2-phenylacetyl)piperazin-1-yl]phenyl]propan-1-one
cid_20853388 SMR000622526 3-(1-acetylindolin-5-yl)sulfonyl-1-[4-(4-acetylphenyl)piperazino]propan-1-one 3-[(1-acetyl-2,3-dihydroindol-5-yl)sulfonyl]-1-[4-(4-acetylphenyl)piperazin-1-yl]propan-1-one 3-[(1-acetyl-2,3-dihydroindol-5-yl)sulfonyl]-1-[4-(4-acetylphenyl)-1-piperazinyl]-1-propanone BDBM90924 MLS000912320 3-[(1-ethanoyl-2,3-dihydroindol-5-yl)sulfonyl]-1-[4-(4-ethanoylphenyl)piperazin-1-yl]propan-1-one
cid_651401 MLS000027129 1-[1-(1-cyclopentyl-5-tetrazolyl)-2-methylpropyl]-3,4-dihydro-2H-quinoline SMR000002425 1-[1-(1-cyclopentyl-1,2,3,4-tetrazol-5-yl)-2-methyl-propyl]-3,4-dihydro-2H-quinoline 1-[1-(1-cyclopentyltetrazol-5-yl)-2-methylpropyl]-3,4-dihydro-2H-quinoline 1-[1-(1-cyclopentyltetrazol-5-yl)-2-methyl-propyl]-3,4-dihydro-2H-quinoline 1-[1-(1-Cyclopentyl-1H-tetrazol-5-yl)-2-methyl-propyl]-1,2,3,4-tetrahydro-quinoline BDBM41286
1-(1-adamantylcarbonyl)-3,5-dimethyl-1H-pyrazole 1-adamantyl-(3,5-dimethyl-1-pyrazolyl)methanone SMR000071865 cid_2932043 1-adamantyl-(3,5-dimethylpyrazol-1-yl)methanone BDBM75724 MLS000063040
2-AMINO-3-METHYL-1-PYRROLIDIN-1-YL-BUTAN-1-ONE BDBM50178428 CHEMBL383705 (S)-2-amino-3-methyl-1-(pyrrolidin-1-yl)butan-1-one
CHEMBL424429 1-(2-Methyl-1-phenyl-cyclohexyl)-piperidine trans-1-(2-Methyl-1-phenyl-cyclohexyl)-piperidine BDBM50009591 cis-1-(2-Methyl-1-phenyl-cyclohexyl)-piperidine
MLS000518901 BDBM52360 2-quinolin-1-ium-1-ylethanamide;iodide cid_11957261 SMR000129321 2-(1-quinolin-1-iumyl)acetamide;iodide 2-quinolin-1-ium-1-ylacetamide;iodide
SMR000625542 1-[4-(1,2,3,4-tetrazol-1-yl)phenyl]sulfonylpiperazine BDBM73003 1-[4-(tetrazol-1-yl)phenyl]sulfonylpiperazine 1-[4-(1-tetrazolyl)phenyl]sulfonylpiperazine MLS001116373 cid_4278096
US20240308995, Example 1-159 US20240308995, Example 1-157 US20240308995, Example 1-165 US20240308995, Example 1-155 US20240308995, Example 1-22 US20240308995, Example 1-161 BDBM696942
1-(2,3-dimethylphenyl)-4-(4-phenoxybutanoyl)piperazine MLS000099578 cid_2164014 1-[4-(2,3-dimethylphenyl)piperazin-1-yl]-4-phenoxy-butan-1-one 1-[4-(2,3-dimethylphenyl)piperazin-1-yl]-4-phenoxybutan-1-one SMR000071334 1-[4-(2,3-dimethylphenyl)-1-piperazinyl]-4-phenoxy-1-butanone 1-[4-(2,3-dimethylphenyl)piperazino]-4-phenoxy-butan-1-one BDBM76985
1-(3,6-dimethyl-4-oxido-1-oxo-2-quinoxalin-1-iumyl)ethanone cid_659760 BDBM96240 MLS000038174 1-(3,6-dimethyl-4-oxidanidyl-1-oxidanylidene-quinoxalin-1-ium-2-yl)ethanone 1-(3,6-dimethyl-4-oxido-1-oxoquinoxalin-1-ium-2-yl)ethanone SMR000037747 1-(1-keto-3,6-dimethyl-4-oxido-quinoxalin-1-ium-2-yl)ethanone
1-[4-(4-chlorophenyl)-1-piperazinyl]-3-phenyl-1-propanone 1-[4-(4-chlorophenyl)piperazino]-3-phenyl-propan-1-one cid_757895 MLS000532877 SMR000140315 1-(4-chlorophenyl)-4-(3-phenylpropanoyl)piperazine BDBM77196 1-[4-(4-chlorophenyl)piperazin-1-yl]-3-phenylpropan-1-one 1-[4-(4-chlorophenyl)piperazin-1-yl]-3-phenyl-propan-1-one
1-[4-(4-fluorophenyl)piperazin-1-yl]-4-phenoxy-butan-1-one BDBM77276 SMR000141837 1-(4-fluorophenyl)-4-(4-phenoxybutanoyl)piperazine MLS000534401 cid_2286724 1-[4-(4-fluorophenyl)piperazin-1-yl]-4-phenoxybutan-1-one 1-[4-(4-fluorophenyl)-1-piperazinyl]-4-phenoxy-1-butanone 1-[4-(4-fluorophenyl)piperazino]-4-phenoxy-butan-1-one
4-(1-naphthylmethyl)-N-(3-pyridinylmethylene)-1-piperazinamine [4-(1-naphthylmethyl)piperazino]-(3-pyridylmethylene)amine cid_873924 N-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-1-pyridin-3-yl-methanimine N-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-1-pyridin-3-ylmethanimine BDBM72133 MLS000570883 SMR000193305 N-[4-(1-naphthalenylmethyl)-1-piperazinyl]-1-(3-pyridinyl)methanimine
BDBM90035 SMR000195829 1-(4-nitrophenyl)-4-(4-phenylbutanoyl)piperazine cid_2907423 1-[4-(4-nitrophenyl)piperazin-1-yl]-4-phenyl-butan-1-one 1-[4-(4-nitrophenyl)piperazin-1-yl]-4-phenylbutan-1-one 1-[4-(4-nitrophenyl)-1-piperazinyl]-4-phenyl-1-butanone MLS000574237 1-[4-(4-nitrophenyl)piperazino]-4-phenyl-butan-1-one
MLS000521152 4-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-1-(1-phenylethyl)-2-pyrrolidinone 4-[4-(4-fluorophenyl)piperazin-1-yl]carbonyl-1-(1-phenylethyl)pyrrolidin-2-one 4-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1-(1-phenylethyl)pyrrolidin-2-one cid_4115048 4-[4-(4-fluorophenyl)piperazine-1-carbonyl]-1-(1-phenylethyl)-2-pyrrolidone SMR000131561 BDBM71972
N-[3-[(1-adamantylcarbonyl)amino]-5-(1-piperidinylcarbonyl)phenyl]-1-adamantanecarboxamide BDBM41588 cid_4287683 N-[3-[[1-adamantyl(oxo)methyl]amino]-5-[oxo(1-piperidinyl)methyl]phenyl]-1-adamantanecarboxamide N-[3-(adamantane-1-carbonylamino)-5-(piperidine-1-carbonyl)phenyl]adamantane-1-carboxamide N-[3-(1-adamantylcarbonylamino)-5-piperidin-1-ylcarbonyl-phenyl]adamantane-1-carboxamide SMR000114790 MLS000549502
(2S)-6-azanyl-2-[4-[(1R)-1-azanyl-2-oxidanyl-ethyl]-1,2,3-triazol-1-yl]-1-piperazin-1-yl-hexan-1-one;hydrochloride (2S)-6-amino-2-[4-[(1R)-1-amino-2-hydroxy-ethyl]triazol-1-yl]-1-piperazino-hexan-1-one;hydrochloride (2S)-6-amino-2-[4-[(1R)-1-amino-2-hydroxyethyl]-1-triazolyl]-1-(1-piperazinyl)-1-hexanone;hydrochloride (2S)-6-amino-2-[4-[(1R)-1-amino-2-hydroxyethyl]triazol-1-yl]-1-piperazin-1-ylhexan-1-one;hydrochloride MLS000560619 BDBM63369 cid_16129564 CD-MONO-SK-DP SMR000327459
1-cetylpyridin-1-ium-4-carboxamide;bromide BDBM48708 1-hexadecylpyridin-1-ium-4-carboxamide;bromide 4-Carbamoyl-1-hexadecyl-pyridinium MLS000551857 SMR000173885 cid_11979277 1-hexadecyl-4-pyridin-1-iumcarboxamide;bromide
BDBM688744 (2S)-2-amino-N-(1-{[((2R)-3-(benzoxy)-1-{1-methansulfonyl-1,2-dihydrospiro[indol-3,4-piperidin]-1-yl}-1-oxopropan-2-yl]carbamoyl}-1-methylethyl)glutaramide US20240190875, Example 1
2-(1-methylpiperidin-1-ium-1-yl)acetic acid (4-tert-butylcyclohexyl) ester;iodide 2-(1-methyl-1-piperidin-1-iumyl)acetic acid (4-tert-butylcyclohexyl) ester;iodide BDBM65275 cid_16188603 (4-tert-butylcyclohexyl) 2-(1-methylpiperidin-1-ium-1-yl)ethanoate;iodide MLS000727632 1-{2-[(4-tert-butylcyclohexyl)oxy]-2-oxoethyl}-1-methylpiperidinium (4-tert-butylcyclohexyl) 2-(1-methylpiperidin-1-ium-1-yl)acetate;iodide SMR000306329
3-(3-phenylpyrrolidino)-1-(2-thienyl)propan-1-one;hydrochloride BDBM96553 3-(3-phenylpyrrolidin-1-yl)-1-thiophen-2-yl-propan-1-one;hydrochloride 3-(3-phenylpyrrolidin-1-yl)-1-thiophen-2-ylpropan-1-one;hydrochloride 3-(3-phenyl-1-pyrrolidinyl)-1-thiophen-2-yl-1-propanone;hydrochloride 3-(3-Phenyl-pyrrolidin-1-yl)-1-thiophen-2-yl-propan-1-one cid_2893244 MLS000035953 SMR000011654
BDBM76310 2-phenyl-1-(4-propoxyphenyl)-3-pyrrolidin-1-yl-propan-1-one;hydrochloride 2-phenyl-1-(4-propoxyphenyl)-3-(1-pyrrolidinyl)-1-propanone;hydrochloride cid_9550023 2-phenyl-1-(4-propoxyphenyl)-3-pyrrolidin-1-ylpropan-1-one;hydrochloride MLS000552436 2-Phenyl-1-(4-propoxy-phenyl)-3-pyrrolidin-1-yl-propan-1-one 2-phenyl-1-(4-propoxyphenyl)-3-pyrrolidino-propan-1-one;hydrochloride SMR000145951
BDBM80445 cid_16187875 2-(1-methylpyrrolidin-1-ium-1-yl)acetic acid (4-tert-butylcyclohexyl) ester;iodide (4-tert-butylcyclohexyl) 2-(1-methylpyrrolidin-1-ium-1-yl)acetate;iodide MLS000727631 1-{2-[(4-tert-butylcyclohexyl)oxy]-2-oxoethyl}-1-methylpyrrolidinium SMR000306328 (4-tert-butylcyclohexyl) 2-(1-methylpyrrolidin-1-ium-1-yl)ethanoate;iodide 2-(1-methyl-1-pyrrolidin-1-iumyl)acetic acid (4-tert-butylcyclohexyl) ester;iodide
1-(4-morpholinyl)-2-(1-phthalazinylthio)ethanone 1-morpholin-4-yl-2-phthalazin-1-ylsulfanylethanone MLS000055598 1-morpholin-4-yl-2-phthalazin-1-ylsulfanyl-ethanone BDBM87644 SMR000060123 cid_740778 1-morpholino-2-(phthalazin-1-ylthio)ethanone
BDBM50102343 1-(2,5-dimethylthiophen-3-yl)-3-(4-(naphthalen-1-yl)piperazin-1-yl)propan-1-one 1-(2,5-Dimethyl-thiophen-3-yl)-3-(4-naphthalen-1-yl-piperazin-1-yl)-propan-1-one CHEMBL441481
MLS000714263 BDBM43446 3-methyl-1-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-1-butanone cid_717239 SMR000274243 3-methyl-1-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]butan-1-one 3-methyl-1-(4-tosylpiperazino)butan-1-one
MLS000861662 N1-(3-chlorophenyl)-2-(1-naphthylmethylidene)hydrazine-1-carbothioamide cid_708594 1-(3-chlorophenyl)-3-(naphthalen-1-ylmethylideneamino)thiourea BDBM44164 SMR000460446 1-(3-chlorophenyl)-3-(1-naphthalenylmethylideneamino)thiourea 1-(3-chlorophenyl)-3-(1-naphthylmethyleneamino)thiourea
SMR000469582 N-(2-hydroxynaphthalen-1-yl)naphthalene-1-sulfonamide N-(2-hydroxy-1-naphthalenyl)-1-naphthalenesulfonamide BDBM63918 N-(2-oxidanylnaphthalen-1-yl)naphthalene-1-sulfonamide MLS001045580 cid_16738608 N-(2-hydroxy-1-naphthyl)naphthalene-1-sulfonamide
US10899738, Cpd. No 357 4-(1-(cyclopent-1-en-1-yl)-1- phenyl-2-(pyrrolidin-1- yl)ethyl)-1-((1-(4-((1- methyl-1H-pyrazol-4- yl)sulfonyl)phenyl)azetidin- 3-yl)methyl)piperidine BDBM480295
(+)-N3-(1-(1-adamantyl)ethyl)-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide BDBM50224046 CHEMBL236333 ((+/-)-N3-(1-(1-adamantyl)ethyl)-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide (-)-N3-(1-(1-adamantyl)ethyl)-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide
1-(2-Fluoro-phenyl)-4-(piperidine-1-sulfonyl)-piperazine 1-(2-fluorophenyl)-4-(1-piperidinylsulfonyl)piperazine 1-(2-fluorophenyl)-4-piperidinosulfonyl-piperazine cid_1094970 1-(2-fluorophenyl)-4-piperidin-1-ylsulfonyl-piperazine SMR000124636 1-(2-fluorophenyl)-4-piperidin-1-ylsulfonylpiperazine MLS000067211 BDBM45445
3-(3,4-dichlorophenyl)-1-(furan-2-ylmethyl)-1-(1-thiophen-2-ylethyl)urea 3-(3,4-dichlorophenyl)-1-(2-furanylmethyl)-1-(1-thiophen-2-ylethyl)urea MLS000521125 cid_5123484 BDBM39678 SMR000131534 3-(3,4-dichlorophenyl)-1-(2-furfuryl)-1-[1-(2-thienyl)ethyl]urea
3-(4-ethylphenyl)-1-(2-furfuryl)-1-[1-(2-thienyl)ethyl]urea 3-(4-ethylphenyl)-1-(2-furanylmethyl)-1-(1-thiophen-2-ylethyl)urea BDBM84158 cid_4613736 SMR000131533 3-(4-ethylphenyl)-1-(furan-2-ylmethyl)-1-(1-thiophen-2-ylethyl)urea MLS000521124
MLS000709391 1-(3-phenylprop-2-ynyl)-1-prop-2-ynylpiperidin-1-ium;iodide 1-(3-phenylprop-2-ynyl)-1-propargyl-piperidin-1-ium;iodide BDBM72519 1-(3-phenylprop-2-ynyl)-1-prop-2-ynyl-piperidin-1-ium;iodide cid_16192999 SMR000290058
MLS001176175 cid_16241912 SMR000588013 2-(3-acetylpyridin-1-ium-1-yl)-N-(1-phenylethyl)acetamide;chloride 2-(3-ethanoylpyridin-1-ium-1-yl)-N-(1-phenylethyl)ethanamide;chloride BDBM80563 2-(3-acetyl-1-pyridin-1-iumyl)-N-(1-phenylethyl)acetamide;chloride
SMR000143429 1-[2-(4-methoxyphenoxy)propanoyl]-4-methylpiperidine cid_2952398 MLS000536392 2-(4-methoxyphenoxy)-1-(4-methyl-1-piperidinyl)-1-propanone 2-(4-methoxyphenoxy)-1-(4-methylpiperidino)propan-1-one BDBM62985 2-(4-methoxyphenoxy)-1-(4-methylpiperidin-1-yl)propan-1-one
cid_4232205 BDBM41367 3-(3,4-dimethylphenyl)-1-(3-methoxypropyl)-1-(1-pyridin-2-ylethyl)urea MLS000120182 3-(3,4-dimethylphenyl)-1-(3-methoxypropyl)-1-[1-(2-pyridyl)ethyl]urea SMR000097099 3-(3,4-dimethylphenyl)-1-(3-methoxypropyl)-1-[1-(2-pyridinyl)ethyl]urea
(E)-3-[1-(4-Methyl-piperazin-1-ylmethyl)-1H-indol-3-yl]-1-phenyl-propenone (E)-3-[1-[(4-methylpiperazino)methyl]indol-3-yl]-1-phenyl-prop-2-en-1-one BDBM49460 cid_6236941 (E)-3-[1-[(4-methylpiperazin-1-yl)methyl]indol-3-yl]-1-phenylprop-2-en-1-one (E)-3-[1-[(4-methylpiperazin-1-yl)methyl]indol-3-yl]-1-phenyl-prop-2-en-1-one SMR000149460 MLS000559144 (E)-3-[1-[(4-methyl-1-piperazinyl)methyl]-3-indolyl]-1-phenyl-2-propen-1-one
1-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]-3-methyl-1-butanone SMR000104788 1-[4-(3-fluorobenzyl)piperazino]-3-methyl-butan-1-one 1-[4-[(3-fluorophenyl)methyl]piperazin-1-yl]-3-methyl-butan-1-one cid_742529 1-[4-[(3-fluorophenyl)methyl]piperazin-1-yl]-3-methylbutan-1-one MLS000108838 BDBM38766
2-[3-(2,5-dimethylbenzyl)sulfonylindol-1-yl]-1-piperidino-ethanone cid_12006156 2-[3-[(2,5-dimethylphenyl)methylsulfonyl]indol-1-yl]-1-piperidin-1-ylethanone 2-[3-[(2,5-dimethylphenyl)methylsulfonyl]indol-1-yl]-1-piperidin-1-yl-ethanone BDBM53835 2-[3-[(2,5-dimethylphenyl)methylsulfonyl]-1-indolyl]-1-(1-piperidinyl)ethanone MLS000696711 SMR000237189
N-[1-(azepan-1-yl)-1-oxo-3-phenylpropan-2-yl]benzamide N-[2-(azepan-1-yl)-1-benzyl-2-keto-ethyl]benzamide SMR000689035 N-[1-(1-azepanyl)-1-oxo-3-phenylpropan-2-yl]benzamide BDBM66912 N-[1-(azepan-1-yl)-1-oxidanylidene-3-phenyl-propan-2-yl]benzamide MLS001151096 cid_24818270
N-mesityl-N'-{[1-(1-phenylethyl)pyrrolidin-3-yl]methyl}thiourea 1-[[1-(1-phenylethyl)pyrrolidin-3-yl]methyl]-3-(2,4,6-trimethylphenyl)thiourea BDBM81074 MLS000682538 SMR000311895 cid_4559464 1-[[1-(1-phenylethyl)-3-pyrrolidinyl]methyl]-3-(2,4,6-trimethylphenyl)thiourea 1-mesityl-3-[[1-(1-phenylethyl)pyrrolidin-3-yl]methyl]thiourea
SMR000427247 1-methyl-N-(1-methyl-2-pyridin-1-iumyl)-2-pyridinimine;iodide 1-Methyl-2-[1-methyl-1H-pyridin-(2E)-ylideneamino]-pyridinium 1-methyl-N-(1-methylpyridin-1-ium-2-yl)pyridin-2-imine;iodide BDBM61314 (1-methylpyridin-1-ium-2-yl)-(1-methyl-2-pyridylidene)amine;iodide MLS001030036 cid_2848485
SMR000538769 1-(4-chlorophenyl)-2-phenyl-3-(1-piperidinyl)-1-propanone;hydrochloride 1-(4-chlorophenyl)-2-phenyl-3-piperidin-1-yl-propan-1-one;hydrochloride cid_24747433 BDBM79581 1-(4-chlorophenyl)-2-phenyl-3-piperidino-propan-1-one;hydrochloride 1-(4-chlorophenyl)-2-phenyl-3-piperidin-1-ylpropan-1-one;hydrochloride MLS001173584
cid_773338 3-Methyl-1-[4-(2-methyl-benzyl)-piperazin-1-yl]-butan-1-one 3-methyl-1-[4-(2-methylbenzyl)piperazino]butan-1-one 3-methyl-1-[4-[(2-methylphenyl)methyl]-1-piperazinyl]-1-butanone MLS001212001 BDBM64050 3-methyl-1-[4-[(2-methylphenyl)methyl]piperazin-1-yl]butan-1-one SMR000516388
1-Nonanol Nonan-1-ol BDBM22607
1-Subsituted 1H-imidazole, 1 BDBM84667
BDBM136690 US8865686, Table 1, Compound 1
BDBM155253 US9006242, 1 US10098888, Compound 1
BDBM160509 US9682969, 1 US10280160, Example 1.
BDBM162310 US9051313, 1 US10307427, Compound 1
BDBM171353 US9085571, Table 1, Compound 1
BDBM177760 US9120785, Example 1 Enantiomer 1
BDBM181158 US9783501, Compound 1 US9139529, 1
BDBM185584 US9156852, 1 USRE47451, Example 1
BDBM186571 US10787472, Compound 1 US9163042, 1
BDBM228661 US9346810, 1 US10369153, Compound 1
BDBM232455 US9604984, Example 1 US9346815, 1
BDBM235713 US10117875, Example 1 US9359361, 1
BDBM238151 US9394291, 1 US10017502, Example 1
BDBM241369 US9951071, Example 1 US9409908, 1
BDBM256503 US9481648, 1 US9790174, Example 1
BDBM260527 US10300066, Compound 1 US9532990, 1
BDBM261741 US10233178, Example 1 US9708309, 1
BDBM294039 Process 1 US10106557, Compound 1
BDBM3 thymidine/ATP (1:1 mixture)
BDBM458487 US10745388, Example 1, Peak 1
BDBM490735 US10968242, Example 1 Peak 1
BDBM50443636 US9174993, 1 CHEMBL3092460 US9221828, 1
BDBM537981 US11248006, Compound 1-1-3
BDBM537982 US11248006, Compound 1-1-4
BDBM538030 US11248006, Compound 4-1-1
BDBM538032 US11248006, Compound 6-1-1
BDBM538033 US11248006, Compound 7-1-1
BDBM538034 US11248006, Compound 8-1-1
BDBM538039 US11248006, Compound 9-1-1
BDBM563686 US11414384, Example 1 Isomer 1
BDBM636152 US20230365541, Compound 1, isomer 1
BDBM724022 US20250066290, Example 2-1/1
LI-1 Legumain Inhibitor -1 BDBM36332
US10000475, Compound 1 BDBM177772 US9120786, 1
US10011593, Ex. 1 BDBM308049 US9650366, 1
US10100018, Example 1 US9464060, 1 BDBM251665
US10137110, Example 2-1-1 BDBM303076
US10336717, Compound 1 BDBM195418 US9212153, 1
US11248006, Compound 1-1-2 BDBM537980
US11248006, Compound 1-1-5 BDBM537983
US11248006, Compound 1-1-6 BDBM537984
US11248006, Compound 1-2-1 BDBM537985
US11248006, Compound 1-3-1 BDBM537987
US11248006, Compound 10-1-1 BDBM538040
US11248006, Compound 3-1-1 BDBM537994
US11248006, Compound 5-1-1 BDBM538031
US11274090, Example 1 Isomer 1 BDBM541995
US11365192, Example 69-1-1 BDBM558455
US11524945, Compound 1 (Csbl-1) BDBM582530
US8957075, Table 1 Compound 1 BDBM147107
US9011882, Table 1, Compound 1 BDBM155508
US9035074, 1 US10966980, Example 1 BDBM159747
US9090621, 1 BDBM197176 US9572811, Example 1
US9161922, Table 1, Compound 1 BDBM185636
US9174999, Table 1, Compound 1 BDBM190233
US9200016, 1 US9902710, Compound 1 BDBM194319
US9200020, Table 1, Compound 1 BDBM194490
US9216999, 1 US9556187, Example 1 BDBM198193
US9233108, 1 BDBM200741 US9757383, Example 1
US9242975, 1 US10227340, Example 1 BDBM203282
US9243020, 1 US9815861, Example 1 BDBM205419
US9340537, 1 US9896444, Example 1 BDBM230747
US9393245, 1 US10085990, Example 1 BDBM235278
US9403810, 1 BDBM239091 US10195181, Example 1
US9493486, 1 US10633384, Example 1 BDBM258479
US9512114, 1 BDBM259442 US9657007, Example 1
US9526727, 1 BDBM259488 US9949975, Example 1
US9540323, 1 BDBM260815 US9540323, example 1
US9656968, Compound 1 US9163008, 1 BDBM185912
US9682141, 1 BDBM118949 US11547697, Compound 1
US9682965, 1 US10023561, Example 1 BDBM148432
US9682966, 1 BDBM152764 US10118915, Compound 1
US9744252, Example 1 BDBM228620 US9345793, 1
US9790212, Example 1 BDBM259324 US9505745, 1
US9920060, 1 BDBM376907 US10329300, Example 1
WO2022093856, Example 1-21-1 BDBM548324
WO2022093856, Example 1-24-1 BDBM548328
Swenson, RE Sphingosine 1-phosphate receptor antagonists US Patent US9663511 (2017)
Dyckman, AJ Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P J Med Chem 60: 5267 -5289 (2017)
Urbano, M; Guerrero, M; Rosen, H; Roberts, E Modulators of the Sphingosine 1-phosphate receptor 1. Bioorg Med Chem Lett 23: 6377 -89 (2013)
Xiang, Y; Asmussen, G; Booker, M; Hirth, B; Kane, JL; Liao, J; Noson, KD; Yee, C Discovery of novel sphingosine kinase 1 inhibitors. Bioorg Med Chem Lett 19: 6119 -21 (2009)
Kennedy, AJ; Mathews, TP; Kharel, Y; Field, SD; Moyer, ML; East, JE; Houck, JD; Lynch, KR; Macdonald, TL Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. J Med Chem 54: 3524 -48 (2011)
Wong, L; Tan, SS; Lam, Y; Melendez, AJ Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases. J Med Chem 52: 3618 -26 (2009)
Marciniak, A; Camp, SM; Garcia, JGN; Polt, R An update on sphingosine-1-phosphate receptor 1 modulators. Bioorg Med Chem Lett 28: 3585 -3591 (2018)
Shrader, CW; Foster, D; Kharel, Y; Huang, T; Lynch, KR; Santos, WL Imidazole-based sphingosine-1-phosphate transporter Spns2 inhibitors. Bioorg Med Chem Lett 96: (2023)
Lynch, KR; Macdonald, TL; Mathews, TP; Kennedy, A; Kharel, Y Imidamide sphingosine kinase inhibitors US Patent US9421177 (2016)
Childress, ES; Kharel, Y; Brown, AM; Bevan, DR; Lynch, KR; Santos, WL Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity. J Med Chem 60: 3933 -3957 (2017)
Wang, J; Knapp, S; Pyne, NJ; Pyne, S; Elkins, JM Crystal Structure of Sphingosine Kinase 1 with PF-543. ACS Med Chem Lett 5: 1329 -33 (2014)
Xiang, Y; Hirth, B; Kane, JL; Liao, J; Noson, KD; Yee, C; Asmussen, G; Fitzgerald, M; Klaus, C; Booker, M Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorg Med Chem Lett 20: 4550 -4 (2010)
Horan, JC; Sanyal, S; Choi, Y; Hill-Drzewi, M; Patnaude, L; Anderson, S; Fogal, S; Mao, C; Cook, BN; Gueneva-Boucheva, K; Fisher, MB; Hickey, E; Pack, E; Bannen, LC; Chan, DS; Mac, MB; Ng, SM; Wang, Y; Xu, W; Modis, LK; Lemieux, RM Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists. Bioorg Med Chem Lett 24: 4807 -11 (2014)
Roberts, E; Rosen, H; Brown, S; Guerrero, MA; Peng, X; Poddutoori, R Modulators of sphingosine phosphate receptors US Patent US10544136 (2020)
Xiao, HY; Watterson, SH; Langevine, CM; Srivastava, AS; Ko, SS; Zhang, Y; Cherney, RJ; Guo, WW; Gilmore, JL; Sheppeck, JE; Wu, DR; Li, P; Ramasamy, D; Arunachalam, P; Mathur, A; Taylor, TL; Shuster, DJ; McIntyre, KW; Shen, DR; Yarde, M; Cvijic, ME; Marino, AM; Balimane, PV; Yang, Z; Banas, DM; Cornelius, G; D'Arienzo, CJ; Warrack, BM; Lehman-McKeeman, L; Salter-Cid, LM; Xie, J; Barrish, JC; Carter, PH; Dyckman, AJ; Dhar, TG Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P J Med Chem 59: 9837 -9854 (2016)
Hengst, JA; Wang, X; Sk, UH; Sharma, AK; Amin, S; Yun, JK Development of a sphingosine kinase 1 specific small-molecule inhibitor. Bioorg Med Chem Lett 20: 7498 -502 (2010)
Hennessy, EJ; Grewal, G; Byth, K; Kamhi, VM; Li, D; Lyne, P; Oza, V; Ronco, L; Rooney, MT; Saeh, JC; Su, Q Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists. Bioorg Med Chem Lett 25: 2041 -5 (2015)
Bell, M; Foley, D; Naylor, C; Robinson, C; Riley, J; Epemolu, O; Scullion, P; Shishikura, Y; Katz, E; McLean, WHI; Wyatt, P; Read, KD; Woodland, A Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1. Bioorg Med Chem Lett 28: 3255 -3259 (2018)
Vachal, P; Toth, LM; Hale, JJ; Yan, L; Mills, SG; Chrebet, GL; Koehane, CA; Hajdu, R; Milligan, JA; Rosenbach, MJ; Mandala, S Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorg Med Chem Lett 16: 3684 -7 (2006)
Santos, WL; Lynch, KR; Macdonald, TL; Kennedy, A; Kharel, Y; Raje, MR; Houck, J Long chain base sphingosine kinase inhibitors US Patent US9688668 (2017)
Fritzemeier, R; Foster, D; Peralta, A; Payette, M; Kharel, Y; Huang, T; Lynch, KR; Santos, WL Discovery of In Vivo Active Sphingosine-1-phosphate Transporter (Spns2) Inhibitors. J Med Chem 65: 7656 -7681 (2022)
Abdel-Magid, AF Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments. ACS Med Chem Lett 4: 1014 -5 (2013)
PubChem, PC Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 1 (S1P1) counterscreen assay PubChem Bioassay (2010)
Vettorazzi, M; Angelina, E; Lima, S; Gonec, T; Otevrel, J; Marvanova, P; Padrtova, T; Mokry, P; Bobal, P; Acosta, LM; Palma, A; Cobo, J; Bobalova, J; Csollei, J; Malik, I; Alvarez, S; Spiegel, S; Jampilek, J; Enriz, RD An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors. Eur J Med Chem 139: 461 -481 (2017)
Bagdanoff, JT; Donoviel, MS; Nouraldeen, A; Tarver, J; Fu, Q; Carlsen, M; Jessop, TC; Zhang, H; Hazelwood, J; Nguyen, H; Baugh, SD; Gardyan, M; Terranova, KM; Barbosa, J; Yan, J; Bednarz, M; Layek, S; Courtney, LF; Taylor, J; Digeorge-Foushee, AM; Gopinathan, S; Bruce, D; Smith, T; Moran, L; O'Neill, E; Kramer, J; Lai, Z; Kimball, SD; Liu, Q; Sun, W; Yu, S; Swaffield, J; Wilson, A; Main, A; Carson, KG; Oravecz, T; Augeri, DJ Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J Med Chem 52: 3941 -53 (2009)
PubChem, PC Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 2 (S1P2) counterscreen assay PubChem Bioassay (2010)
PubChem, PC Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 3 (S1P3) counterscreen assay PubChem Bioassay (2010)
PubChem, PC Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 5 (S1P5) counterscreen assay PubChem Bioassay (2010)
Bell, M; Foley, D; Naylor, C; Wood, G; Robinson, C; Riley, J; Epemolu, O; Ellis, L; Scullion, P; Shishikura, Y; Osuna-Cabello, M; Ferguson, L; Pinto, E; Fletcher, D; Katz, E; McLean, WHI; Wyatt, P; Read, KD; Woodland, A Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1). ACS Med Chem Lett 10: 341 -347 (2019)
Park, SJ; Yeon, SK; Kim, Y; Kim, HJ; Kim, S; Kim, J; Choi, JW; Kim, B; Lee, EH; Kim, R; Seo, SH; Lee, J; Kim, JW; Lee, HY; Hwang, H; Bahn, YS; Cheong, E; Park, JH; Park, KD Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis. J Med Chem 65: 3539 -3562 (2022)
Ibrahim, MA; Johnson, HW; Jeong, JW; Lewis, GL; Shi, X; Noguchi, RT; Williams, M; Leahy, JW; Nuss, JM; Woolfrey, J; Banica, M; Bentzien, F; Chou, YC; Gibson, A; Heald, N; Lamb, P; Mattheakis, L; Matthews, D; Shipway, A; Wu, X; Zhang, W; Zhou, S; Shankar, G Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonists. J Med Chem 55: 1368 -81 (2012)
Xu, H; Zhang, H; Luan, L; Xu, Y; Li, C; Wang, Y; Han, F; Yang, T; Ren, F; Xiang, JN; Elliott, JD; Zhao, Y; Guo, TB; Lu, H; Zhang, W; Hirst, D; Lindon, M; Lin, X Discovery of thiadiazole amides as potent, S1P3-sparing agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorg Med Chem Lett 22: 2456 -9 (2012)
Colandrea, VJ; Legiec, IE; Huo, P; Yan, L; Hale, JJ; Mills, SG; Bergstrom, J; Card, D; Chebret, G; Hajdu, R; Keohane, CA; Milligan, JA; Rosenbach, MJ; Shei, GJ; Mandala, SM 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorg Med Chem Lett 16: 2905 -8 (2006)
Butler, KJ; Castro, AA; Dwyer, TS; Hardwick, LM; Iacino, MC; Manore, SG; Mays, KM; McGlade, CA; Hair, LN; Parker, EW; Smith, MR; Turnow, MT; Wilson, MR; Woodson, SR; Cotham, WE; Walla, MD; Hurlbert, JC; Christian Grattan, T Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailability. Bioorg Med Chem Lett 50: (2021)
Dinges, J; Harris, CM; Wallace, GA; Argiriadi, MA; Queeney, KL; Perron, DC; Dominguez, E; Kebede, T; Desino, KE; Patel, H; Vasudevan, A Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors. Bioorg Med Chem Lett 26: 2297 -302 (2016)
Houck, JD; Dawson, TK; Kennedy, AJ; Kharel, Y; Naimon, ND; Field, SD; Lynch, KR; Macdonald, TL Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles. ACS Med Chem Lett 7: 487 -92 (2016)
Qu, W; Ploessl, K; Truong, H; Kung, MP; Kung, HF Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation. Bioorg Med Chem Lett 19: 3382 -5 (2009)
Futerman, AH; Joseph, T; Shaw, WA; Burgess, SW; Li, S Sphingosine analogs and use thereof against bacterial lung infections US Patent US11471430 (2022)
Tu, Z; Rosenberg, A; Liu, H; Han, J Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof US Patent US10676467 (2020)
Buzard, DJ; Kim, SH; Lopez, L; Kawasaki, A; Zhu, X; Moody, J; Thoresen, L; Calderon, I; Ullman, B; Han, S; Lehmann, J; Gharbaoui, T; Sengupta, D; Calvano, L; Montalban, AG; Ma, YA; Sage, C; Gao, Y; Semple, G; Edwards, J; Barden, J; Morgan, M; Chen, W; Usmani, K; Chen, C; Sadeque, A; Christopher, RJ; Thatte, J; Fu, L; Solomon, M; Mills, D; Whelan, K; Al-Shamma, H; Gatlin, J; Le, M; Gaidarov, I; Anthony, T; Unett, DJ; Blackburn, A; Rueter, J; Stirn, S; Behan, DP; Jones, RM Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor. ACS Med Chem Lett 5: 1313 -7 (2014)
Evindar, G; Deng, H; Bernier, SG; Doyle, E; Lorusso, J; Morgan, BA; Westlin, WF Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. Bioorg Med Chem Lett 23: 472 -5 (2012)
Guo, J; Watterson, SH; Spergel, SH; Kempson, J; Langevine, CM; Shen, DR; Yarde, M; Cvijic, ME; Banas, D; Liu, R; Suchard, SJ; Gillooly, K; Taylor, T; Rex-Rabe, S; Shuster, DJ; McIntyre, KW; Cornelius, G; D'Arienzo, C; Marino, A; Balimane, P; Salter-Cid, L; McKinnon, M; Barrish, JC; Carter, PH; Pitts, WJ; Xie, J; Dyckman, AJ Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1). Bioorg Med Chem Lett 26: 2470 -4 (2016)
SanllehÃ, P; Abad, JL; Casas, J; Bujons, J; Delgado, A Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors. Bioorg Med Chem 24: 4381 -4389 (2016)
Urbano, M; Guerrero, M; Zhao, J; Velaparthi, S; Schaeffer, MT; Brown, S; Rosen, H; Roberts, E SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor. Bioorg Med Chem Lett 21: 5470 -4 (2011)
Angst, D; Janser, P; Quancard, J; Buehlmayer, P; Berst, F; Oberer, L; Beerli, C; Streiff, M; Pally, C; Hersperger, R; Bruns, C; Bassilana, F; Bollbuck, B An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation. J Med Chem 55: 9722 -34 (2012)
Knott, K; Kharel, Y; Raje, MR; Lynch, KR; Santos, WL Effect of alkyl chain length on sphingosine kinase 2 selectivity. Bioorg Med Chem Lett 22: 6817 -20 (2012)
Baek, DJ; MacRitchie, N; Anthony, NG; Mackay, SP; Pyne, S; Pyne, NJ; Bittman, R Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors. J Med Chem 56: 9310 -27 (2013)
Evindar, G; Bernier, SG; Doyle, E; Kavarana, MJ; Satz, AL; Lorusso, J; Blanchette, HS; Saha, AK; Hannig, G; Morgan, BA; Westlin, WF Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists. Bioorg Med Chem Lett 20: 2520 -4 (2010)
Meng, Q; Zhao, B; Xu, Q; Xu, X; Deng, G; Li, C; Luan, L; Ren, F; Wang, H; Xu, H; Xu, Y; Zhang, H; Xiang, JN; Elliott, JD; Guo, TB; Zhao, Y; Zhang, W; Lu, H; Lin, X Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists. Bioorg Med Chem Lett 22: 2794 -7 (2012)
Zécri, FJ; Albert, R; Landrum, G; Hinterding, K; Cooke, NG; Guerini, D; Streiff, M; Bruns, C; Nuesslein-Hildesheim, B Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P(1)) receptor agonists. Bioorg Med Chem Lett 20: 35 -7 (2010)
Evindar, G; Bernier, SG; Kavarana, MJ; Doyle, E; Lorusso, J; Kelley, MS; Halley, K; Hutchings, A; Wright, AD; Saha, AK; Hannig, G; Morgan, BA; Westlin, WF Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists. Bioorg Med Chem Lett 19: 369 -72 (2008)
Ren, F; Deng, G; Wang, H; Luan, L; Meng, Q; Xu, Q; Xu, H; Xu, X; Zhang, H; Zhao, B; Li, C; Guo, TB; Yang, J; Zhang, W; Zhao, Y; Jia, Q; Lu, H; Xiang, JN; Elliott, JD; Lin, X Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)). J Med Chem 55: 4286 -96 (2012)
Byun, HS; Pyne, S; Macritchie, N; Pyne, NJ; Bittman, R Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells. Medchemcomm 4: (2013)
Burgio, AL; Shrader, CW; Kharel, Y; Huang, T; Salamoun, JM; Lynch, KR; Santos, WL 2-Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2). J Med Chem 66: 5873 -5891 (2023)
Yan, L; Budhu, R; Huo, P; Lynch, CL; Hale, JJ; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Chrebet, G; Bergstrom, J; Card, D; Mandala, SM 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorg Med Chem Lett 16: 3564 -8 (2006)
Hanessian, S; Charron, G; Billich, A; Guerini, D Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors. Bioorg Med Chem Lett 17: 491 -4 (2007)
Li, H; Sibley, CD; Kharel, Y; Huang, T; Brown, AM; Wonilowicz, LG; Bevan, DR; Lynch, KR; Santos, WL Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors. Bioorg Med Chem 30: (2021)
Koide, Y; Uemoto, K; Hasegawa, T; Sada, T; Murakami, A; Takasugi, H; Sakurai, A; Mochizuki, N; Takahashi, A; Nishida, A Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold. J Med Chem 50: 442 -54 (2007)
Kurata, H; Otsuki, K; Kusumi, K; Kurono, M; Terakado, M; Seko, T; Mizuno, H; Ono, T; Hagiya, H; Minami, M; Nakade, S; Habashita, H Structure-activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-ß-alanine moiety. Bioorg Med Chem Lett 21: 1390 -3 (2011)
Luo, Z; Liu, H; Yu, Y; Gropler, RJ; Klein, RS; Tu, Z Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2. RSC Med Chem 13: 202 -207 (2022)
Kurata, H; Kusumi, K; Otsuki, K; Suzuki, R; Kurono, M; Komiya, T; Hagiya, H; Mizuno, H; Shioya, H; Ono, T; Takada, Y; Maeda, T; Matsunaga, N; Kondo, T; Tominaga, S; Nunoya, KI; Kiyoshi, H; Komeno, M; Nakade, S; Habashita, H Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P J Med Chem 60: 9508 -9530 (2017)
Hennessy, EJ; Oza, V; Adam, A; Byth, K; Castriotta, L; Grewal, G; Hamilton, GA; Kamhi, VM; Lewis, P; Li, D; Lyne, P; Öster, L; Rooney, MT; Saeh, JC; Sha, L; Su, Q; Wen, S; Xue, Y; Yang, B Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. J Med Chem 58: 7057 -75 (2015)
Watterson, SH; Guo, J; Spergel, SH; Langevine, CM; Moquin, RV; Shen, DR; Yarde, M; Cvijic, ME; Banas, D; Liu, R; Suchard, SJ; Gillooly, K; Taylor, T; Rex-Rabe, S; Shuster, DJ; McIntyre, KW; Cornelius, G; D'Arienzo, C; Marino, A; Balimane, P; Warrack, B; Salter-Cid, L; McKinnon, M; Barrish, JC; Carter, PH; Pitts, WJ; Xie, J; Dyckman, AJ Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series. J Med Chem 59: 2820 -40 (2016)
Raje, MR; Knott, K; Kharel, Y; Bissel, P; Lynch, KR; Santos, WL Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors. Bioorg Med Chem 20: 183 -94 (2011)
Gustin, DJ; Li, Y; Brown, ML; Min, X; Schmitt, MJ; Wanska, M; Wang, X; Connors, R; Johnstone, S; Cardozo, M; Cheng, AC; Jeffries, S; Franks, B; Li, S; Shen, S; Wong, M; Wesche, H; Xu, G; Carlson, TJ; Plant, M; Morgenstern, K; Rex, K; Schmitt, J; Coxon, A; Walker, N; Kayser, F; Wang, Z Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorg Med Chem Lett 23: 4608 -16 (2013)
Hale, JJ; Lynch, CL; Neway, W; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Parent, SA; Chrebet, G; Bergstrom, J; Card, D; Ferrer, M; Hodder, P; Strulovici, B; Rosen, H; Mandala, S A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists. J Med Chem 47: 6662 -5 (2004)
Lanman, BA; Cee, VJ; Cheruku, SR; Frohn, M; Golden, J; Lin, J; Lobera, M; Marantz, Y; Muller, KM; Neira, SC; Pickrell, AJ; Rivenzon-Segal, D; Schutz, N; Sharadendu, A; Yu, X; Zhang, Z; Buys, J; Fiorino, M; Gore, A; Horner, M; Itano, A; McElvain, M; Middleton, S; Schrag, M; Vargas, HM; Xu, H; Xu, Y; Zhang, X; Siu, J Discovery of a Potent, S1P3 -Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1 ) ACS Med Chem Lett 2: 102 -106 (2011)
Beard, RL; Yuan, H; Donello, JE; Liu, X; Duong, T 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity US Patent US8524917 (2013)
Luo, Z; Liu, H; Klein, RS; Tu, Z Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor. Bioorg Med Chem 27: 3619 -3631 (2019)
Guerrero, M; Urbano, M; Zhao, J; Crisp, M; Chase, P; Hodder, P; Schaeffer, MT; Brown, S; Rosen, H; Roberts, E Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists. Bioorg Med Chem Lett 22: 537 -42 (2011)
SanllehÃ, P; Abad, JL; Bujons, J; Casas, J; Delgado, A Studies on the inhibition of sphingosine-1-phosphate lyase by stabilized reaction intermediates and stereodefined azido phosphates. Eur J Med Chem 123: 905 -915 (2016)
Clemens, JJ; Davis, MD; Lynch, KR; Macdonald, TL Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. Bioorg Med Chem Lett 14: 4903 -6 (2004)
Clemens, JJ; Davis, MD; Lynch, KR; Macdonald, TL Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists. Bioorg Med Chem Lett 13: 3401 -4 (2003)
Adams, DR; Tawati, S; Berretta, G; Rivas, PL; Baiget, J; Jiang, Z; Alsfouk, A; Mackay, SP; Pyne, NJ; Pyne, S Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2. J Med Chem 62: 3658 -3676 (2019)
Skidmore, J; Heer, J; Johnson, CN; Norton, D; Redshaw, S; Sweeting, J; Hurst, D; Cridland, A; Vesey, D; Wall, I; Ahmed, M; Rivers, D; Myatt, J; Giblin, G; Philpott, K; Kumar, U; Stevens, A; Bit, RA; Haynes, A; Taylor, S; Watson, R; Witherington, J; Demont, E; Heightman, TD Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles. J Med Chem 57: 10424 -42 (2014)
Vogt, D; Weber, J; Ihlefeld, K; Brüggerhoff, A; Proschak, E; Stark, H Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors. Bioorg Med Chem 22: 5354 -67 (2014)
Demont, EH; Bailey, JM; Bit, RA; Brown, JA; Campbell, CA; Deeks, N; Dowell, SJ; Eldred, C; Gaskin, P; Gray, JR; Haynes, A; Hirst, DJ; Holmes, DS; Kumar, U; Morse, MA; Osborne, GJ; Renaux, JF; Seal, GA; Smethurst, CA; Taylor, S; Watson, R; Willis, R; Witherington, J Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses. J Med Chem 59: 1003 -20 (2016)
Guerrero, M; Urbano, M; Velaparthi, S; Zhao, J; Schaeffer, MT; Brown, S; Rosen, H; Roberts, E Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists. Bioorg Med Chem Lett 21: 3632 -6 (2011)
PubChem, PC Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) PubChem Bioassay (2009)
Foss, FW; Snyder, AH; Davis, MD; Rouse, M; Okusa, MD; Lynch, KR; Macdonald, TL Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg Med Chem 15: 663 -77 (2006)
Liu, Z; MacRitchie, N; Pyne, S; Pyne, NJ; Bittman, R Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators. Bioorg Med Chem 21: 2503 -10 (2013)
Li, Z; Chen, W; Hale, JJ; Lynch, CL; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Chrebet, G; Parent, SA; Bergstrom, J; Card, D; Forrest, M; Quackenbush, EJ; Wickham, LA; Vargas, H; Evans, RM; Rosen, H; Mandala, S Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3. J Med Chem 48: 6169 -73 (2005)
Evindar, G; Satz, AL; Bernier, SG; Kavarana, MJ; Doyle, E; Lorusso, J; Taghizadeh, N; Halley, K; Hutchings, A; Kelley, MS; Wright, AD; Saha, AK; Hannig, G; Morgan, BA; Westlin, WF Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists. Bioorg Med Chem Lett 19: 2315 -9 (2009)
Schnute, ME; McReynolds, MD; Carroll, J; Chrencik, J; Highkin, MK; Iyanar, K; Jerome, G; Rains, JW; Saabye, M; Scholten, JA; Yates, M; Nagiec, MM Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits. J Med Chem 60: 2562 -2572 (2017)
PubChem, PC Late stage fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) PubChem Bioassay (2010)
Clemens, JJ; Davis, MD; Lynch, KR; Macdonald, TL Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists. Bioorg Med Chem Lett 15: 3568 -72 (2005)
Yan, L; Huo, P; Hale, JJ; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Chrebet, G; Bergstrom, J; Card, D; Mandala, SM SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties. Bioorg Med Chem Lett 17: 828 -31 (2007)
Yan, L; Hale, JJ; Lynch, CL; Budhu, R; Gentry, A; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Chrebet, G; Bergstrom, J; Card, D; Rosen, H; Mandala, SM Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorg Med Chem Lett 14: 4861 -6 (2004)
Gilmore, JL; Sheppeck, JE; Watterson, SH; Haque, L; Mukhopadhyay, P; Tebben, AJ; Galella, MA; Shen, DR; Yarde, M; Cvijic, ME; Borowski, V; Gillooly, K; Taylor, T; McIntyre, KW; Warrack, B; Levesque, PC; Li, JP; Cornelius, G; D'Arienzo, C; Marino, A; Balimane, P; Salter-Cid, L; Barrish, JC; Pitts, WJ; Carter, PH; Xie, J; Dyckman, AJ Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). J Med Chem 59: 6248 -64 (2016)
Zhang, S; Chen, X; Wu, C; Xu, H; Xie, X; Feng, M; Hu, S; Bai, H; Gao, F; Tong, L; Ding, J; Liu, H; Xie, Z; Wang, J Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer. J Med Chem 65: 7697 -7716 (2022)
Wang, S; Huo, Y; Zhang, J; Li, L; Cao, F; Song, Y; Zhang, Y; Yang, K Design, synthesis, antitumor activity, and molecular dynamics simulations of novel sphingosine kinase 2 inhibitors. Bioorg Med Chem 93: (2023)
Hengst, JA; Hegde, S; Paulson, RF; Yun, JK Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization. Bioorg Med Chem Lett 30: (2020)
Congdon, MD; Kharel, Y; Brown, AM; Lewis, SN; Bevan, DR; Lynch, KR; Santos, WL Structure-Activity Relationship Studies and Molecular Modeling of Naphthalene-Based Sphingosine Kinase 2 Inhibitors. ACS Med Chem Lett 7: 229 -34 (2016)
Congdon, MD; Childress, ES; Patwardhan, NN; Gumkowski, J; Morris, EA; Kharel, Y; Lynch, KR; Santos, WL Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors. Bioorg Med Chem Lett 25: 4956 -60 (2015)
PubChem, PC Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) PubChem Bioassay (2010)
Ohno, H; Honda, M; Hamada, N; Miyagaki, J; Iwata, A; Otsuki, K; Maruyama, T; Nakamura, S; Nakanishi, I; Inuki, S; Fujii, N; Oishi, S Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B. Bioorg Med Chem 25: 3046 -3052 (2017)
PubChem, PC Late stage fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized analogues PubChem Bioassay (2010)
PubChem, PC Late-stage fluorescence dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized compounds PubChem Bioassay (2010)
Yan, L; Huo, P; Doherty, G; Toth, L; Hale, JJ; Mills, SG; Hajdu, R; Keohane, CA; Rosenbach, MJ; Milligan, JA; Shei, GJ; Chrebet, G; Bergstrom, J; Card, D; Quackenbush, E; Wickham, A; Mandala, SM Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorg Med Chem Lett 16: 3679 -83 (2006)
Hobson, AD; Harris, CM; van der Kam, EL; Turner, SC; Abibi, A; Aguirre, AL; Bousquet, P; Kebede, T; Konopacki, DB; Gintant, G; Kim, Y; Larson, K; Maull, JW; Moore, NS; Shi, D; Shrestha, A; Tang, X; Zhang, P; Sarris, KK Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders. J Med Chem 58: 9154 -70 (2015)
PubChem, PC Late-stage fluorescence dose response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): purchased compounds EC50 PubChem Bioassay (2011)
Weiler, S; Braendlin, N; Beerli, C; Bergsdorf, C; Schubart, A; Srinivas, H; Oberhauser, B; Billich, A Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis. J Med Chem 57: 5074 -84 (2014)
PubChem, PC Fluorescence-based counterscreen assay for S1P4 agonists: Cell-based dose response high throughput screening assay to identify agonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) PubChem Bioassay (2010)
Sibley, CD; Morris, EA; Kharel, Y; Brown, AM; Huang, T; Bevan, DR; Lynch, KR; Santos, WL Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity. J Med Chem 63: 1178 -1198 (2020)
Congdon, M; Fritzemeier, RG; Kharel, Y; Brown, AM; Serbulea, V; Bevan, DR; Lynch, KR; Santos, WL Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors. Eur J Med Chem 212: (2021)
Gilmore, JL; Xiao, HY; Dhar, TGM; Yang, MG; Xiao, Z; Xie, J; Lehman-McKeeman, LD; Gong, L; Sun, H; Lecureux, L; Chen, C; Wu, DR; Dabros, M; Yang, X; Taylor, TL; Zhou, XD; Heimrich, EM; Thomas, R; McIntyre, KW; Borowski, V; Warrack, BM; Li, Y; Shi, H; Levesque, PC; Yang, Z; Marino, AM; Cornelius, G; D'Arienzo, CJ; Mathur, A; Rampulla, R; Gupta, A; Pragalathan, B; Shen, DR; Cvijic, ME; Salter-Cid, LM; Carter, PH; Dyckman, AJ Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P J Med Chem 62: 2265 -2285 (2019)
Bombrun, A; Schwarz, M; Crosignani, S; Covini, D; Marin, D 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis US Patent US9150519 (2015)
PubChem, PC Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 2 (S1P2) PubChem Bioassay (2010)
PubChem, PC Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) PubChem Bioassay (2010)
PubChem, PC Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 5 (S1P5) PubChem Bioassay (2010)
PubChem, PC Late-stage fluorescence dose response cell-based counterscreening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): inhibition by S1P4-selective antagonist PubChem Bioassay (2010)
Xi, M; Ge, J; Wang, X; Sun, C; Liu, T; Fang, L; Xiao, Q; Yin, D Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice. Bioorg Med Chem 24: 3218 -30 (2016)
Luo, D; Zhang, Y; Yang, S; Tian, X; Lv, Y; Guo, Z; Liu, X; Han, G; Liu, S; Wang, W; Cui, S; Qu, X; Wan, S Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer. Eur J Med Chem 225: (2021)
Hamada, M; Nakamura, M; Kiuchi, M; Marukawa, K; Tomatsu, A; Shimano, K; Sato, N; Sugahara, K; Asayama, M; Takagi, K; Adachi, K Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate. J Med Chem 53: 3154 -68 (2010)
Tangadanchu, VKR; Jiang, H; Yu, Y; Graham, TJA; Liu, H; Rogers, BE; Gropler, R; Perlmutter, J; Tu, Z Structure-activity relationship studies and bioactivity evaluation of 1,2,3-triazole containing analogues as a selective sphingosine kinase-2 inhibitors. Eur J Med Chem 206: (2020)
Patwardhan, NN; Morris, EA; Kharel, Y; Raje, MR; Gao, M; Tomsig, JL; Lynch, KR; Santos, WL Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors. J Med Chem 58: 1879 -99 (2015)
Plano, D; Amin, S; Sharma, AK Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. J Med Chem 57: 5509 -24 (2014)
Aurelio, L; Scullino, CV; Pitman, MR; Sexton, A; Oliver, V; Davies, L; Rebello, RJ; Furic, L; Creek, DJ; Pitson, SM; Flynn, BL From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II). J Med Chem 59: 965 -84 (2016)
Lane, T; Makarov, V; Nelson, JAE; Meeker, RB; Sanna, G; Riabova, O; Kazakova, E; Monakhova, N; Tsedilin, A; Urbina, F; Jones, T; Suchy, A; Ekins, S -Phenyl-1-(phenylsulfonyl)-1 J Med Chem 66: 6193 -6217 (2023)
Ma, C; Li, Q; Zhao, M; Fan, G; Zhao, J; Zhang, D; Yang, S; Zhang, S; Gao, D; Mao, L; Zhu, L; Li, W; Xu, G; Jiang, Y; Ding, Q Discovery of 1-Amino-1 J Med Chem 64: 16242 -16270 (2021)
Chrovian, CC; Soyode-Johnson, A; Wall, JL; Rech, JC; Schoellerman, J; Lord, B; Coe, KJ; Carruthers, NI; Nguyen, L; Jiang, X; Koudriakova, T; Balana, B; Letavic, MA 1 ACS Med Chem Lett 10: 261 -266 (2019)
ChEMBL_643861 (CHEMBL1211760) Inhibition of sphingosine kinase 1
ChEMBL_1276448 (CHEMBL3088544) Inhibition of sphingosine kinase 1 (unknown origin)
ChEMBL_686925 (CHEMBL1291294) Competitive inhibition of recombinant sphingosine kinase 1 using D-erythro-sphingosine as substrate by Lineweaver-Burke plot analysis
Inhibition Assay Inhibition assay using sphingosine-1-phosphate receptor 3.
ChEMBL_653533 (CHEMBL1226736) Antagonist activity at human S1P1 receptor expressed in CHO cells assessed as inhibition of SEW2871-induced [35S]GTPgamma binding
ChEMBL_499713 (CHEMBL980648) Displacement of [33P]sphingosine-1-phosphate from human S1P1 receptor
ChEMBL_499714 (CHEMBL980649) Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL_499715 (CHEMBL980650) Displacement of [33P]sphingosine-1-phosphate from human S1P4 receptor
ChEMBL_499716 (CHEMBL980651) Displacement of [33P]sphingosine-1-phosphate from human S1P5 receptor
ChEMBL_540418 (CHEMBL1029035) Displacement of [33P]sphingosine-1-phosphate from human S1P1 receptor
ChEMBL_540419 (CHEMBL1029036) Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor
ChEMBL_540420 (CHEMBL1029037) Displacement of [33P]sphingosine-1-phosphate from human S1P4 receptor
ChEMBL_540421 (CHEMBL1029038) Displacement of [33P]sphingosine-1-phosphate from human S1P5 receptor
ChEMBL_1276446 (CHEMBL3088542) Inhibition of recombinant sphingosine kinase 1 (unknown origin) expressed in HEK293 cells using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP
ChEMBL_1276445 (CHEMBL3088541) Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP
ChEMBL_519984 (CHEMBL951813) Inhibition of sphingosine-1-phosphate lyase in mouse spleen by scintillation counting
ChEMBL_590261 (CHEMBL1052796) Inhibition of human sphingosine kinase 1 by off chip mobility shift assay
ChEMBL_304296 (CHEMBL830091) Effective concentration against sphingosine-1-phosphate receptor 1 determined by a [c-35S]-GTP binding assay
ChEMBL_1575591 (CHEMBL3803908) Inhibition of human sphingosine 1-phosphate lyase after 22 hrs by umbelliferone fluorescence analysis
ChEMBL_430293 (CHEMBL913919) Displacement of [33P]sphingosine 1 phosphate from human S1P1 receptor expressed in CHO cells
ChEMBL_430294 (CHEMBL913920) Displacement of [33P]sphingosine 1 phosphate from human S1P2 receptor expressed in CHO cells
ChEMBL_430295 (CHEMBL913921) Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells
ChEMBL_430296 (CHEMBL913922) Displacement of [33P]sphingosine 1 phosphate from human S1P4 receptor expressed in CHO cells
ChEMBL_430297 (CHEMBL913923) Displacement of [33P]sphingosine 1 phosphate from human S1P5 receptor expressed in CHO cells
ChEMBL_1632373 (CHEMBL3875079) Inhibition of PI3Kbeta in HUVEC assessed as reduction in sphingosine-1-phosphate stimulated akt phosphorylation at Ser473 residue preincubated for 15 mins followed by sphingosine-1-phosphate stimulation for 5 mins by HTRF assay
ChEMBL_201317 (CHEMBL806167) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes
ChEMBL_306053 (CHEMBL833009) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes
ChEMBL_1575592 (CHEMBL3803909) Inhibition of wild-type full-length human sphingosine 1-phosphate lyase transfected in HEK293-H cells preincubated for 30 mins followed by addition of NBD-sphingosine for 3 hrs by fluorescence analysis
ChEMBL_304306 (CHEMBL830101) Effective concentration against sphingosine 1-phosphate receptor 2 determined by a [c-35S]-GTP binding assay
ChEMBL_304307 (CHEMBL830102) Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay
ChEMBL_304308 (CHEMBL830103) Effective concentration against sphingosine 1-phosphate receptor 4 determined by a [c-35S]-GTP binding assay
ChEMBL_304309 (CHEMBL830104) Effective concentration against sphingosine 1-phosphate receptor 5 determined by a [c-35S]-GTP binding assay
ChEBML_1553848 Inhibition of SK1 (unknown origin) using 5 uM of sphingosine as substrate
ChEMBL_201334 (CHEMBL806183) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL_201335 (CHEMBL806184) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 4 expressed on CHO cell membranes
ChEMBL_201454 (CHEMBL807599) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 5 expressed on CHO cell membranes
ChEMBL_306054 (CHEMBL833010) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 2 expressed on CHO cell membranes
ChEMBL_306055 (CHEMBL833011) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes
ChEMBL_306056 (CHEMBL833012) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 4 expressed on CHO cell membranes
ChEMBL_306057 (CHEMBL833013) Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 5 expressed on CHO cell membranes
ChEBML_201314 Binding affinity to human Sphingosine 1-phosphate receptor 1 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201315 Binding affinity to human sphingosine 1-phosphate receptor 1 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201312 (CHEMBL800919) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL_201311 (CHEMBL805799) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL_201314 (CHEMBL800921) Binding affinity to human Sphingosine 1-phosphate receptor 1 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201316 (CHEMBL806166) Binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_1553848 (CHEMBL3767362) Inhibition of SK1 (unknown origin) using 5 uM of sphingosine as substrate
ChEMBL_1553849 (CHEMBL3767363) Inhibition of SK1 (unknown origin) using 3 uM of sphingosine as substrate
ChEMBL_1700859 (CHEMBL4051841) Inhibition of recombinant mouse SPHK1 using sphingosine as substrate in presence ATP
ChEMBL_1700860 (CHEMBL4051842) Inhibition of recombinant mouse SPHK2 using sphingosine as substrate in presence ATP
ChEMBL_1700865 (CHEMBL4051847) Inhibition of recombinant human SPHK1 using sphingosine as substrate in presence ATP
ChEMBL_1800086 (CHEMBL4272378) Binding affinity to SK1 (unknown origin) assessed as inhibition of sphingosine phosphorylation
ChEMBL_1365136 (CHEMBL3292343) Inhibition of SphK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate
ChEMBL_1582610 (CHEMBL3816951) Inhibition of SphK1 in mouse erythrocytes using sphingosine as substrate by luminescence assay
ChEMBL_1700862 (CHEMBL4051844) Inhibition of recombinant human SPHK1 using sphingosine as substrate by ADP-Quest assay
ChEMBL_1700866 (CHEMBL4051848) Inhibition of recombinant human SPHK2 using sphingosine as substrate by ADP-Quest assay
ChEMBL_201313 (CHEMBL800920) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand. (Experiment 2)
ChEMBL_201319 (CHEMBL806169) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL_201327 (CHEMBL806176) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL_201456 (CHEMBL807601) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 1)
ChEMBL_304394 (CHEMBL830044) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEBML_201322 Binding affinity to human sphingosine 1-phosphate receptor 2 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201324 Binding affinity towards human sphingosine 1-phosphate receptor 2 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201331 Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201333 Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201448 Binding affinity to human sphingosine 1-phosphate receptor 4 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201449 Binding affinity to human sphingosine 1-phosphate receptor 4 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEBML_201450 Binding affinity towards human sphingosine 1-phosphate receptor 4 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_627320 (CHEMBL1108112) Displacement of [33P]sphingosine-1-phosphate from human S1P1 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL_627321 (CHEMBL1108113) Displacement of [33P]sphingosine-1-phosphate from human S1P3 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL_627322 (CHEMBL1108114) Displacement of [33P]sphingosine-1-phosphate from human S1P4 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL_627323 (CHEMBL1108115) Displacement of [33P]sphingosine-1-phosphate from human S1P5 receptor expressed in HEK293T cells after 60 mins by scintillation counting
ChEMBL_1683754 (CHEMBL4034233) Inhibition of human SphK1 using sphingosine as substrate in presence of [gamma-32P]ATP
ChEMBL_1683755 (CHEMBL4034234) Inhibition of human SphK2 using sphingosine as substrate in presence of [gamma-32P]ATP
ChEMBL_201318 (CHEMBL806168) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL_201322 (CHEMBL806172) Binding affinity to human sphingosine 1-phosphate receptor 2 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201323 (CHEMBL806173) Binding affinity to human sphingosine 1-phosphate receptor 2 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201324 (CHEMBL873240) Binding affinity towards human sphingosine 1-phosphate receptor 2 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201326 (CHEMBL806175) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL_201331 (CHEMBL806180) Binding affinity to human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201333 (CHEMBL806182) Binding affinity towards human sphingosine 1-phosphate receptor 3 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201444 (CHEMBL807590) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL_201448 (CHEMBL873237) Binding affinity to human sphingosine 1-phosphate receptor 4 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201451 (CHEMBL807596) Binding affinity to human sphingosine 1-phosphate receptor 5 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201452 (CHEMBL807597) Binding affinity to human sphingosine 1-phosphate receptor 5 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201453 (CHEMBL807598) Binding affinity towards human sphingosine 1-phosphate receptor 5 expressed in CHO cells was determined by using [33P]-S1P as radioligand
ChEMBL_201455 (CHEMBL807600) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand
ChEMBL_304458 (CHEMBL832506) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 1 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand; partial agonist
ChEMBL_2055639 (CHEMBL4710640) Inhibition of recombinant SphK2 (unknown origin) using sphingosine as substrate by [gamma32P]-ATP based assay
ChEMBL_2251055 (CHEMBL5165265) Inhibition of SPHK2 (unknown origin) using sphingosine-fluorescein as substrate incubated for 1 hr in presence of ATP by mobility shift assay
ChEMBL_2251057 (CHEMBL5165267) Inhibition of SPHK1 (unknown origin) using sphingosine-fluorescein as substrate incubated for 1 hr in presence of ATP by mobility shift assay
Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 1 (S1P1) counterscreen assay Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P1_AG_BLA_384_3XEC50 Name: Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 1 (S1P1) counterscreen assay. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled rece
ChEMBL_855991 (CHEMBL2161992) Inhibition of human recombinant SphK2 using NBD-sphingosine as substrate after 2 hrs by HPLC analysis
ChEMBL_201320 (CHEMBL806170) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL_201328 (CHEMBL806177) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL_201445 (CHEMBL807591) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL_201457 (CHEMBL884095) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand (Experiment 2)
ChEMBL_201458 (CHEMBL807602) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells using [gamma-35S]-GTP as radioligand; Not determined
ChEMBL_304395 (CHEMBL830045) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 2 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL_304396 (CHEMBL830046) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 3 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL_304397 (CHEMBL830047) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 4 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL_304398 (CHEMBL830048) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand
ChEMBL_1875673 (CHEMBL4377067) Inhibition of human TRPC4 expressed in HEK293 cells assessed as reduction in sphingosine-1-phosphate-induced current at -100 mV by patch clamp assay
ChEMBL_1875674 (CHEMBL4377068) Inhibition of human TRPC4 expressed in HEK293 cells assessed as reduction in sphingosine-1-phosphate-induced current at +100 mV by patch clamp assay
ChEMBL_1300233 (CHEMBL3136697) Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins
ChEMBL_1300234 (CHEMBL3136698) Inhibition of recombinant SK1 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins
ChEMBL_1365138 (CHEMBL3292345) Competitive inhibition of human recombinant SphK1 using sphingosine and ATP as substrate by ADP-Quest kinase assay
ChEMBL_1365139 (CHEMBL3292346) Competitive inhibition of human recombinant SphK2 using sphingosine and ATP as substrate by ADP-Quest kinase assay
ChEMBL_1717750 (CHEMBL4132750) Inhibition of V5-His-tagged human SphK1 using sphingosine as substrate in presence of [gamma-32P]ATP
Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 2 (S1P2) counterscreen assay Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P2_AG_BLA_384_3XEC50 Name: Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 2 (S1P2) counterscreen assay. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled rece
Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 3 (S1P3) counterscreen assay Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P3_AG_BLA_384_3XEC50 Name: Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 3 (S1P3) counterscreen assay. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled rece
Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 5 (S1P5) counterscreen assay Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P5_AG_BLA_384_3XEC50 Name: Late-stage fluorescence-based dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Sphingosine 1-Phosphate Receptor 5 (S1P5) counterscreen assay. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled rece
ChEMBL_304459 (CHEMBL832507) In vitro binding affinity towards human Sphingosine 1-phosphate receptor 5 expressed in HEK293T cells was determined using [gamma-35S]-GTP as radioligand; partial agonist
ChEBML_1553858 Inhibition of human SK2 using D-erythro sphingosine as substrate and gamma[33P]ATP by Lineweaver-Burk plot analysis
ChEBML_1717751 Inhibition of recombinant human GST-tagged SphK1 using [3H]-sphingosine as substrate after 30 mins by scintillation counting method
ChEMBL_2161850 (CHEMBL5046711) Displacement of sphingosine D-erythro [3-3H] I- phosphate from human S1P2 receptor expressed in CHO cell membrane
ChEMBL_2354974 Inhibition of recombinant SphK2 (unknown origin) using sphingosine as substrate assessed as inhibition constant by Lineweaver-burk plot analysis
ChEBML_1683748 Inhibition of recombinant human SphK1 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method
ChEMBL_1553856 (CHEMBL3767370) Inhibition of recombinant SK2 (unknown origin) using sphingosine as substrate and gamma[32P]ATP by Lineweaver-Burk plot analysis
ChEMBL_1553857 (CHEMBL3767371) Inhibition of human SK1 using D-erythro sphingosine as substrate and gamma[33P]ATP by Lineweaver-Burk plot analysis
ChEMBL_1553858 (CHEMBL3767372) Inhibition of human SK2 using D-erythro sphingosine as substrate and gamma[33P]ATP by Lineweaver-Burk plot analysis
ChEMBL_1717751 (CHEMBL4132751) Inhibition of recombinant human GST-tagged SphK1 using [3H]-sphingosine as substrate after 30 mins by scintillation counting method
ChEMBL_2267127 Inhibition of recombinant SphK1 (unknown origin) using NBD-sphingosine as substrate in presence of ATP by fluorescence plate reader analysis
ChEMBL_2267128 Inhibition of recombinant SphK2 (unknown origin) using NBD-sphingosine as substrate in presence of ATP by fluorescence plate reader analysis
ChEMBL_522923 (CHEMBL995445) Inhibition of human cloned SPHK2 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot
ChEMBL_855992 (CHEMBL2161993) Inhibition of SphK2 using sphingosine as substrate and [32gammaP]ATP after 15 to 20 mins by Cerenkov counting analysis
ChEMBL_2267133 Inhibition of recombinant GST-tagged SphK1 (unknown origin) (1 to 384 residues) expressed in baculovirus using sphingosine as substrate incubated for 1 hr in presence of ATP by electrophoretic mobility shift assay
ChEMBL_2267134 Inhibition of recombinant GST-tagged SphK2 (unknown origin) (1 to 618 residues) expressed in baculovirus using sphingosine as substrate incubated for 1 hr in presence of ATP by electrophoretic mobility shift assay
ChEMBL_1700861 (CHEMBL4051843) Inhibition of recombinant human C-terminal His-tagged SPHK1 expressed in fall armyworm sf21 cells using sphingosine as substrate after 1 hr by FITC-based caliper assay
ChEMBL_1365140 (CHEMBL3292347) Competitive inhibition of C-terminal His6-tagged human recombinant SphK1 expressed in baculovirus-infected Sf9 cells using sphingosine as substrate
ChEMBL_522922 (CHEMBL995444) Inhibition of EGFP-fused human SPHK1 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot
ChEBML_1970806 Inhibition of recombinant full length GST-tagged human SPHK2 expressed in baculovirus expression system using Sphingosine lipid as substrate in presence of ATP after 1 hr by Adapta assay
ChEMBL_1583242 (CHEMBL3816960) Inhibition of GST-tagged full length human recombinant SPHK1 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay
ChEMBL_1583243 (CHEMBL3816961) Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay
ChEMBL_627326 (CHEMBL1108118) Antagonist activity at human S1P1 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL_627327 (CHEMBL1108119) Antagonist activity at human S1P3 receptor expressed in HEK293T cells assessed as inhibition of sphingosine-1-phosphate-induced gamma-[35S]GTP binding after 30 mins by scintillation counting
ChEMBL_1700863 (CHEMBL4051845) Inhibition of recombinant human SPHK1 expressed in Escherichia coli using [3-3H]sphingosine as substrate after 30 mins by scintillation counting
ChEMBL_1700864 (CHEMBL4051846) Inhibition of recombinant human SPHK2 expressed in Escherichia coli using [3-3H]sphingosine as substrate after 30 mins by scintillation counting
ChEMBL_2055640 (CHEMBL4710641) Inhibition of recombinant SphK2 (unknown origin) using sphingosine as substrate incubated for 15 to 20 mins by [gamma32P]-ATP based assay
Kinase Assay Sphingosine kinase activity was assessed as described previously (Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O'Neill, S. L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K., Tung, K. S. K., Engelhard, V. H., Macdonald, T. L. and Lynch, K. R. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biological Chemistry 280: 36865-36872 (2005)). High levels of human sphingosine kinase type 1 (mSK1) and mouse sphingosine kinase type 2 (mSK2) were expressed in Sf9 insect cells by infection with cognate baculoviruses. Crude homogenates were incubated with γ-[32P]ATP and 10 micromolar D-erythro-sphingosine in the presence of 100 micromolar concentrations of test compounds for 20 minutes at 37 C. The product, radiolabeled S1P, was isolated by extraction into organic solvents after acidification and displaced by thin layer chromatography.
ChEMBL_1683746 (CHEMBL4034225) Inhibition of recombinant N-terminal GST-tagged human SphK1 (1 to 384 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay
ChEMBL_1683747 (CHEMBL4034226) Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay
ChEMBL_1582612 (CHEMBL3817020) Inhibition of human SphK1 using sphingosine as substrate incubated for 50 mins by scintillation counting analysis in presence of [gamma-33P]ATP
ChEMBL_1582613 (CHEMBL3817021) Inhibition of human SphK2 using sphingosine as substrate incubated for 50 mins by scintillation counting analysis in presence of [gamma-33P]ATP
ChEMBL_1700849 (CHEMBL4051831) Inhibition of recombinant human SPHK1 using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting
ChEMBL_2055635 (CHEMBL4710636) Inhibition of recombinant human Flag-tagged SphK2 transfected in HEK293 cells using d-erythro-sphingosine as substrate by [gamma32P]-ATP based assay
ChEMBL_2055636 (CHEMBL4710637) Inhibition of recombinant human Flag-tagged SphK1 transfected in HEK293 cells using d-erythro-sphingosine as substrate by [gamma32P]-ATP based assay
ChEMBL_792465 (CHEMBL1929795) Inhibition of human SphK1 expressed in baculovirus infected Sf9 insect cells using sphingosine and [gamma-(32)P]-ATP by scintillation proximity assay
ChEMBL_792466 (CHEMBL1929796) Inhibition of mouse SphK2 expressed in baculovirus infected Sf9 insect cells using sphingosine and [gamma-(32)P]-ATP by scintillation proximity assay
ChEMBL_855989 (CHEMBL2161990) Inhibition of recombinant SphK1 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting
ChEMBL_855990 (CHEMBL2161991) Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting
ChEMBL_1582604 (CHEMBL3816945) Inhibition of human recombinant SphK1 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP
ChEMBL_1582605 (CHEMBL3816946) Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP
ChEMBL_1683756 (CHEMBL4034235) Inhibition of human SphK1 using sphingosine as substrate after 15 to 20 mins in presence of [gamma-32P]ATP by Cerenkov counting method
ChEMBL_1683757 (CHEMBL4034236) Inhibition of human SphK2 using sphingosine as substrate after 15 to 20 mins in presence of [gamma-32P]ATP by Cerenkov counting method
ChEMBL_1700850 (CHEMBL4051832) Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting
ChEMBL_957868 (CHEMBL2378981) Activation of recombinant GFP-tagged SK1 (unknown origin) expressed in HEK293 cells using sphingosine as substrate after 30 mins by Cerenkov counting analysis
ChEMBL_1660109 (CHEMBL4009721) Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in S1P formation using sphingosine as substrate after 1 hr by FITC-based caliper assay
ChEMBL_2055643 (CHEMBL4710644) Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay
ChEMBL_1443662 (CHEMBL3380135) Inhibition of His6 tagged human SphK1 expressed in Sf21 cells using FITC-sphingosine as substrate preincubated for 90 mins prior substrate addition by Caliper assay
ChEMBL_1580685 (CHEMBL3811131) Inhibition of human SphK1 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method
ChEMBL_1580686 (CHEMBL3811132) Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method
ChEMBL_2034879 (CHEMBL4689037) Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method
ChEMBL_2267117 Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells using d-erythro-sphingosine and [gamma-32P]ATP as substrate by liquid scintillation counting method
ChEMBL_2267118 Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells using d-erythro-sphingosine and [gamma-32P]ATP as substrate by liquid scintillation counting method
ChEMBL_1683750 (CHEMBL4034229) Inhibition of recombinant C-terminal His6-tagged human SphK1 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay
ChEMBL_1683751 (CHEMBL4034230) Inhibition of human recombinant C-terminal His6 tagged SphK2 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay
ChEBML_1683753 Inhibition of recombinant mouse SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate in presence of [gamma-33P]ATP by scintillation counting method
ChEMBL_1717752 (CHEMBL4132752) Inhibition of SphK1 (unknown origin) expressed in HEK293 cells using sphingosine as substrate after 30 mins in presence of [gamma-32P]ATP by Cerenkov counting method
ChEMBL_1474026 (CHEMBL3419997) Inhibition of human recombinant SphK1 expressed in Sf9 cells assessed as radiolabeled products using 5 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting
ChEMBL_1474027 (CHEMBL3419998) Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting
ChEMBL_1583238 (CHEMBL3816956) Inhibition of His-tagged full length human recombinant SPHK1 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay
ChEMBL_1583239 (CHEMBL3816957) Inhibition of His-tagged full length human recombinant SPHK2 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay
ChEMBL_1683752 (CHEMBL4034231) Inhibition of recombinant human SphK1 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate in presence of [gamma-33P]ATP by scintillation counting method
ChEMBL_1890503 (CHEMBL4392257) Inhibition of recombinant SK1 (unknown origin) expressed in Sf9 insect cells using D-erythro-sphingosine as substrate measured in presence of [gamma32P]ATP by scintillation proximity assay
ChEMBL_1890504 (CHEMBL4392258) Inhibition of recombinant SK2 (unknown origin) expressed in Sf9 insect cells using D-erythro-sphingosine as substrate measured in presence of [gamma32P]ATP by scintillation proximity assay
ChEMBL_2015690 (CHEMBL4669268) Inhibition of recombinant His6x-tagged human SphK1 expressed in HEK293 cells assessed as reduction in S1P formation using D-erythro-sphingosine as substrate by Western blot analysis
ChEMBL_1365135 (CHEMBL3292342) Competitive inhibition of V5-His-tagged human SphK2 expressed in HEK293 cells assessed as S1P production using sphingosine and [gamma-32P]ATP as substrate by thin layer chromatography
ChEMBL_2080390 (CHEMBL4736181) Inhibition of recombinant human N-terminal His-tagged Sphk2 (2 to 593 residues) expressed in Escherichia coli using varying level of sphingosine as substrate by ADP quest assay
ChEBML_1970498 Inhibition of recombinant full length human GST-tagged SPHK1 expressed in baculovirus expression system using sphingosine lipid as substrate incubated for 60 mins in presence of ATP by Adapta assay
ChEMBL_1553850 (CHEMBL3767364) Inhibition of recombinant His-tagged human SK1 assessed as production of [32P]-S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP
ChEMBL_1553854 (CHEMBL3767368) Inhibition of recombinant SK1 (unknown origin) expressed in Sf9 cells assessed as [33P]S1P formation using D-erythro sphingosine as substrate and gamma[33P]ATP by liquid scintillation counting
ChEMBL_1553855 (CHEMBL3767369) Inhibition of recombinant SK2 (unknown origin) expressed in Sf9 cells assessed as [33P]S1P formation using D-erythro sphingosine as substrate and gamma[33P]ATP by liquid scintillation counting
ChEMBL_2267123 Inhibition of recombinant human SphK1 expressed in Sf9 cells assessed as decrease in [33P]SIP production using d-erythro-sphingosine and [gamma-32P]ATP as substrate by scintillation counting method
ChEMBL_2267124 Inhibition of recombinant human SphK2 expressed in Sf9 cells assessed as decrease in [33P]SIP production using d-erythro-sphingosine and [gamma-32P]ATP as substrate by scintillation counting method
ChEMBL_2267125 Inhibition of recombinant mouse SphK1 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine and [gamma-32P]ATP as substrate incubated for 30 mins by liquid scintillation counting analysis
ChEMBL_2267126 Inhibition of recombinant mouse SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine and [gamma-32P]ATP as substrate incubated for 30 mins by liquid scintillation counting analysis
Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Hugh Rosen, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: 1 R03 MH076533-01 Grant Proposal PI: Germana Sanna, TSRI External Assay ID: S1P3_ANT_BLA_384_IC50 Name: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) Description: Sphingosine 1-phosphate (S1P) influences heart rate [1, 2], coronary artery caliber, endothelial integrity, lung epithelial integrity [3] and lymphocyte recirculation [1, 4-6] through five related high affinity G-protein coupled receptors [7, 8] which are involved in diverse biology. For example, S1P1 activation is sufficient to control lymphocyte numbers, with no discernable role in sinus rhythm control, whereas S1P3 regulates sinus rhythm but not lymphocyte recirculation.
Fluorescence-based counterscreen assay for S1P4 agonists: Cell-based dose response high throughput screening assay to identify agonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Center Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P1_AG_BLA_1536_3XEC50 Name: Fluorescence-based counterscreen assay for S1P4 agonists: Cell-based dose response high throughput screening assay to identify agonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-
Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P1_ANT_BLA_384_3XIC50 Name: Counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors
ChEBML_1683759 Inhibition of recombinant human SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence of gamma-[32P]ATP by autoradiography based TLC analysis
ChEMBL_1553851 (CHEMBL3767365) Inhibition of recombinant human SK2 assessed as production of [32P] S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP relative to control
ChEMBL_2055638 (CHEMBL4710639) Inhibition of recombinant human N-terminal His-tagged full length SphK2 expressed in baculovirus infected Sf9 cells using C17-sphingosine as substrate incubated for 2 hrs by ADQ Quest assay
ChEMBL_2253409 (CHEMBL5167619) Inhibition of recombinant mouse SphK2 transfected in HEK293T cells using D-erythro-sphingosine measured after 20 mins in presence of gamma-[p32]-ATP by autoradiography and liquid scintillation counting method
ChEMBL_1660110 (CHEMBL4009722) Inhibition of human C-terminal His6-tagged SPHK1 expressed in fall armyworm sf9 cells assessed as reduction in ADP formation using sphingosine as substrate preincubated for 15 mins followed by substrate addition after 1 hr by transcreener-based fluorescence polarization assay
ChEMBL_1683758 (CHEMBL4034237) Inhibition of recombinant human SphK1 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence of gamma-[32P]ATP by autoradiography based TLC analysis
ChEMBL_1683759 (CHEMBL4034238) Inhibition of recombinant human SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence of gamma-[32P]ATP by autoradiography based TLC analysis
Late stage fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized analogues Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P4_ANT_BLA_384_3XIC50_Synthesized_Analogues Name: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized analogues Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled recept
ChEMBL_1856902 (CHEMBL4357631) Inhibition of recombinant mouse SphK1 expressed in baculovirus infected Sf9 insect cells using D-erythro-sphingosine as substrate measured after 30 mins in presence of [gamma32P]-ATP by liquid scintillation counting method
ChEMBL_1856903 (CHEMBL4357632) Inhibition of recombinant mouse SphK2 expressed in baculovirus infected Sf9 insect cells using D-erythro-sphingosine as substrate measured after 30 mins in presence of [gamma32P]-ATP by liquid scintillation counting method
ChEMBL_2080389 (CHEMBL4736180) Competitive-inhibition of recombinant human C-terminal His6-tagged Sphk1 expressed in baculovirus infected Sf21 insect cells using varying levels of sphingosine as substrate measured after 30 mins by LC-MS analysis
ChEMBL_1660112 (CHEMBL4009724) Inhibition of SPHK1 in human MDA1483 cells using C17-sphingosine as substrate assessed as reduction in C17-S1P formation preincubated for 30 mins with substrate measured after 15 mins by LC-MS analysis
ChEMBL_1856901 (CHEMBL4357630) Inhibition of recombinant human His6/HA-fusion-tagged SphK2 expressed in baculovirus infected sf9 insect cells using d-erythro-sphingosine as substrate in presence of [gamma32P]-ATP and ATP by radioactivity-based assay
ChEMBL_2034878 (CHEMBL4689036) Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]SIP production using D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method
ChEMBL_2055637 (CHEMBL4710638) Competitive inhibition of recombinant human C-terminal His-tagged SphK1 expressed in baculovirus infected Sf21 cells using varying concentrations of FITC-sphingosine as substrate incubated for 30 mins by LC-MS/MS analysis
ChEMBL_2080383 (CHEMBL4736174) Inhibition of recombinant human Sphk1 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis
ChEMBL_2080384 (CHEMBL4736175) Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis
Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 2 (S1P2) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P2_ANT_BLA_384_3XIC50 Name: Counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 2 (S1P2) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors
Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P3_ANT_BLA_384_3XIC50 Name: Counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors
Late stage counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 5 (S1P5) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P5_ANT_BLA_384_3XIC50 Name: Counterscreen assay for S1P4 antagonists: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 5 (S1P5) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors
Late stage fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P4_ANT_BLA_384_3XIC50 Name: Fluorescence dose response cell-based screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors. Recently, modulation of S1P receptors lo
Late-stage fluorescence dose response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): purchased compounds EC50 Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P4_AG_BLA_384_3XEC50 Name: Late-stage fluorescence dose response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): purchased compounds EC50. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors. Recently, modulation of S1P receptor
Late-stage fluorescence dose response cell-based counterscreening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): inhibition by S1P4-selective antagonist Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRISMC) Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Probe Production Centers Network (MLPCN) Grant Proposal Number: U01 AI074564 Fast Track Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P4_AG_BLA_384_3XIC50_Antagonist Name: Late-stage fluorescence dose response cell-based counterscreening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): inhibition by S1P4-selective antagonist. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity
Late-stage fluorescence dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized compounds Source (MLSCN Center Name): The Scripps Research Institute Molecular Screening Center Center Affiliation: The Scripps Research Institute (TSRI) Assay Provider: Michael Oldstone, TSRI Network: Molecular Library Screening Center Network (MLSCN) Grant Proposal Number: U01 AI074564 Grant Proposal PI: Michael Oldstone, TSRI External Assay ID: S1P4_AG_BLA_384_3XEC50_SYNTHESIZED Name: Late-stage fluorescence dose-response cell-based assay to identify agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4): Synthesized compounds. Description: Pandemic influenza represents a significant public health threat, due in part to immune cell-mediated lung tissue damage induced during viral infection. Sphingosine 1-phosphate (S1P) is a bioactive phospholipid released by activated blood platelets and serves to influence endothelial integrity, lung epithelial integrity (1), and lymphocyte recirculation (2-5) through five related high affinity G-protein coupled receptors. Recently, modulation of S1P
ChEMBL_1660119 (CHEMBL4009731) Inhibition of SPHK1 in human whole-blood using C17-sphingosine as substrate assessed as reduction in C17-S1P production preincubated for 30 mins followed by substrate addition measured after 10 mins by MS analysis
ChEMBL_2251148 (CHEMBL5165358) Inhibition of recombinant SPHK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells using D-erythro-sphingosine as substrate incubated for 20 mins in presence of gamma-[32P]ATP by liquid scintillation counting method
ChEMBL_2251149 (CHEMBL5165359) Inhibition of recombinant SPHK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells using D-erythro-sphingosine as substrate incubated for 20 mins in presence of gamma-[32P]ATP by liquid scintillation counting method
ChEMBL_2267119 Inhibition of recombinant human C-terminus His-tagged SphK1 expressed in baculovirus infected Sf21 cells using FITC-sphingosine as substrate preincubated for 90 mins followed by substrate addition in presence of ATP by caliper fluorescent assay
ChEMBL_2267120 Inhibition of recombinant human C-terminus His-tagged SphK2 expressed in baculovirus infected Sf21 cells using FITC-sphingosine as substrate preincubated for 90 mins followed by substrate addition in presence of ATP by caliper fluorescent assay
ChEMBL_1856907 (CHEMBL4357636) Inhibition of recombinant human SphK1 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]SIP production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay
ChEMBL_1856910 (CHEMBL4357639) Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay
ChEMBL_1856900 (CHEMBL4357629) Inhibition of recombinant human C-terminal TEV cleavage site-fused-His6-tagged SphK1 expressed in baculovirus infected sf9 insect cells using d-erythro-sphingosine as substrate in presence of [gamma32P]-ATP and ATP by radioactivity-based assay
ChEMBL_2251143 (CHEMBL5165353) Inhibition of C-terminal His6-tagged human SPHK1 expressed in baculovirus infected Sf21 insect cells using FITC-sphingosine as substrate preincubated for 90 mins followed by substrate addition in presence of ATP by caliper mobility shift assay
Activity Assays The ability of the sphingo sine analogs presented herein to kill Pseudomonas aeruginosa in vitro, and based on the data shown below, concluded that the SPH analogs presented herein are highly efficient in killing bacteria. Compounds 791598 and 791577 were used as activity assay control references. To determine whether the sphingosine analogs presented herein can be metabolized by ceramide synthases (CerS natural sphingosine is a substrate for CerS), their N-acylation using 14C labeled CoA as a substrate was examined. The results confirmed that neither 791995 nor 791996 could be N-acylated, demonstrating that these SPH analogs are not substrates for CerS, and indicating that there is no concern that N-acylation might be an off-target effect (raw data and results not shown).
S1P Receptor Binding Assay The assay measures the displacement of [33P]-labeled sphingosine-1-phosphate (S1P) by test compounds from human S1P receptors expressed on CHO cell membranes. Binding was performed for 60 min at room temperature and terminated by collecting the membranes onto GF/B filter plates with a Packard Filtermate Universal Harvester. Filter bound radionuclide was measured on a PerkinElmer 1450 MicroBeta. Specific binding was calculated by subtracting radioactivity that remained in the presence of 1000-fold excess of unlabeled S1P.
Assay 1 Assay 1 ...